{\rtf1\adeflang1025\ansi\ansicpg10000\uc1\adeff0\deff0\stshfdbch0\stshfloch0\stshfhich0\stshfbi0\deflang1033\deflangfe1033\themelang1033\themelangfe0\themelangcs0{\fonttbl{\f0\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f1\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Arial;}{\f2\fbidi \fnil\fcharset0\fprq2{\*\panose 02070309020205020404}Courier New{\*\falt Courier};}{\f6\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Courier;}{\f6\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Courier;}{\flomajor\f31500\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Arial;}{\fdbmajor\f31501\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e;}{\fhimajor\f31502\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0502020204030204}Calibri;}{\fbimajor\f31503\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\flominor\f31504\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\fdbminor\f31505\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9;}{\fhiminor\f31506\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050406030204}Cambria;}{\fbiminor\f31507\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f831\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\f832\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\f834\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\f835\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\f836\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\f837\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\f838\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\f839\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}{\f841\fbidi \fnil\fcharset238\fprq2 Arial CE;}{\f842\fbidi \fnil\fcharset204\fprq2 Arial Cyr;}{\f844\fbidi \fnil\fcharset161\fprq2 Arial Greek;}{\f845\fbidi \fnil\fcharset162\fprq2 Arial Tur;}{\f846\fbidi \fnil\fcharset177\fprq2 Arial (Hebrew);}{\f847\fbidi \fnil\fcharset178\fprq2 Arial (Arabid);}{\f848\fbidi \fnil\fcharset186\fprq2 Arial Baltic;}{\f849\fbidi \fnil\fcharset163\fprq2 Arial (Vietnamese);}{\f851\fbidi \fnil\fcharset238\fprq2 Courier CE{\*\falt Courier};}{\f852\fbidi \fnil\fcharset204\fprq2 Courier Cyr{\*\falt Courier};}{\f854\fbidi \fnil\fcharset161\fprq2 Courier Greek{\*\falt Courier};}{\f855\fbidi \fnil\fcharset162\fprq2 Courier Tur{\*\falt Courier};}{\f856\fbidi \fnil\fcharset177\fprq2 Courier (Hebrew){\*\falt Courier};}{\f857\fbidi \fnil\fcharset178\fprq2 Courier (Arabid){\*\falt Courier};}{\f858\fbidi \fnil\fcharset186\fprq2 Courier Baltic{\*\falt Courier};}{\f859\fbidi \fnil\fcharset163\fprq2 Courier (Vietnamese){\*\falt Courier};}{\flomajor\f31508\fbidi \fnil\fcharset238\fprq2 Arial CE;}{\flomajor\f31509\fbidi \fnil\fcharset204\fprq2 Arial Cyr;}{\flomajor\f31511\fbidi \fnil\fcharset161\fprq2 Arial Greek;}{\flomajor\f31512\fbidi \fnil\fcharset162\fprq2 Arial Tur;}{\flomajor\f31513\fbidi \fnil\fcharset177\fprq2 Arial (Hebrew);}{\flomajor\f31514\fbidi \fnil\fcharset178\fprq2 Arial (Arabid);}{\flomajor\f31515\fbidi \fnil\fcharset186\fprq2 Arial Baltic;}{\flomajor\f31516\fbidi \fnil\fcharset163\fprq2 Arial (Vietnamese);}{\fdbmajor\f31520\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\fdbmajor\f31518\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\fdbmajor\f31519\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\fdbmajor\f31521\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\fdbmajor\f31522\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\fdbmajor\f31525\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\fhimajor\f31528\fbidi \fnil\fcharset238\fprq2 Calibri CE;}{\fhimajor\f31529\fbidi \fnil\fcharset204\fprq2 Calibri Cyr;}{\fhimajor\f31531\fbidi \fnil\fcharset161\fprq2 Calibri Greek;}{\fhimajor\f31532\fbidi \fnil\fcharset162\fprq2 Calibri Tur;}{\fhimajor\f31535\fbidi \fnil\fcharset186\fprq2 Calibri Baltic;}{\fhimajor\f31536\fbidi \fnil\fcharset163\fprq2 Calibri (Vietnamese);}{\fbimajor\f31538\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\fbimajor\f31539\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\fbimajor\f31541\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\fbimajor\f31542\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\fbimajor\f31543\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\fbimajor\f31544\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\fbimajor\f31545\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\fbimajor\f31546\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}{\flominor\f31548\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\flominor\f31549\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\flominor\f31551\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\flominor\f31552\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\flominor\f31553\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\flominor\f31554\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\flominor\f31555\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\flominor\f31556\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}{\fdbminor\f31560\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Western;}{\fdbminor\f31558\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 CE;}{\fdbminor\f31559\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Cyr;}{\fdbminor\f31561\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Greek;}{\fdbminor\f31562\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Tur;}{\fdbminor\f31565\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Baltic;}{\fhiminor\f31568\fbidi \fnil\fcharset238\fprq2 Cambria CE;}{\fhiminor\f31569\fbidi \fnil\fcharset204\fprq2 Cambria Cyr;}{\fhiminor\f31571\fbidi \fnil\fcharset161\fprq2 Cambria Greek;}{\fhiminor\f31572\fbidi \fnil\fcharset162\fprq2 Cambria Tur;}{\fhiminor\f31575\fbidi \fnil\fcharset186\fprq2 Cambria Baltic;}{\fhiminor\f31576\fbidi \fnil\fcharset163\fprq2 Cambria (Vietnamese);}{\fbiminor\f31578\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\fbiminor\f31579\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\fbiminor\f31581\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\fbiminor\f31582\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\fbiminor\f31583\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\fbiminor\f31584\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\fbiminor\f31585\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\fbiminor\f31586\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}}{\colortbl;\red0\green0\blue0;\red0\green0\blue255;\red0\green255\blue255;\red0\green255\blue0;\red255\green0\blue255;\red255\green0\blue0;\red255\green255\blue0;\red255\green255\blue255;\red0\green0\blue128;\red0\green128\blue128;\red0\green128\blue0;\red128\green0\blue128;\red128\green0\blue0;\red128\green128\blue0;\red128\green128\blue128;\red192\green192\blue192;\red235\green235\blue216;\red204\green0\blue51;}{\*\defchp }{\*\defpap \ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 }\noqfpromote {\stylesheet{\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 \snext0 \sqformat \spriority0 Normal;}{\*\cs10 \additive \ssemihidden \sunhideused \spriority1 Default Paragraph Font;}{\*\ts11\tsrowd\trftsWidthB3\trpaddl108\trpaddr108\trpaddfl3\trpaddft3\trpaddfb3\trpaddfr3\tblind0\tblindtype3\tsvertalt\tsbrdrt\tsbrdrl\tsbrdrb\tsbrdrr\tsbrdrdgl\tsbrdrdgr\tsbrdrh\tsbrdrv \ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 \snext11 \ssemihidden \sunhideused Normal Table;}}{\*\revtbl {Unknown;}}{\*\rsidtbl \rsid1384955\rsid7698271\rsid8980100}{\mmathPr\mmathFont34\mbrkBin0\mbrkBinSub0\msmallFrac0\mdispDef1\mlMargin0\mrMargin0\mdefJc1\mwrapIndent1440\mintLim0\mnaryLim1}{\info{\author Duco Wiertsema}{\operator Duco Wiertsema}{\creatim\yr2013\mo11\dy26\hr12\min14}{\revtim\yr2013\mo11\dy26\hr12\min14}{\version2}{\edmins3}{\nofpages105}{\nofwords46899}{\nofchars267327}{\nofcharsws313599}{\vern49555}{\*\saveprevpict}}{\*\xmlnstbl {\xmlns1 http://schemas.microsoft.com/office/word/2003/wordml}}\paperw12240\paperh15840\margl1296\margr1296\margt1728\margb1296\gutter0\ltrsect \ftnbj\aenddoc\trackmoves0\trackformatting1\donotembedsysfont0\relyonvml0\donotembedlingdata1\grfdocevents0\validatexml0\showplaceholdtext0\ignoremixedcontent0\saveinvalidxml0\showxmlerrors0\hyphauto1\horzdoc\dghspace120\dgvspace120\dghorigin1701\dgvorigin1984\dghshow0\dgvshow3\jcompress\viewkind1\viewscale140\rsidroot1384955\outdisponlyhtml \fet0{\*\wgrffmtfilter 2450}\ilfomacatclnup0{\*\ftnsep \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid7698271 \chftnsep \par }}{\*\ftnsepc \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid7698271 \chftnsepc \par }}{\*\aftnsep \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid7698271 \chftnsep \par }}{\*\aftnsepc \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid7698271 \chftnsepc \par }}\ltrpar \sectd \ltrsect\linex0\sectdefaultcl\sftnbj {\*\pnseclvl1\pnucrm\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl2\pnucltr\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl3\pndec\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl4\pnlcltr\pnstart1\pnindent720\pnhang {\pntxta )}}{\*\pnseclvl5\pndec\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl6\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl7\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl8\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl9\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 {\*\shppict{\pict{\*\picprop\shplid1025{\sp{\sn shapeType}{\sv 75}}{\sp{\sn fFlipH}{\sv 0}}{\sp{\sn fFlipV}{\sv 0}}{\sp{\sn fLine}{\sv 0}}{\sp{\sn fLayoutInCell}{\sv 1}}}\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw2787\pich847\picwgoal1580\pichgoal480\pngblip\bliptag833577996 89504e470d0a1a0a0000000d494844520000004f0000001808030000008c6150fb00000300504c5445ffffff231f205a5758c8c7c7918f8f312d2ef1f1f14c494ad6d5d5767374acabab3f3b3ce3e3e3848182bab9b96865669e9d9d0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000009b312fed0000000174524e530040e6d8660000023c4944415478daad54898edd200cb4b921e7ff7f65aba6ab94cdb1c6405ef2b24fea766b450a8719b0676c400b679328e02f4c6a0c9fef20fa7fc053f8c28f56e7005f3603605fbd0fd17df97d1046f3028e5f1f0fbc0d37f886d16b022c08ffcb086f5510fd3720a47b0a38500ac75bfe7a2f84f03d0fc9a192e610bbe4862ae7d1260244da3583108e13d8d192bce2b98684a4ba066dba9d1c749b89b5ec50f13c364186265d015e0d83cd8488c3bfe0399d81e8b84e44daaa378fd63cf064de357c5848e17df652c4c9fb4900665d00671ac45d2d0bfdb5823d018cf3490b002dac6916e594ee34ed9f2de3c5c4897cf86d0bb839ef10105d3e1161ab03f713fc7c4afe2fd0fce7b515d0628e170e4e72bc94bcbe1c190b5794c2a66d0a0b355e81b7322e789513c633343607e1a5c029851a07b8e00d89dbfe5aff65100947862876dc01d287d9f40aebce4cecdb66ded722db1d04d511a669d48d89273dd796f1c449b1778a930713f1bd3dedcf2cbc65fadddde2658de0c0f15234f70a4cdb87d80f3d831b450a43ddf19813918eb4a7fc1d12b248ea7ee2a3a886526b3fc1634ef809fac16fb58136dc5147173cd2f303e512992878fed67e3bae046acb5c104f7874cedef8289ce4eb49c5e10834a56202491c52635bceada82d13ffc0b9669e922e6a2a4b0369909773036a752d5cfe75dc0848f3a5fa6f7804946f0a74500fca37a8fb949f2ae4beca9ef18888a653d4338e2aa1e5e50a086ff925b8a501ba2542ff06a22a769ca0fd01ed0c7bd272bfc70861e37ec0f6019a0662fb16f1f5ff0000000049454e44ae426082}}{\nonshppict{\pict\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw79\pich24\picwgoal1580\pichgoal480\macpict\bliptag833577996 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000018004f001102ff0c00fffe00000048000000480000000000000018004f00000000001e0001000a000000000018004f820000001e3a00000001000000000000000000000000000000010000000000000000000000000000400000000000000000000000000000000000000000000018004f000003000000000000000056726177200000000000000000000000006170706c0000040000000400004f0018004800000048000000001da0000100000000000000000000000000000000000000000000000000000000000000000020ffffff231f20ff4c494a00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff312d2eff231f20ffacabab00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f20ff76737400ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff918f8fff231f20ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f20ff231f20ffacabab00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffacababff231f20ff231f20ff76737400ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f20ff231f20ff231f20ffd6d5d500ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffacababff9e9d9dfff1f1f100ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f20ff231f20ff231f20ff312d2efff1f1f100ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f20ff3f3b3cff231f20ff231f20ff4c494a00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f20ffd6d5d5ff312d2eff231f20ff231f20ff76737400ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ffd6d5d500ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffffffacababff231f20ff231f20ff231f20ff9e9d9d00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffbab9b9ff767374ff5a5758ff5a5758ff5a5758ff767374ffbab9b900ffffff00ffffff00ffffff00ffffffffbab9b9ff231f20ff231f20ff231f20ffacabab00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffd6d5d5ff231f20ff231f20ff84818200ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffff00ffffffffacababff4c494aff231f20ff231f20ff231f20ff231f20ff5a5758ffacabab00ffffff00ffffff00fffffffff1f1f1ff686566ff5a5758ff5a5758ffd6d5d5ff231f20ff231f2000ffffff00ffffffff848182ff231f20ff231f20ff231f20ffc8c7c700ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffffffd6d5d5ff3f3b3cff231f20ff231f20ff767374ff918f8fff848182ff3f3b3cff231f20ff4c494affd6d5d500ffffff00ffffff00ffffffff848182ff231f20ff231f20ff312d2effe3e3e300ffffff00ffffff00ffffff00ffffff00fffffffff1f1f1ff4c494aff231f20ff5a575800ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffffff767374ff231f20ff3f3b3cffacababffc8c7c7ffacababff3f3b3cff231f20ff84818200ffffff00ffffff00ffffffff767374ff918f8fff686566ff686566ff4c494aff231f20ff231f2000ffffff00ffffff00ffffffff5a5758ff231f20ff231f20ff312d2effe3e3e300ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffff00ffffffffd6d5d5ff312d2eff231f20ff4c494affd6d5d500ffffff00ffffff00fffffffff1f1f1ff4c494aff231f20ff312d2efff1f1f100ffffff00ffffff00ffffffff4c494aff231f20ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffffff767374ff231f20ff4c494afff1f1f100ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffffc8c7c7ff231f20ff312d2efff1f1f100ffffff00ffffff00fffffffff1f1f1ff312d2effe3e3e300ffffff00ffffff00ffffffff5a5758ffc8c7c7ff5a5758ff767374ff767374ff231f20ff231f2000ffffff00ffffff00fffffffff1f1f1ff3f3b3cff231f20ff231f20ff4c494afff1f1f100ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00fffffffff1f1f1ff312d2eff231f20ff231f20ffd6d5d500ffffff00ffffff00ffffff00ffffff00fffffffff1f1f1ff312d2eff231f20ff5a575800ffffff00ffffff00ffffffffe3e3e3ff312d2eff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffff9e9d9dff231f20ff312d2effd6d5d500ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffff686566ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffffffd6d5d500ffffff00ffffff00ffffff00ffffffff767374ff767374ffbab9b9ff5a5758ff4c494aff231f20ff231f2000ffffff00ffffff00ffffff00ffffffffd6d5d5ff312d2eff231f20ff231f20ff76737400ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffffff918f8fff231f20ff231f20ff76737400ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff767374ff231f20ff231f20ffe3e3e300ffffff00ffffff00ffffffffbab9b9ff231f20ff231f20ff231f20ffd6d5d500ffffffffd6d5d5ff231f20ff231f20ffbab9b900ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffff5a5758ff231f20ff4c494a00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00fffffffff1f1f1ff767374ff686566ff767374ffd6d5d5ff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffffffacababff231f20ff231f20ff231f20ff9e9d9d00ffffff00ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffff00ffffffff3f3b3cff231f20ff231f20ffbab9b900ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff9e9d9dff231f20ff231f20ff9e9d9d00ffffff00ffffff00ffffff00ffffffff848182ff231f20ff231f20ff3f3b3cffe3e3e3ff3f3b3cff231f20ff918f8f00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffff5a5758ff231f20ff231f20ffacabab00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff848182ff231f20ff231f20ff231f20ffc8c7c700ffffff00ffffffffc8c7c7ff231f20ff5a575800ffffff00fffffffff1f1f1ff231f20ff231f20ff231f20fff1f1f100ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff76737400ffffff00ffffff00ffffff00ffffff00ffffffff4c494aff231f20ff231f20ff312d2eff231f20ff68656600ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffff686566ff231f20ff231f20ff231f20ff5a5758ffbab9b900ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff5a5758ff231f20ff231f20ff312d2effe3e3e300ffffffffc8c7c7ff231f20ff5a575800ffffff00ffffffffc8c7c7ff231f20ff231f20ff231f20ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff4c494aff231f20ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffffffe3e3e3ff312d2eff231f20ff231f20ff4c494afff1f1f100ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffffd6d5d5ff231f20ff231f20ff231f20ff231f20ff231f20ff312d2eff848182ffe3e3e300ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00fffffffff1f1f1ff3f3b3cff231f20ff231f20ff4c494afff1f1f1ffc8c7c7ff231f20ff5a575800ffffff00ffffffffc8c7c7ff231f20ff231f20ff231f20ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff5a5758ff84818200ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff848182ff231f20ff231f20ff312d2effe3e3e300ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffffffc8c7c7ff3f3b3cff231f20ff231f20ff231f20ff231f20ff231f20ff231f20ff84818200ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffd6d5d5ff312d2eff231f20ff231f20ff686566ffc8c7c7ff231f20ff5a575800ffffff00ffffffffc8c7c7ff231f20ff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffd6d5d5ff312d2eff231f20ff231f20ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffd6d5d5ff9e9d9dff5a5758ff231f20ff231f20ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffacababff231f20ff231f20ff231f20ff5a5758ff231f20ff5a575800ffffff00ffffffffe3e3e3ff231f20ff231f20ff231f20fff1f1f100ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00fffffffff1f1f1ff4c494aff231f20ff848182ff3f3b3cff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffe3e3e3ff4c494aff231f20ff231f20ff4c494a00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff848182ff231f20ff231f20ff231f20ff231f20ff5a575800ffffff00ffffff00ffffffff312d2eff231f20ff231f20ffbab9b900ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff686566ff231f20ff5a575800ffffffffd6d5d5ff231f20ff231f20ff231f20ffc8c7c700ffffff00ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00fffffffff1f1f1ff312d2eff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff5a5758ff231f20ff231f20ff231f20ff5a575800ffffff00ffffff00ffffffff767374ff231f20ff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff848182ff231f20ff312d2efff1f1f100ffffff00ffffffff918f8fff231f20ff231f20ff312d2efff1f1f100ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff5a5758ff231f20ff4c494a00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00fffffffff1f1f1ff3f3b3cff231f20ff231f20ff5a575800ffffff00ffffff00ffffffffe3e3e3ff312d2eff231f20ff231f20ffacabab00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00fffffffff1f1f1ff4c494a00ffffff00ffffff00ffffffffacababff231f20ff231f20ffd6d5d500ffffff00ffffff00ffffff00ffffffff5a5758ff231f20ff231f20ff68656600ffffff00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffffe3e3e3ff76737400ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff3f3b3cff231f20ff76737400ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffd6d5d5ff312d2eff231f20ff5a575800ffffff00ffffff00ffffff00ffffffffacababff231f20ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffff00ffffff00ffffffffacababff3f3b3cff231f2000ffffff00ffffffffd6d5d5ff312d2eff231f20ff9e9d9d00ffffff00ffffff00ffffff00ffffff00ffffffffe3e3e3ff312d2eff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffff848182ff231f20ff84818200ffffff00ffffff00ffffff00ffffffff9e9d9dff231f20ff312d2effe3e3e300ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff231f20ff231f2000ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffacababff231f20ff5a575800ffffff00ffffff00ffffff00ffffff00ffffffffacababff312d2eff231f20ff231f20ff312d2eff686566ff918f8fff767374ff3f3b3cff231f20ff312d2effbab9b900fffffffff1f1f1ff312d2eff231f20ff68656600ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffbab9b9ff231f20ff231f20ff231f20ffc8c7c700ffffff00ffffffffc8c7c7ff231f20ff231f20ff918f8f00ffffff00ffffff00ffffffff4c494aff231f20ff231f20ff3f3b3cff848182ff918f8fff4c494aff231f20ff312d2effacabab00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff918f8fff918f8f00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffacababffacabab00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffffe3e3e3ff848182ff3f3b3cff231f20ff231f20ff231f20ff231f20ff5a5758ffacababfff1f1f100ffffff00ffffffffbab9b9ff918f8fff918f8ffff1f1f100ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffffff9e9d9dff918f8fff918f8fff9e9d9d00ffffff00ffffffffe3e3e3ff918f8fff918f8fffc8c7c700ffffff00ffffff00ffffff00ffffffffbab9b9ff848182ff4c494aff231f20ff231f20ff3f3b3cff767374ffe3e3e300ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff00ffffff000700ae00700007000100010003000300040000000d000c0010004f004f00ba00ba00280007001110517569636b54696d65aa20616e642061000028000c00140d206465636f6d70726573736f720028001100001f617265206e656564656420746f20736565207468697320706963747572652e000000a100e007ac00000000000007a86170706c022000006d6e74725247422058595a2007d900020019000b001a000b616373704150504c000000006170706c000000000000000000000000000000000000f6d6000100000000d32d6170706c00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000b64657363000001080000006f6473636d000001780000056c63707274000006e400000038777470740000071c000000147258595a00000730000000146758595a00000744000000146258595a0000075800000014725452430000076c0000000e636861640000077c0000002c625452430000076c0000000e675452430000076c0000000e64657363000000000000001447656e65726963205247422050726f66696c6500000000000000000000001447656e65726963205247422050726f66696c6500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000006d6c7563000000000000001e0000000c736b534b00000028000001786872485200000028000001a06361455300000024000001c87074425200000026000001ec756b55410000002a0000021266724655000000280000023c7a685457000000160000026469744954000000280000027a6e624e4f00000026000002a26b6f4b5200000016000002c86373435a00000022000002de6865494c0000001e00000300646544450000002c0000031e68754855000000280000034a7376534500000026000002a27a68434e00000016000003726a614a500000001a00000388726f524f00000024000003a2656c475200000022000003c67074504f00000026000003e86e6c4e4c000000280000040e6573455300000026000003e874685448000000240000043674725452000000220000045a66694649000000280000047c706c504c0000002c000004a47275525500000022000004d06172454700000026000004f2656e555300000026000005186461444b0000002e0000053e005601610065006f006200650063006e00fd0020005200470042002000700072006f00660069006c00470065006e006500720069010d006b00690020005200470042002000700072006f00660069006c00500065007200660069006c0020005200470042002000670065006e00e800720069006300500065007200660069006c0020005200470042002000470065006e00e9007200690063006f0417043004330430043b044c043d043804390020043f0440043e044404300439043b002000520047004200500072006f00660069006c0020006700e9006e00e9007200690071007500650020005200560042901a75280020005200470042002082725f6963cf8ff000500072006f00660069006c006f0020005200470042002000670065006e0065007200690063006f00470065006e0065007200690073006b0020005200470042002d00700072006f00660069006cc77cbc1800200052004700420020d504b85cd30cc77c004f006200650063006e00fd0020005200470042002000700072006f00660069006c05e405e805d505e405d905dc0020005200470042002005db05dc05dc05d90041006c006c00670065006d00650069006e006500730020005200470042002d00500072006f00660069006c00c1006c00740061006c00e1006e006f00730020005200470042002000700072006f00660069006c666e901a0020005200470042002063cf8ff065874ef64e00822c0020005200470042002030d730ed30d530a130a430eb00500072006f00660069006c0020005200470042002000670065006e0065007200690063039303b503bd03b903ba03cc002003c003c103bf03c603af03bb002000520047004200500065007200660069006c0020005200470042002000670065006e00e9007200690063006f0041006c00670065006d00650065006e0020005200470042002d00700072006f006600690065006c0e420e1b0e230e440e1f0e250e4c002000520047004200200e170e310e480e270e440e1b00470065006e0065006c0020005200470042002000500072006f00660069006c00690059006c00650069006e0065006e0020005200470042002d00700072006f006600690069006c00690055006e006900770065007200730061006c006e0079002000700072006f00660069006c0020005200470042041e04310449043804390020043f0440043e04440438043b044c00200052004700420645064406410020062a06390631064a0641002000520047004200200627064406390627064500470065006e00650072006900630020005200470042002000500072006f00660069006c006500470065006e006500720065006c0020005200470042002d006200650073006b0072006900760065006c007300657465787400000000436f707972696768742032303037204170706c6520496e632e2c20616c6c207269676874732072657365727665642e0058595a20000000000000f35200010000000116cf58595a20000000000000744d00003dee000003d058595a200000000000005a750000ac730000173458595a20000000000000281a0000159f0000b83663757276000000000000000101cd0000736633320000000000010c42000005defffff326000007920000fd91fffffba2fffffda3000003dc0000c06c00a100e000040000000200ff}}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 \par \par \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 Download Request: All Documents: 1-29\par Time Of Request: Tuesday, November 26, 2013  11:58:21\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 Send To:\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 UNIVERSITEIT VAN AMSTERDAM\par POSTBUS 19185\par AMSTERDAM, NLD 1000 GD\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 \par \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 Terms: ((Cipla AND WTO) and Date(geq(01/01/2003) and leq(01/01/2011)))\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 \par \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 Source: Major World Publications (English)\par Project ID: \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af2 \ltrch\fcs0 \f2\insrsid1384955 \par \sect }\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\ltrrow\trowd \irow0\irowband0\ltrrow\ts11\trgaph60\trleft-60\trhdr\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth540\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth9180\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx9660\pard\plain \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_1_0}{\*\bkmkstart cite_id_1}{\*\bkmkend DOC_ID_1_0}{\*\bkmkend cite_id_1} \cell Results\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\ltrrow\ts11\trgaph60\trleft-60\trhdr\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth540\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth9180\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx9660\row \ltrrow}\trowd \irow1\irowband1\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 1.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_1"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Uganda;  Bill Shouldn't Block Generics, Minister Agrees}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   Africa News, April 29, 2010 Thursday, 875 words, Inter Press Service (Johannesburg)\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow1\irowband1\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_2_0}{\*\bkmkstart cite_id_2}{\*\bkmkend DOC_ID_2_0}{\*\bkmkend cite_id_2}2.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_2"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Bill Shouldn't Block Generics, Minister Agrees}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   Inter Press Service (Johannesburg), April 29, 2010 Thursday, 875  words, Wambi Michael\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_3_0}{\*\bkmkstart cite_id_3}{\*\bkmkend DOC_ID_3_0}{\*\bkmkend cite_id_3}3.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_3"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Uganda;  Counterfeits Bill Threatens Access to Medicine}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   Africa News, November 6, 2009 Friday, 1120 words, Inter Press Service (Johannesburg)\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_4_0}{\*\bkmkstart cite_id_4}{\*\bkmkend DOC_ID_4_0}{\*\bkmkend cite_id_4}4.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_4"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Land ofdiscovery INTRODUCTION: India is pushing into fresh territory by evolving from a commodity-driven drug market into a research-driven development center. But challenges abound}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   ICIS Chemical Business, July 7, 2008, FEATURES, 1509  words, Feliza Mirasol\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_5_0}{\*\bkmkstart cite_id_5}{\*\bkmkend DOC_ID_5_0}{\*\bkmkend cite_id_5}5.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_5"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Land ofdiscovery PARA:: INTRODUCTION:: PARA:: India is pushing into fresh territory by evolving from a commodity-driven drug market into a research-driven development center. But challenges abound PARA::}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   ICIS Chemical Business, July 7, 2008, FEATURES, 1558  words, Feliza Mirasol\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_6_0}{\*\bkmkstart cite_id_6}{\*\bkmkend DOC_ID_6_0}{\*\bkmkend cite_id_6}6.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_6"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Uganda;  $10m HIV Drugs Ordered From New Factory}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   Africa News, January 28, 2008 Monday, 719 words, East African Business Week\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_7_0}{\*\bkmkstart cite_id_7}{\*\bkmkend DOC_ID_7_0}{\*\bkmkend cite_id_7}7.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_7"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Uganda;  New Factory to Improve Access to Arvs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   Africa News, October 24, 2007 Wednesday, 753 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_8_0}{\*\bkmkstart cite_id_8}{\*\bkmkend DOC_ID_8_0}{\*\bkmkend cite_id_8}8.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_8"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Africa;  Daily HIV/Aids Report}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   Africa News, October 9, 2007 Tuesday, 3231 words, Kaisernetwork.org\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_9_0}{\*\bkmkstart cite_id_9}{\*\bkmkend DOC_ID_9_0}{\*\bkmkend cite_id_9}9.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_9"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Uganda;  Country to Begin Producing ARVs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   Africa News, September 21, 2007 Friday, 371 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_10_0}{\*\bkmkstart cite_id_10}{\*\bkmkend DOC_ID_10_0}{\*\bkmkend cite_id_10}10.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_10"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Uganda;  Quality Courts Cipla for Drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   Africa News, April 3, 2007 Tuesday, 591 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_11_0}{\*\bkmkstart cite_id_11}{\*\bkmkend DOC_ID_11_0}{\*\bkmkend cite_id_11}11.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_11"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Indian pharma firms go shopping abroad;  They are acquiring Western companies to overcome the restrictions of a new patent regime}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   The Business Times Singapore, May 25, 2006 Thursday, VIEWS AND OPINIONS; BT Comment Others, 1125  words, Yogi Aggarwal\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_12_0}{\*\bkmkstart cite_id_12}{\*\bkmkend DOC_ID_12_0}{\*\bkmkend cite_id_12}12.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_12"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 U.S. pushes to limit generic drug rights;  Agreements seek to extend monopolies in exchange for improvements in trade}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   The International Herald Tribune, April 19, 2006 Wednesday, NEWS; Pg. 1, 1610 words, Anand Giridharadas\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_13_0}{\*\bkmkstart cite_id_13}{\*\bkmkend DOC_ID_13_0}{\*\bkmkend cite_id_13}13.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_13"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 U.S. pushes to limit generic-drug rights in trade pacts}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   The International Herald Tribune, April 19, 2006 Wednesday, FINANCE; Pg. 13, 1381 words, Anand Giridharadas\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_14_0}{\*\bkmkstart cite_id_14}{\*\bkmkend DOC_ID_14_0}{\*\bkmkend cite_id_14}14.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_14"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 HIV-Aids and STDs; Global Aids Treatment Drive Takes Off}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  Africa News, April 28, 2005 Thursday, 3207 words, Africa Renewal\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_15_0}{\*\bkmkstart cite_id_15}{\*\bkmkend DOC_ID_15_0}{\*\bkmkend cite_id_15}15.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_15"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Is it the end of cheap drugs from India?; Medicine prices may soar in a few years as the country can no longer make generic drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  The Business Times Singapore, April 12, 2005 Tuesday, VIEWS AND OPINIONS; BT Comment Others, 1347 words, Yogi Aggarwal\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_16_0}{\*\bkmkstart cite_id_16}{\*\bkmkend DOC_ID_16_0}{\*\bkmkend cite_id_16}16.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_16"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 PanAfrica; New Law in India Drives Up Africa's Cost of Halting Aids}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  Africa News, March 29, 2005 Tuesday, 752 words, Business Day\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_17_0}{\*\bkmkstart cite_id_17}{\*\bkmkend DOC_ID_17_0}{\*\bkmkend cite_id_17}17.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_17"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Zambia; India's Cheap Medicines}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  Africa News, March 29, 2005 Tuesday, 776 words, The Post\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_18_0}{\*\bkmkstart cite_id_18}{\*\bkmkend DOC_ID_18_0}{\*\bkmkend cite_id_18}18.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_18"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 PanAfrica; Goodbye to Cheap Indian Aids Drugs?}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  Africa News, November 26, 2004 Friday, 1225 words, Inter Press Service\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_19_0}{\*\bkmkstart cite_id_19}{\*\bkmkend DOC_ID_19_0}{\*\bkmkend cite_id_19}19.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_19"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 PanAfrica; Daily HIV/Aids Report}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  Africa News, July 13, 2004 Tuesday, 11362 words, Kaisernetwork.org\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_20_0}{\*\bkmkstart cite_id_20}{\*\bkmkend DOC_ID_20_0}{\*\bkmkend cite_id_20}20.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_20"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 AIDS; Daily HIV/Aids Report}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  Africa News, July 7, 2004 Wednesday, 4531 words, Kaisernetwork.org\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_21_0}{\*\bkmkstart cite_id_21}{\*\bkmkend DOC_ID_21_0}{\*\bkmkend cite_id_21}21.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_21"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Indian drug firms stand to gain much from WTO talks; Potential to carve out slice of US$15b US generics market}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  The Business Times Singapore, June 7, 2004 Monday, THE NEWS; South Asia, 632 words, Yogi Aggarwal in Bombay\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_22_0}{\*\bkmkstart cite_id_22}{\*\bkmkend DOC_ID_22_0}{\*\bkmkend cite_id_22}22.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_22"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 WTO drug deal to spark competition}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  The Business Times Singapore, September 2, 2003 Tuesday, THE NEWS; World, 610 words, By RAVI KANTH IN GENEVA\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_23_0}{\*\bkmkstart cite_id_23}{\*\bkmkend DOC_ID_23_0}{\*\bkmkend cite_id_23}23.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_23"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Cheap drug plan founders}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955   The Globe and Mail (Canada), August 30, 2003 Saturday, REPORT ON BUSINESS: INTERNATIONAL; Pg. B6, 544 words, WARREN GILES, Bloomberg News\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_24_0}{\*\bkmkstart cite_id_24}{\*\bkmkend DOC_ID_24_0}{\*\bkmkend cite_id_24}24.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_24"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Proposed WTO deal set to bring hope to poorer nations; It calls for relaxing patent provisions, issuing of licences to producers in poorer nations}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  The Business Times Singapore, August 29, 2003 Friday, THE NEWS; World, 416 words, Ravi Kanth\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_25_0}{\*\bkmkstart cite_id_25}{\*\bkmkend DOC_ID_25_0}{\*\bkmkend cite_id_25}25.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_25"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Last-minute deal on cheap drugs: Late deal on cheap drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  The Guardian (London), August 28, 2003, Guardian Home Pages, Pg. 1, 757 words, Charlotte Denny and Sarah Boseley\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_26_0}{\*\bkmkstart cite_id_26}{\*\bkmkend DOC_ID_26_0}{\*\bkmkend cite_id_26}26.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_26"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Americans seeking pledges on drug rules}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  The Toronto Star, August 26, 2003 Tuesday, 238 words, Warren Giles, Bloomberg News\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_27_0}{\*\bkmkstart cite_id_27}{\*\bkmkend DOC_ID_27_0}{\*\bkmkend cite_id_27}27.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_27"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Uganda; 3 Firms to Supply Cheap Aids Drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  Africa News, May 8, 2003 Thursday, 363 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_28_0}{\*\bkmkstart cite_id_28}{\*\bkmkend DOC_ID_28_0}{\*\bkmkend cite_id_28}28.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_28"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 PanAfrica; Aids: Even With Discounts from Drug Firms, Generics Remain Far Cheaper}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  Africa News, May 5, 2003 Monday, 1233 words, The East African\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\bkmkstart DOC_ID_29_0}{\*\bkmkstart cite_id_29}{\*\bkmkend DOC_ID_29_0}{\*\bkmkend cite_id_29}29.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 HYPERLINK \\l"doc_id_29"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid1384955 Saving grace: Yusuf Hamied Generic drugs boss: He says he could save millions from death if the western giants would waive their patent rights and more governments would buy his drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955  The Guardian (London), February 18, 2003, Guardian Special Supplement, Pg. 8, 1353 words\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid1384955 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda; Bill Shouldn't Block Generics, Minister Agrees Africa News April 29, 2010 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_30}{\*\bkmkstart DOC_ID_30_0}{\*\bkmkstart doc_id_1}{\*\bkmkend DOC_ID_30}{\*\bkmkend DOC_ID_30_0}{\*\bkmkend doc_id_1}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_1"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  29, 2010 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Uganda; \par Bill Shouldn't Block Generics, Minister Agrees}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Inter Press Service (Johannesburg)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 875 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda's trade minister is in agreement that his government's controversial Counterfeit Goods Bill should not restrict the manufacture or import of life-saving generic medicines.\par The bill, drafted with funding from the European Union, suggests criminal penalties for counterfeiting.\par Counterfeiting is defined expansively as the manufacturing, producing, packaging, re-packaging, labelling or making of any goods which are imitated so as to be substantially similar to the protected goods without the authority of the intellectual property (IP) right owner subsisting in the country or elsewhere. \par With reference to the World Trade Organisation's 2001 Doha Declaration, Gagawala Wambuzi, Uganda's minister for trade who is spearheading the bill, indicated that his government is aware that the U.S. and the EU have agreed that least developed countries (LDCs) should enjoy greater flexibility with regards IP and medicines.\par "Basically the issue of generic drugs for LDCs like Uganda, Tanzania, Rwanda and Burundi is not a big story. They have to allow us to manufacture generics. An LDC must be allowed to do certain things so that we are able to catch up (developmentally) and so that we are able to manufacture generic drugs. That is what it is all about," Wambuzi acknowledged.\par Regarding the civil society campaign about the detrimental consequences of the bill as it currently stands, Wambuzi said, "we cannot make a bill against ourselves. Why would we do it; to favour whom? The bill is for us."\par He added that Uganda's interest in such a law is to have its industries protected from counterfeiters whom he said are targeting all Ugandan products.\par The Uganda Registration Services Bureau, which is charged with the registration of patents, trademarks and copyright, also realises the dangers of the bill in its current form.\par Bisereko Kyomuhendo, acting registrar general of the bureau, told IPS that, "we are trying to highlight to the sponsoring ministry that intellectual property issues should not be mixed up with issue to do with enforc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment and access to medicine".\par The bureau believes the bill should be redrafted to specifically only fill the gaps in the existing IP legal frameworks in the Copyright Act and Trademarks Act.\par Regarding the progress with redrafting, Elizabeth Tamale, the principal commercial officer in the trade mini}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 try, told IPS: "At the moment there are some comments which we have to include into the final document." These were to be forwarded to the drafters of the bill, she confirmed.\par India-based pharmaceutical company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ltd has partnered with Quality Chemicals in Uganda to locally produce generic antiretroviral (ARVs) and anti-malarial medicines. Similar initiatives, under compulsory l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 censing arrangements, are happening in Ghana, South Africa, and Mozambique.\par Compulsory licensing "is when a government allows someone else to produce the patented product or pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cess without the consent of the patent owner", according to the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ) website. The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement of 1995 allows for this.\par Apart from the Ugandan Counterfeit Goods Bill and the Kenyan Anti-Counterfeit Act of 2008, Tanzania also adopted new regulations in 2008, attached to the Merchandise Marks Act, that threaten to have a similar e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 fect on the production of generic medicines as the legislative measures taken by its neighbours.\par George Baguma, chief commercial officer with Quality Chemicals, told IPS that, "the anti-counterfeits bills in East Africa should be shelved. I think we are comfortable without them. We still need more pharmaceutical companies in East Africa if we are to provide affordable medicines to our people.\par "The effect of these bills is that our plant will close and we shall not produce any more drugs. But what are more important are not even the drugs we are producing now. There are newer drugs which are being pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 duced. We need to access that technology. Basically, if those laws are passed we shall limit our people to old drugs," he cautioned.\par The local production of ARVs by Quality Chemicals will assist Uganda in providing treatment to the projected 263,000 people who will need it by 2012 and the 342,200 people who will require treatment by 2020.\par Hakiel Mgonja, assistant registrar at Tanzania's Business Registration and Licensing Agency, agreed at a recent meeting in Arusha, Tanzania, that it would be a mistake for the region to prevent local production of medicines, given that most people still cannot access essential medicines because of cost.\par "In Tanzania we are saying we have the merchandise law and it is working, even for fighting counterfeits. You cannot make a monster and keep it at home because it will eat your children and later on eat you. So we have to create mechanisms for an atmosphere for the pharmaceutical industry if we are to attain universal access," said Mgonja.\par The 2009 World Health Organisation report titled "Towards Universal Access" indicated that 66 percent (or 6,7 million) of eligible people in sub-Saharan Africa are still not receiving ARV treatment. It also indicated that about three million people, who are already on treatment, will need to continue receiving ARVs for the rest of their lives.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GENERIC PRODUCTS (92%); GENERIC DRUGS (91%); COMMERCE DEPARTMENTS (90%); COUNTERFEITING (90%); INTELLECTUAL PROPERTY LAW (90%); DEVELOPING COUNTRIES (90%); TRADEMARKS (89%); IMPORT TRADE (89%); PATENTS (89%); LICENSING AGREEMENTS (89%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TELLECTUAL PROPERTY (89%); COPYRIGHT (78%); PHARMACEUTICALS INDUSTRY (78%); PHA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MACEUTICAL PREPARATION MFG (78%); PACKAGING MATERIALS (78%); EUROPEAN UNION (78%); COPYRIGHT LAW (77%); INTERNATIONAL ECONOMIC ORGANIZATIONS (77%); TRADEMARK LAW (77%); ANTI-INFECTIVES (73%); ANTIVIRALS (72%); MALARIA (60%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 EUROPEAN UNION (58%); WORLD TRADE ORGANIZATION (57%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (80%); SIC2834 PHARMACEUTICAL PREPARATIONS (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 JOHANNESBURG, SOUTH AFRICA (50%) UGANDA (95%); EUROPE (92%); EUROPEAN UNION MEMBER STATES (88%); INDIA (79%); GHANA (79%); MOZAMBIQUE (79%); UNITED STATES (79%); TANZANIA, UNITED REPUBLIC OF (79%); BURUNDI (79%); RWANDA (79%); SOUTH AFRICA (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 April 29, 2010\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2010 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Bill Shouldn't Block Generics, Minister Agrees Inter Press Service (Johannesburg) April 29, 2010 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_31}{\*\bkmkstart DOC_ID_31_0}{\*\bkmkstart doc_id_2}{\*\bkmkend DOC_ID_31}{\*\bkmkend DOC_ID_31_0}{\*\bkmkend doc_id_2}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_2"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 2 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Inter Press Service (Johannesburg)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  29, 2010 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Bill Shouldn't Block Generics, Minister Agrees}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Wambi Michael\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 875  words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Kampala \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda's trade minister is in agreement that his government's controversial Counterfeit Goods Bill should not restrict the manufacture or import of life-saving generic medicines.\par The bill, drafted with funding from the European Union, suggests criminal penalties for counterfeiting.\par Counterfeiting is defined expansively as the manufacturing, producing, packaging, re-packaging, labelling or making of any goods which are imitated so as to be substantially similar to the protected goods without the authority of the intellectual property (IP) right owner subsisting in the country or elsewhere. \par With reference to the World Trade Organisation's 2001 Doha Declaration, Gagawala Wambuzi, Uganda's minister for trade who is spearheading the bill, indicated that his government is aware that the U.S. and the EU have agreed that least developed countries (LDCs) should enjoy greater flexibility with regards IP and medicines.\par "Basically the issue of generic drugs for LDCs like Uganda, Tanzania, Rwanda and Burundi is not a big story. They have to allow us to manufacture generics. An LDC must be allowed to do certain things so that we are able to catch up (developmentally) and so that we are able to manufacture generic drugs. That is what it is all about," Wambuzi acknowledged.\par Regarding the civil society campaign about the detrimental consequences of the bill as it currently stands, Wambuzi said, "we cannot make a bill against ourselves. Why would we do it; to favour whom? The bill is for us."\par He added that Uganda's interest in such a law is to have its industries protected from counterfeiters whom he said are targeting all Ugandan products.\par The Uganda Registration Services Bureau, which is charged with the registration of patents, trademarks and copyright, also realises the dangers of the bill in its current form.\par Bisereko Kyomuhendo, acting registrar general of the bureau, told IPS that, "we are trying to highlight to the sponsoring ministry that intellectual property issues should not be mixed up with issue to do with enforc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment and access to medicine".\par The bureau believes the bill should be redrafted to specifically only fill the gaps in the existing IP legal frameworks in the Copyright Act and Trademarks Act.\par Regarding the progress with redrafting, Elizabeth Tamale, the principal commercial officer in the trade mini}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 try, told IPS: "At the moment there are some comments which we have to include into the final document." These were to be forwarded to the drafters of the bill, she confirmed.\par India-based pharmaceutical company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ltd has partnered with Quality Chemicals in Uganda to locally produce generic antiretroviral (ARVs) and anti-malarial medicines. Similar initiatives, under compulsory l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 censing arrangements, are happening in Ghana, South Africa, and Mozambique.\par Compulsory licensing "is when a government allows someone else to produce the patented product or pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cess without the consent of the patent owner", according to the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ) website. The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement of 1995 allows for this.\par Apart from the Ugandan Counterfeit Goods Bill and the Kenyan Anti-Counterfeit Act of 2008, Tanzania also adopted new regulations in 2008, attached to the Merchandise Marks Act, that threaten to have a similar e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 fect on the production of generic medicines as the legislative measures taken by its neighbours.\par George Baguma, chief commercial officer with Quality Chemicals, told IPS that, "the anti-counterfeits bills in East Africa should be shelved. I think we are comfortable without them. We still need more pharmaceutical companies in East Africa if we are to provide affordable medicines to our people.\par "The effect of these bills is that our plant will close and we shall not produce any more drugs. But what are more important are not even the drugs we are producing now. There are newer drugs which are being pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 duced. We need to access that technology. Basically, if those laws are passed we shall limit our people to old drugs," he cautioned.\par The local production of ARVs by Quality Chemicals will assist Uganda in providing treatment to the projected 263,000 people who will need it by 2012 and the 342,200 people who will require treatment by 2020.\par Hakiel Mgonja, assistant registrar at Tanzania's Business Registration and Licensing Agency, agreed at a recent meeting in Arusha, Tanzania, that it would be a mistake for the region to prevent local production of medicines, given that most people still cannot access essential medicines because of cost.\par "In Tanzania we are saying we have the merchandise law and it is working, even for fighting counterfeits. You cannot make a monster and keep it at home because it will eat your children and later on eat you. So we have to create mechanisms for an atmosphere for the pharmaceutical industry if we are to attain universal access," said Mgonja.\par The 2009 World Health Organisation report titled "Towards Universal Access" indicated that 66 percent (or 6,7 million) of eligible people in sub-Saharan Africa are still not receiving ARV treatment. It also indicated that about three million people, who are already on treatment, will need to continue receiving ARVs for the rest of their lives.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GENERIC PRODUCTS (92%); GENERIC DRUGS (91%); COUNTERFEITING (90%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 LECTUAL PROPERTY LAW (90%); DEVELOPING COUNTRIES (90%); COMMERCE DEPARTMENTS (90%); LICENSING AGREEMENTS (89%); IMPORT TRADE (89%); TRADEMARKS (89%); INTELLECTUAL PROPERTY (89%); PATENTS (89%); PHARMACEUTICALS INDUSTRY (78%); PHARMACEUTICAL PREPARATION MFG (78%); PACKAGING MATERIALS (78%); EUROPEAN UNION (78%); COPYRIGHT (78%); TRADEMARK LAW (77%); INTERNATIONAL ECONOMIC ORGANIZATIONS (77%); COPYRIGHT LAW (77%); ANTI-INFECTIVES (73%); ANTIVIRALS (72%); MALARIA (60%) Uganda; Legal and Judicial Affairs\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (80%); SIC2834 PHARMACEUTICAL PREPARATIONS (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 KAMPALA, UGANDA (79%) UGANDA (95%); EUROPE (92%); EUROPEAN UNION ME}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 BER STATES (88%); TANZANIA, UNITED REPUBLIC OF (79%); RWANDA (79%); BURUNDI (79%); INDIA (79%); MOZAMBIQUE (79%); GHANA (79%); UNITED STATES (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 April 29, 2010\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Web Publication\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2010 AllAfrica Global Media.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda; Counterfeits Bill Threatens Access to Medicine Africa News November 6, 2009 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_32}{\*\bkmkstart DOC_ID_32_0}{\*\bkmkstart doc_id_3}{\*\bkmkend DOC_ID_32}{\*\bkmkend DOC_ID_32_0}{\*\bkmkend doc_id_3}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_3"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 3 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  6, 2009 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Uganda; \par Counterfeits Bill Threatens Access to Medicine}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Inter Press Service (Johannesburg)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1120 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda is considering an anti-counterfeit bill which analysts say will impair the country's ability to import and export cheap but effective generic medicines. Activists fear that the bill, once enacted, will deny Ugandans access to safe, effective, quality and affordable generic medication which currently forms the bulk of Uganda's medicine imports.\par The Counterfeit Goods Bill seeks to prohibit trade in goods that ostensibly infringe intellectual property rights. The bill, which was tabled by Uganda's trade ministry, will empower the commissioner of customs to seize suspected counterfeit goods. \par The bill defines "counterfeiting" as manufacturing, producing, packaging, re-packaging, labelling or making, whether in Uganda or outside Uganda, any goods which are imitated so as to be substantially similar to the protected goods without the authority of the intellectual property right owner subsisting in the country or elsewhere.\par President Yoweri Museveni in February asked his trade ministry to draft a strict law to curb counterfeit goods that he said were affecting local industries.\par "I think in China they've got some good solutions because you remember the other man who sold milk which killed children? I think he was put in front of the firing squad. If somebody kills children, do you think the Ch}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nese are very wrong?" he asked.\par But Edgar Tabaro, a Ugandan lawyer specialising in trade-related matters, questions the necessity of the bill. He told IPS that whatever the bill ostensibly seeks to address is covered by different laws like the Trad}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 marks Act, Copyright Act, the Patents Act and the Trade Secrets Act.\par "So we are asking whether this bill is being pursued on behalf of our national agenda or whether there are some embedded interests behind this bill. Why should we deny our people cheaper drugs by making laws that are not in our interest?" he asked.\par Rosette Mutambi, executive director of the Coalition for Health Promotion and Social Development (HEPS-Uganda), regards the bill as a threat to the lives of many Ugandans who largely depend on generic anti-retroviral drugs and other medicine. HEPS is a health consumers' organisation advocating for health rights and also represents health practitioners.\par Mutambi said only about 10 percent of the medicines used in Uganda are locally manufactured. And only about five to seven percent of the imported medicines are original brands, meaning that about 93 percent of imported drugs are generics. These are mostly imported from India.\par Patrick Mubangizi, the coordinator of Health Action International Africa's (HAI-Africa) office in Nairobi, said during a recent meeting in Kampala that he was "very concerned" about the bill because policy makers and the public didn't understand its implications for public health. HAI-Africa is part of an independent global ne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 work seeking to enhance access to medicines.\par HAI-Africa is opposed to the Ugandan bill because it deviates from the official definition of counterfeit med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cine as provided by the World Health Organisation (WHO).\par "WHO describes counterfeit medicine as 'medicine which is deliberately and fraudulently mislabelled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products and cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 terfeit products may include products with the correct ingredients or with the wrong ingredients, without a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tive ingredients, with insufficient active ingredients, or with fake packaging'," explained Mubangizi.\par Geoffrey Nalima, a manager at Quality Chemicals Limited, the first antiretrovirals (ARVs) manufacturing plant in East Africa, told IPS that they were alarmed by the bill because it classifies their products as counterfeits. Moreover, the bill will make it difficult for their products to be exported to other countries in the region.\par Other countries in the region have expressed interest in the drugs, which are being manufactured under a license from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  of India.\par Sisule Musungu, a policy analyst specialising in intellectual property, trade and innovation, told IPS that Uganda, like Kenya, will become a victim of multinational companies pushing for intellectual property right enforcement.\par "Internationally, there is a big push towards intellectual property enforcement for trade reasons. With the trade negotiations going on at the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ), the U.S. and European Union will have to reduce subsidies for agricultural production. All that remains are technology-based goods. That is where intellectual property rights enforcement comes in," Musungu explained.\par Uganda as a least developed country (LDC) which, under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, does not have to provide protection for trademarks, copyrights, patents and other intellectual property rights until July 2013. Regarding pharmaceuticals, Uganda does not have to put in place protections on medicine until 2016.\par The idea behind these "allowances" is for developing countries to take advantage of technological advanc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ments and gain the capacity to produce their own drugs. Uganda would therefore be preventing itself from doing so by adopting this bill, according to Musungu.\par "If Uganda wants to pass an intellectual property rights law, the benchmark should not be to comply with TRIPS. The benchmark should be determined by asking what Uganda wants for this law. And, therefore, which type of law should we have. The draft bill goes beyond TRIPS's requirements," he said.\par Nathan Irumba, a former Ugandan ambassador to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  and now senior strategic advisor to the Southern and Eastern African Trade Information and Negotiations Institute (SEATINI), agreed that Ugandan gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment needed to protect its citizen from counterfeits. But, he said, the problem with the bill is that it mixes i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sues of trademarks and the question of standards.\par "I agree counterfeits should be dealt with but in the process we should not outlaw generic medicine. We should not be tricked by multinationals to have their rights enforced in our courts. We should instead utilise our space for development. TRIPS gives us leeway. But in the bill we (Ugandans) are trying to restrain these flexibilities," he pointed out.\par Elimu Elyetu, a project manager with Uganda's Trade Capacity Enhancement project that is also steering the bill, told IPS that they were ready to include amendments to the bill to take care of activists' concerns.\par Uganda's trade minister Gagawala Wambuzi told IPS that government was determined to have the bill e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 acted into law before the end of this year. "There has been a disease of counterfeits. People are crying. Some of the counterfeits are manufactured inside here; some are from abroad. And we are saying this must stop."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 COUNTERFEITING (93%); INTELLECTUAL PROPERTY LAW (91%); GENERIC DRUGS (91%); COMMERCE DEPARTMENTS (90%); IMPORT TRADE (90%); TRADE DEVELOPMENT (89%); TRADEMARKS (89%); PATENT LAW (89%); PHARMACEUTICALS TRADE (89%); EXPORT TRADE (89%); INTELLECTUAL PROPERTY (89%); COPYRIGHT INFRINGEMENT (78%); COPYRIGHT LAW (78%); HEALTH CARE ACCESS (78%); GENERIC PRODUCTS (78%); PUBLIC POLICY (76%); TRADE SECRETS LAW (76%); PATENTS (76%); PACKAGING MATERIALS (75%); COPYRIGHT (73%); ANTIV}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 RALS (73%); PREVENTION & WELLNESS (71%); TRADEMARK LAW (71%); EXECUTIVES (68%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 KAMPALA, UGANDA (79%); NAIROBI, KENYA (51%) UGANDA (99%); AFRICA (94%); INDIA (79%); CHINA (79%); KENYA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 November 6, 2009\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2009 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Land ofdiscovery INTRODUCTION: India is pushing into fresh territory by evolving from a commodity-driven drug market into a research-driven development center. But challenges abound ICIS Chemical Business July 7, 2008 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_33}{\*\bkmkstart DOC_ID_33_0}{\*\bkmkstart doc_id_4}{\*\bkmkend DOC_ID_33}{\*\bkmkend DOC_ID_33_0}{\*\bkmkend doc_id_4}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_4"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 4 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\shppict{\pict{\*\picprop\shplid1026{\sp{\sn shapeType}{\sv 75}}{\sp{\sn fFlipH}{\sv 0}}{\sp{\sn fFlipV}{\sv 0}}{\sp{\sn fLine}{\sv 0}}{\sp{\sn fLayoutInCell}{\sv 1}}}\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw8573\pich2152\picwgoal4860\pichgoal1220\pngblip\bliptag28590503 89504e470d0a1a0a0000000d49484452000000f30000003d08030000004fcaafc900000300504c5445000000000000800000008000808000000080800080008080808080c0c0c0ff000000ff00ffff000000ffff00ff00ffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000330000660000990000cc0000ff0033000033330033660033990033cc0033ff0066000066330066660066990066cc0066ff0099000099330099660099990099cc0099ff00cc0000cc3300cc6600cc9900cccc00ccff00ff0000ff3300ff6600ff9900ffcc00ffff3300003300333300663300993300cc3300ff3333003333333333663333993333cc3333ff3366003366333366663366993366cc3366ff3399003399333399663399993399cc3399ff33cc0033cc3333cc6633cc9933cccc33ccff33ff0033ff3333ff6633ff9933ffcc33ffff6600006600336600666600996600cc6600ff6633006633336633666633996633cc6633ff6666006666336666666666996666cc6666ff6699006699336699666699996699cc6699ff66cc0066cc3366cc6666cc9966cccc66ccff66ff0066ff3366ff6666ff9966ffcc66ffff9900009900339900669900999900cc9900ff9933009933339933669933999933cc9933ff9966009966339966669966999966cc9966ff9999009999339999669999999999cc9999ff99cc0099cc3399cc6699cc9999cccc99ccff99ff0099ff3399ff6699ff9999ffcc99ffffcc0000cc0033cc0066cc0099cc00cccc00ffcc3300cc3333cc3366cc3399cc33cccc33ffcc6600cc6633cc6666cc6699cc66cccc66ffcc9900cc9933cc9966cc9999cc99cccc99ffcccc00cccc33cccc66cccc99ccccccccccffccff00ccff33ccff66ccff99ccffccccffffff0000ff0033ff0066ff0099ff00ccff00ffff3300ff3333ff3366ff3399ff33ccff33ffff6600ff6633ff6666ff6699ff66ccff66ffff9900ff9933ff9966ff9999ff99ccff99ffffcc00ffcc33ffcc66ffcc99ffccccffccffffff00ffff33ffff66ffff99ffffccffffff3c2191110000000174524e530040e6d866000009104944415478daed5bcf6b1b49167eb68374b74920d7d91632d590ab47c30a725d081288e818984181dce6109d1a7c9e9e8b7ddbcb42c3808e3231ddffc1c0401fe6dc4d06f59c6326ec983d4aacc8bef7ea5575b72cc91ea93d6b9151517e5d3f545d55afbef7bd574af6c2c4dd26f92addb9b4f79d9bd4a7f5696db6a1bcd8bd45efa3aea698669b4a6f17f55c9b91d6b6c817bba7e7196b6d8beced9e9eb7c0f28e627a7f1b2cef28a62bc0b3601a400fb94ebec4bedd49234f617d1adde17bd5ca836fafdc0feed6b977a93eca2e2e93c3fed19b17fd93fe17cfe6cfe74f29fde2b2c432d59ff4bf797eb9e6fbd5caadf95964b6f228799f1a93bba65fc77fc6e13ef836413d91b6b693f3dee58dc19dd3c33727fd8fa8d1f7aed6ec6df2bfd8ffa87db91b789eddd47430696c9ca287cecf929dd281ee8ec0cddc4df370e43c747e5ec0f44ba731a922450f999f456add7446ff7027a8adedf370f4d0f18c79ac3ad568b89006d5f3737578c6ec0d198f20b8ac448e02d10e54260f9e21163fd43fd4aeb697d965f77de3fd11a70ae5e36f8207163f1b99f968c206a2a149b572d4f11e229ec566578f678beb07c6cfd985a1a968734ebe258f86952dfae0d9f6582e7a60bf1f6a2cde43ae0cd7dbf3f3dfca4e67540d372fcda36af1ecc11ffcf8869317f92f9834ee314515f0f39edc6f77a23f76af6dfa2fb9df1ecd6ab35aaae8ef3dc8707b3defe3c4eb9820e9b2ac49f936092cb36557fa63c0562781e45e6427a82c7e6e5effbddd6afff6e4aef172f31ae5f28b8283afee1c2f6f247fdfde6ed7aec802b7dfb511a4c7cd9f3fe8f26db9fdaef6af8315836687f764b939673f56c5cfe8dbf2e7ad47e58b5b3919dc3517bcf7c5d19c2f2ae367ad67fa1cfdfb75f375b3cd1a5fcdcbedafd70c7a7f1cfdbef1eea0327e06d7d74bcec26eaef195bc9cc1ba41ef93a3b32aec768dad3124355ee9f9b86629b82e6d3773960226e1bb2532c2f11af792cfd6bef76e32c7f38cb58ccf912c395aed5f5314ba364ead3e8e165945fc9cf3b3eb9f038c897f65c92bf9392becda4bc773fa220bc7e7369e753a2bdb95b3e67b95dc7f2ff3c33a7ac9ab7c30465430e01b6c71595b6aa8e86f3ef0903da7c49d2d950ebd60453bb585ae631156ea57ba160c4a6fdc08cf49ddf73ef133e17a0d962d3acc9281bc58289935ad9946b25c52ef55edd4d64872c7be53682fdf8402bcdcd00fd3bf3935af51fe00c7adf657ede89777d72b7f9b12bbd98d719f0dbd41377e8d7fbf2feae08df69c96e743b41c6bdae0e353eaf1d3c1d57f7e6ac2716cda162f7f7ff871433d6b8c02495981b3c6d7ce722bc8108070d01ab4e0869e95686679c64861753b7d121c5097e544705ef4f736c4f3234129b8d678219a92fe2ce3fa3ebdd3e7a7648f96ec045806b6828146320d437f01086116d5015a76c2217ed751c8f958c26794a1a943e968fbcf657aa23a1a758278d6fd6619cec0d5e3bcb2bf9260400485dfc5f212b67c8285da42dd42fc4cf1f05bbde45fa7b5a18e8f0d5ecfa8cdaf4fb340ca17710b62ea6be2d900d73c08c06c4360b6af31e95a64a6f2ac653a6928db4b95fb538f5422667e52a9fe5d03cd16f08bf1352807691c664329e23c740b99d7d818575b57b8dfce2c3fbb53dd6f6f4a5ccdf7d56835333f03e036e265ac680d002e482b6c540def612790858ed06a9b6512afda8f32cbd775ae8252990d83f47739132f777549b9f42e9ab82c999ee8bc7587a664171af0a913e32a75457e7e9492bf554f3a84599ff49a127681e2630fd2108fe7b83e65ac239663dec301e339d643995f21f5ae76708a8e72e895037e9e31228d4e45d35c078eae414d268d506b14ad74e8480f1536d05e7749f749036bf6520da0d8c247f3453a600641f2d4b3c3b310e0890b2333af1b84b68fa6807c68605f5aa379ca5a458c0ba6d8c706f274f3458a9eed40b201ecc3a51e1f26970c9b127ceadd9e14ea327b1252b9c74eadceb95f5775e96444e46763bd2fcbccdfcada03be04c6c1d291cc0ecf61ca279052083723837dfc63f9198dd8b95fd3163ca975c02ff0320f98426ced36afce0e44c5b354785ab7bcd216b8c0b7a1c8c4aa392cf173a1bf2af333c02bb3ccd46e3ceb39b4cf4ee1e64b1f70d98c257a56638367d7373e3680c1b4c93c206e61ec14f4acec40991c74de09d2a2e7785901bbf2ece675cae09d33e95415fae3285994d19435c623bb1c9ac330d7b36b750e26e6c2fd1cd84563ef60899e952ffc9cf330eeb7c6b4e567bd24b48e5e90eb39df43478e9c594da7e3753a566f82e0c44af3319c9cbb9ab9b6b92d0d59d3e0e4c7992c74d0377a760aba75e280126e19cd238865c6100437f44c8b86727c4c561aa010379b2b5db2da341828bf8467b5a06728d964c1b33b7117ecb4c4c5f4b5304b4bfd95b485f43d73a2f88d3487b7b1c17341cf3446e4e3e9f015394a5ac32da4291597f50ce23595fc6a009d4dd9cfcd578b9910b4b90a4c84050b7a8656ab751eb2bf95e33929e2599ea8ce59c47a83fd308999f1290289d7450e70c363b1dbf9fb1101afce7ccc8c7d689dcbfcce5adc3b8f9f356f65508e9109cb1978a65cf8276f4a7851192ee4fa385ad433d68f5dcbcf4bf09c5a3c1b8d97b93b357133d960c4339823ccf36d197e967981855a3ecfb1e5658264217eb67150c9b7262c8ff54d09955591a6f4fe9ad704b1d30fe27011cf6c42749cbc0ecf0e6156499b5ac0b3c4d33cf14e8ee7c2612ed9ed9bb454a4b56411cf589995eebc18cb3ebced733933480a727bc93cc81f0f5dd6088a7a1ee8cd08c812afc4739669df4cbcb3a207c6fdf5efcfd4daa2b78fb4bb81e6cb334f0b761be7a0db522f8dcd810f46f25408481e15f87601cfe4976184dcc134901d36eea546317b5ad6b52be8391d04b98fed303e1b82e786d5ba93ccac97cd1e989689eeef50599b73f2a35ab1639c48d07c201e74c16ed35ba52d340e6a2b50b90f6ee3e77fce7bc7ed79aff9fce4d9fcf917263f86a724af1e6bd3303fbd6ac39363b910f6af5fb8cd27f3d3238e7579227d7ada6bcf4f49a6bd1771535a621d0fb7b9e211c6c02c0b75f4394ef93d51d7b63d3dcc231377de7bd1d7651f672197d211ce01527c5fda3b7e73d5c3e7defcda0c98ca937f6a7ae30ab0df898bf274efcb1dfc4f24dbde6f7f7e4b567b5fc29ffeefa7ffdf72bfc27f77b52bf2a0fe179e3f87f4979e3f8ff43f297a92c78a2a3b3e0000000049454e44ae426082}}{\nonshppict{\pict\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw243\pich61\picwgoal4860\pichgoal1220\macpict\bliptag28590503 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000003d00f3001102ff0c00fffe0000004800000048000000000000003d00f300000000001e0001000a00000000003d00f382000000e8360000000100000000000000000000000000000001000000000000000000000000000040000000000000000000000000000000000000000000003d00f3000003000000000000000056726177200000000000000000000000006170706c000004000000040000f3003d00480000004800000000e79c000100000000000000000000000000000000000000000000000000000000000000000020ffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff66ccccff6699ccff66ccffff6699ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff6699ccff66ccffff6699ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff66ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff66ccccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff3399ccff0066ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccffffffffff6699ccffccccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccffffffffff6699ccff99ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffffffffffffffffffffffffffffffffffff99ccccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccffffffffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffccffffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccffffffffffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff3399ccff0066ccffffffffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccffffffffffffffffffffffffffffffffffccffffff6699ccff99ccffff6699ccff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccffffffffff6699ccff99ccffff6699ccff66ccffffffffffffffffffff6699ccff66ccccff6699ccff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff66ccccff6699ccff99ccffff6699ccff66ccffff0066ccff3399ccff0066ccff66ccccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccffccccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccff6699ccff66ccffff0066ccffffffffff99ccccff66ccffff6699ccff66ccccff6699ccffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccffccccffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffccffffff99ccffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccffffffffff6699ccff66ccffff6699ccff66ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccff3399ccff99ccccffffffffffffffffffffffffffffffffffffffffff99ccccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccffccffffffccccffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffccffffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccffccffffff99ccccff99ccffff6699ccff99ccffff6699ccff3399ccff6699ccffffffffffffffffffffffffff6699ccff3399ccff0066ccff3399ccffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccccffffffffffffffffffffffffff99ccccffccffffffccccffffccffffff99ccccffccffffffffffffffffffffff99ccccffccffffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffffccffffff99ccccffccffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffffffffffffffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffffffffffffffffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccff6699ccff66ccffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff66ccccff6699ccff66ccffffffffffffffffffff6699ccff66ccffff6699ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff66ccccff0066ccffffffffff0066ccff0066ccffffffffffffffffffffffffffffffffff99ccccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffffffffffffccccffff99ccccffccccffff99ccccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff0066ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff0066ccffffffffffffffffff3399ccff0066ccffffffffff99ccccff66ccccffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff0066ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffffffffff99ccffffccffffff6699ccffccffffffffffffffffffffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccff3399ccff0066ccffffffffffffffffff99ccffff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffff0066ccff3399ccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffff99ccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffffccccffffccffffffccccffffffffffffffffffffccffffffccccffff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccffff6699ccffffffffff6699ccff99ccffff6699ccff66ccffff6699ccffffffffffffffffffffffffffffffffffccccffff6699ccff66ccffff6699ccff66ccffffffffffffffffffff6699ccff99ccffff6699ccffffffffffffffffffccccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff99ccccffffffffffffffffffffffffffffffffff3399ccff6699ccffffffffffffffffffffffffffffffffff3399ccff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffccccffff99ccccffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffff99ccccff99ccffff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffffccccffff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffff3399ccffffffffffffffffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffccccffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccffffffffffffffffffffffffffffffffffffffffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccccffffffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffccffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccff6699ccff66ccffff6699ccffffffffffffffffff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff66ccccffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffffffffffffffffffff0066ccff3399ccff0066ccffccccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccffffffffffffffffffffffffffffffffffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffccccffff0066ccff3399ccff0066ccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffccccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffff99ccffff99ccffff6699ccff99ccffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffccccffffccffffff99ccffffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccffffccffffffccccffffffffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffffffffffffccccffff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff6699ccff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccffffffffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffffffffffffffffffff6699ccff66ccffffffffffffffffffff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffff99ccccffccccffffffffffffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff66ccffff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccffffffffff3399ccff6699ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffffffffffffffffffccffffff99ccccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffffffffffff99ccccffccffffffccccffff99ccffff6699ccffccffffffccccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff6699ccffffffffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff66ccccffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccffffffffffffffffff3399ccff0066ccffffffffff0066ccff0066ccffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffff0066ccff0066ccff0066ccff66ccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffff99ccccff3399ccffffffffffffffffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffffffffffff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff0066ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff66ccffffffffffffffffffffffffffff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccffffffffffffffffffffffffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccffccffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff99ccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffff99ccffffccffffffffffffffffffffffffffffffffffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffffccffffff99ccffffccffffffccccffffccffffffccccffffffffffffffffffffffffffffffffffffccffffffccccffffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffffffffffffffffff3399ccff0066ccffffffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffffffffffffffffffff6699ccff99ccffff6699ccffffffffffffffffff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff66ccffffffffffffffffffff99ccccffccccffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff99ccccffccccffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffff3399ccff0066ccffffffffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff99ccccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffccffffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccffffffffff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccffccccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffffffffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccccffccffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccffffffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffff3399ccffffffffff99ccffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffff3399ccffffffffffffffffff0066ccff3399ccffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffffffffffff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff0066ccffffffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccffffffffff0066ccff3399ccff0066ccff3399ccff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff99ccffff99ccffff6699ccff99ccffffffffffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffffffffffffffffffccffffffccccffffccffffff99ccffffccffffffccccffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccffccffffff6699ccffffffffffffffffff99ccffff99ccffff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffffccccffff99ccffffffffffff99ccffff6699ccffccffffff99ccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccffff99ccffff6699ccffccffffffffffffffffffffffffffffffffffffff6699ccff99ccffffccccffff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffffffffffffffffffffffffffffffffffccccffffffffffff99ccffffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffffffffff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffffffffffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccffff6699ccff99ccffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccffffffffffffffffff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccccffff99ccffffffffffffffffffff6699ccffccffffffffffffffffffffff6699ccff99ccffff99ccffffccffffff6699ccff99ccffffffffffffffffffff6699ccff99ccffff6699ccff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccffccffffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccffccffffff6699ccff99ccffff99ccffffccffffffccccffff99ccffff6699ccffccffffff6699ccffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399cc000700ae00700007000100010003000300040000000d000c001000f300f300f300f300280012004410517569636b54696d65aa20616e642061000028001e004c0d206465636f6d70726573736f720028002a001c1f617265206e656564656420746f20736565207468697320706963747572652e000000a100e007ac00000000000007a86170706c022000006d6e74725247422058595a2007d900020019000b001a000b616373704150504c000000006170706c000000000000000000000000000000000000f6d6000100000000d32d6170706c00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000b64657363000001080000006f6473636d000001780000056c63707274000006e400000038777470740000071c000000147258595a00000730000000146758595a00000744000000146258595a0000075800000014725452430000076c0000000e636861640000077c0000002c625452430000076c0000000e675452430000076c0000000e64657363000000000000001447656e65726963205247422050726f66696c6500000000000000000000001447656e65726963205247422050726f66696c6500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000006d6c7563000000000000001e0000000c736b534b00000028000001786872485200000028000001a06361455300000024000001c87074425200000026000001ec756b55410000002a0000021266724655000000280000023c7a685457000000160000026469744954000000280000027a6e624e4f00000026000002a26b6f4b5200000016000002c86373435a00000022000002de6865494c0000001e00000300646544450000002c0000031e68754855000000280000034a7376534500000026000002a27a68434e00000016000003726a614a500000001a00000388726f524f00000024000003a2656c475200000022000003c67074504f00000026000003e86e6c4e4c000000280000040e6573455300000026000003e874685448000000240000043674725452000000220000045a66694649000000280000047c706c504c0000002c000004a47275525500000022000004d06172454700000026000004f2656e555300000026000005186461444b0000002e0000053e005601610065006f006200650063006e00fd0020005200470042002000700072006f00660069006c00470065006e006500720069010d006b00690020005200470042002000700072006f00660069006c00500065007200660069006c0020005200470042002000670065006e00e800720069006300500065007200660069006c0020005200470042002000470065006e00e9007200690063006f0417043004330430043b044c043d043804390020043f0440043e044404300439043b002000520047004200500072006f00660069006c0020006700e9006e00e9007200690071007500650020005200560042901a75280020005200470042002082725f6963cf8ff000500072006f00660069006c006f0020005200470042002000670065006e0065007200690063006f00470065006e0065007200690073006b0020005200470042002d00700072006f00660069006cc77cbc1800200052004700420020d504b85cd30cc77c004f006200650063006e00fd0020005200470042002000700072006f00660069006c05e405e805d505e405d905dc0020005200470042002005db05dc05dc05d90041006c006c00670065006d00650069006e006500730020005200470042002d00500072006f00660069006c00c1006c00740061006c00e1006e006f00730020005200470042002000700072006f00660069006c666e901a0020005200470042002063cf8ff065874ef64e00822c0020005200470042002030d730ed30d530a130a430eb00500072006f00660069006c0020005200470042002000670065006e0065007200690063039303b503bd03b903ba03cc002003c003c103bf03c603af03bb002000520047004200500065007200660069006c0020005200470042002000670065006e00e9007200690063006f0041006c00670065006d00650065006e0020005200470042002d00700072006f006600690065006c0e420e1b0e230e440e1f0e250e4c002000520047004200200e170e310e480e270e440e1b00470065006e0065006c0020005200470042002000500072006f00660069006c00690059006c00650069006e0065006e0020005200470042002d00700072006f006600690069006c00690055006e006900770065007200730061006c006e0079002000700072006f00660069006c0020005200470042041e04310449043804390020043f0440043e04440438043b044c00200052004700420645064406410020062a06390631064a0641002000520047004200200627064406390627064500470065006e00650072006900630020005200470042002000500072006f00660069006c006500470065006e006500720065006c0020005200470042002d006200650073006b0072006900760065006c007300657465787400000000436f707972696768742032303037204170706c6520496e632e2c20616c6c207269676874732072657365727665642e0058595a20000000000000f35200010000000116cf58595a20000000000000744d00003dee000003d058595a200000000000005a750000ac730000173458595a20000000000000281a0000159f0000b83663757276000000000000000101cd0000736633320000000000010c42000005defffff326000007920000fd91fffffba2fffffda3000003dc0000c06c00a100e000040000000200ff}}}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par ICIS Chemical Business\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  7, 2008\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Land ofdiscovery INTRODUCTION: India is pushing into fresh territory by evolving from a commodity-driven drug market into a research-driven development center. But challenges abound}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Feliza Mirasol\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 FEATURES\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1509  words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 India's reputation as a hub for pharmaceutical research and development (R&D) is growing. The country's drug industry is famous for its skill in copying products developed elsewhere, but Indian companies, promp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ed by new patent laws, have begun discovery programs of their own and set their eyes on the global market for innovative drugs.\par "There are Indian companies that are engaged in the discovery of their own products, and are offering these for licensing to third parties, even at very early stages," observes Enrico Polastro, vice president of global management consultancy firm Arthur D. Little. "These types of companies are 'active' in their own discovery activities."\par "There are also other various Indian companies engaged in CRAMS [contract research and manufacturing services]," he adds. \par An interesting move being noticed recently is that some Indian drug companies are spinning off their disco}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ery activities from their manufacturing and marketing operations.\par "Examples are Nicholas Piramal, Dr. Reddy's Laboratories, and Ranbaxy, which have spun off their disco}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ery divisions in an effort to capture the interest of Western companies. This has been quite fashionable since the end of last year," says Polastro.\par In addition, there are also service providers that are focusing only on contract development, medicinal che}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 istry, toxicology, and other narrow areas.\par "I think most Western generic players are already doing a significant amount of bioavailability studies in India because it's cheaper, and it's easier if you want to do these studies during the period of patent exclusivity," Polastro says.\par Innovators that once would source only raw materials from Asia are becoming more comfortable with the region.\par "Global pharmaceutical companies are increasingly outsourcing early-stage drug discovery to China and I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 dia," says UK-based consulting firm Decision Resources. "This trend is not simply a matter of cost. Reloca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing these functions to China and India helps to gain access to enormous emerging markets."\par The intellectual challenge\par However, intellectual property (IP) protection remains a sticky, and often complicated, issue.\par }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\highlight7\insrsid1384955\charrsid1384955 India's drug industry has historically been driven by the dynamics of the generic drug market. Now it must prove that it can respect patent exclusivity and protect the IP of innovator partners. So far, the results are mixed.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par "Patents in India are still being overruled in the interest of affordability for the general population," Polastro notes, pointing to Roche's cancer drug Tarceva (erlotinib). The Swiss pharmaceutical company had applied for an Indian patent for Tarceva in 1996. In 2005, Indian regulatory authorities granted Roche the right to market the drug, and in 2007, Roche was granted an Indian patent. So when Mumbai-based }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  launched Erlocip, a generic version of Tarceva, this past January, Roche immediately sued. In March, however, the Delhi High Court overruled Roche's Indian patent on Tarceva, clearing the way for the copy. Another hearing is scheduled for August 6.\par "The argument [in India] is to make the product more affordable for the general population. As a result, orig}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nators are not comfortable with IP in India," Polastro explains. "Another issue is that there is a lot of labor turnover, and this puts IP at risk."\par The situation is evolving. Regulatory authorities began recognizing drug patents in January 2005 to meet the terms of its membership in the World Trade Organization, (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ) and Indian drug firms increasingly have an interest of their own in the international norms of IP protection.\par In principle, at least, the country has a new patent plan and a promise to better protect IP rights. In practice, this has been difficult, as the Tarceva example demonstrates.\par "India's development is entrepreneurial and market-driven [but] it must continue improving IP protection to attract additional global pharmaceutical company investment," says Decision Resources.\par Indian contract research organizations (CROs) have benefited from trust engendered by the government's new IP protection laws. However, each firm on its own will still need to demonstrate that respect for intelle}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tual property is part of its culture and ensured by its systems.\par "Intellectual property protection in China and India is improving. Both countries are now bound by the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  IP rules, however global pharmaceutical companies (GPCs) continue to face IP hurdles. The development of local life sciences industries will help to improve the IP environment," says Decision Resources.\par Attractive shores\par Pharmaceutical companies have been moving R&D functions and operations to India, as well as China, only in recent years. In some cases, companies began offshoring their business, either relocating internal oper}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tions to these countries or establishing joint ventures with Indian or Chinese partners, but they are also ou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sourcing as well.\par Driving these choices is the need to improve pharmaceutical R&D productivity and bring a larger number of drugs to market more efficiently, states Decision Resources.\par Western pharmaceutical companies have typically tapped into CROs in both China and India to perform sp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cific tasks in clinical development, data management, and preclinical toxicology studies. Now these CROs are moving upstream in the R&D value chain. They are increasingly offering their services in chemistry, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 say development and even target identification, according to Decision Resources.\par "This trend is a consequence of higher government investments in basic research and improved technology transfer between universities and industry," says the consultancy.\par Both India's and China's governments are striving to create outsourcing opportunities. More importantly, they want to establish domestic high-tech industries and a high-value research base in lucrative therapeutic ar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 as.\par The nature of the relationship between Western pharmaceutical companies and Indian drug discovery se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 vice providers remains tentative, as drug discovery outsourcing to India is still in the early stages.\par "I think the jury is still out," says Polastro. "And the same applies to China. I think at this stage, everyone is still searching their own way for the best solutions, feeling their way through the R&D dilemma."\par He adds: "Another issue with IP, for example, is that everybody is moving into new territory, everybody is talking the game, but not many people have actually done it. So it remains somewhat theoretical."\par Polastro also notes that some companies, such as European-headquartered pharmaceutical research firms Sanofi-Aventis and Novartis, have their own R&D activities in both China and India. "They are setting up shop with their own facilities and their own employees," he says.\par Who's on the table\par Leading Indian CROs include GVK Biosciences, Syngene, Sai Advantium and Accutest. Meanwhile, leading Indian hybrid companies - those offering contract services as well as conducting their own internal drug di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 covery - include Advinus Therapeutics, Avra Laboratories, Dr. Reddy's Laboratories, Jubilant Biosys, Suven Life Sciences and Nicholas Piramal, according to Decisions Resources.\par GVK grabbed attention when it signed a high-profile outsourcing deal with Wyeth Pharmaceuticals in 2006. The deal was the first large multiyear contract awarded to an Indian company for contract research services, the two companies stated.\par In May, GVK and Wyeth signed another research agreement to discover and develop drug candidates from prediscovered targets.\par Also in May, US-based Merck established an alliance with India's Ranbaxy Laboratories for drug discovery and clinical development for new candidates in the antiinfectives therapy market. The deal, which has an initial five-year term, is potentially worth over $100m (?64m).\par In June, Ranbaxy agreed to sell a majority stake to Japan-based Daiichi Sankyo in a transaction valued at roughly $8.5bn. Ranbaxy is known to be in Phase II clinical testing of what some are calling the next i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 portant antimalaria drug.\par Aurigene, Advinus, Nicholas Piramal and Jubilant have all negotiated long-term contracts with Western pharmaceutical firms for discovery and development of new chemical entities.\par The growing outsourcing markets of China and India are attracting Western companies such as Switzerland-based RCC Pharma and US-based Albany Molecular Research, Covance, and Charles River Laboratories. \par Indian players have been getting more play in early drug discovery, giving them an edge over their Chinese peers. India is said to have far more experience from selling generic drugs and from having a track record of meeting the US Food & Drug Administration's standards, lending it a more mature market reputation for chemistry and drug discovery activities.\par "Some Indian companies seeking to enter Western markets are contracting with Western CROs. This situ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion offers significant opportunities for Western CROs able to comply with US or European regulations," states Decision Resources.\par ?? Sign up for the ICIS fine chemical and pharma e-newsletter: www.icis.com/e-newsletters\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PHARMACEUTICALS INDUSTRY (93%); RESEARCH & DEVELOPMENT (91%); PHARM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 CEUTICAL CHEMISTRY (90%); CHEMICALS RESEARCH (90%); PHARMACEUTICALS PRODUCT D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 VELOPMENT (90%); PRODUCT DEVELOPMENT (90%); DRUG DESIGN & DISCOVERY (90%); PATENT LAW (89%); INTELLECTUAL PROPERTY LAW (89%); GENERIC DRUGS (89%); PATENTS (89%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 LECTUAL PROPERTY (89%); PHARMACEUTICAL PREPARATION MFG (88%); EMERGING MARKETS (79%); OUTSOURCING (79%); TOXICOLOGY (78%); PRODUCT INNOVATION (78%); MULTINATIONAL CORPORATIONS (78%); CONSULTING SERVICES (75%); ENTERPRISE GLOBALIZATION (73%); CHEMISTRY (73%); CANCER (73%); CANCER DRUGS (73%); INTERNATIONAL TRADE (71%); MA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AGEMENT CONSULTING (70%) Land ofdiscovery\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ROCHE HOLDING AG (85%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (58%); RANBAXY LABORATORIES LTD (55%); DR REDDY'S LABORATORIES LTD (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ROG (SWX) (85%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (58%); RANBAXY (NSE) (55%); RDY (NYSE) (55%); DRRE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 DY (NSE) (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (85%); NAICS325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING (85%); SIC2834 PHARMACEUTICAL PREP}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 RATIONS (58%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (55%); SIC2833 MEDIC}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAL CHEMICALS & BOTANICAL PRODUCTS (55%); SIC2835 IN VITRO & IN VIVO DIAGNOSTIC SU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 B}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 STANCES (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 DELHI, INDIA (74%); MUMBAI, INDIA (74%) INDIA (96%); CHINA (92%); ASIA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 July 11, 2008\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Magazine\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2008 Reed Business Information Ltd.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Land ofdiscovery PARA:: INTRODUCTION:: PARA:: India is pushing into fresh territory by evolving from a commodity-driven drug market into a research-driven development center. But challenges abound PARA:: ICIS Chemical Business July 7, 2008 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_34}{\*\bkmkstart DOC_ID_34_0}{\*\bkmkstart doc_id_5}{\*\bkmkend DOC_ID_34}{\*\bkmkend DOC_ID_34_0}{\*\bkmkend doc_id_5}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_5"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 5 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\shppict{\pict{\*\picprop\shplid1027{\sp{\sn shapeType}{\sv 75}}{\sp{\sn fFlipH}{\sv 0}}{\sp{\sn fFlipV}{\sv 0}}{\sp{\sn fLine}{\sv 0}}{\sp{\sn fLayoutInCell}{\sv 1}}}\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw8573\pich2152\picwgoal4860\pichgoal1220\pngblip\bliptag28590503 89504e470d0a1a0a0000000d49484452000000f30000003d08030000004fcaafc900000300504c5445000000000000800000008000808000000080800080008080808080c0c0c0ff000000ff00ffff000000ffff00ff00ffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000330000660000990000cc0000ff0033000033330033660033990033cc0033ff0066000066330066660066990066cc0066ff0099000099330099660099990099cc0099ff00cc0000cc3300cc6600cc9900cccc00ccff00ff0000ff3300ff6600ff9900ffcc00ffff3300003300333300663300993300cc3300ff3333003333333333663333993333cc3333ff3366003366333366663366993366cc3366ff3399003399333399663399993399cc3399ff33cc0033cc3333cc6633cc9933cccc33ccff33ff0033ff3333ff6633ff9933ffcc33ffff6600006600336600666600996600cc6600ff6633006633336633666633996633cc6633ff6666006666336666666666996666cc6666ff6699006699336699666699996699cc6699ff66cc0066cc3366cc6666cc9966cccc66ccff66ff0066ff3366ff6666ff9966ffcc66ffff9900009900339900669900999900cc9900ff9933009933339933669933999933cc9933ff9966009966339966669966999966cc9966ff9999009999339999669999999999cc9999ff99cc0099cc3399cc6699cc9999cccc99ccff99ff0099ff3399ff6699ff9999ffcc99ffffcc0000cc0033cc0066cc0099cc00cccc00ffcc3300cc3333cc3366cc3399cc33cccc33ffcc6600cc6633cc6666cc6699cc66cccc66ffcc9900cc9933cc9966cc9999cc99cccc99ffcccc00cccc33cccc66cccc99ccccccccccffccff00ccff33ccff66ccff99ccffccccffffff0000ff0033ff0066ff0099ff00ccff00ffff3300ff3333ff3366ff3399ff33ccff33ffff6600ff6633ff6666ff6699ff66ccff66ffff9900ff9933ff9966ff9999ff99ccff99ffffcc00ffcc33ffcc66ffcc99ffccccffccffffff00ffff33ffff66ffff99ffffccffffff3c2191110000000174524e530040e6d866000009104944415478daed5bcf6b1b49167eb68374b74920d7d91632d590ab47c30a725d081288e818984181dce6109d1a7c9e9e8b7ddbcb42c3808e3231ddffc1c0401fe6dc4d06f59c6326ec983d4aacc8bef7ea5575b72cc91ea93d6b9151517e5d3f545d55afbef7bd574af6c2c4dd26f92addb9b4f79d9bd4a7f5696db6a1bcd8bd45efa3aea698669b4a6f17f55c9b91d6b6c817bba7e7196b6d8beced9e9eb7c0f28e627a7f1b2cef28a62bc0b3601a400fb94ebec4bedd49234f617d1adde17bd5ca836fafdc0feed6b977a93eca2e2e93c3fed19b17fd93fe17cfe6cfe74f29fde2b2c432d59ff4bf797eb9e6fbd5caadf95964b6f228799f1a93bba65fc77fc6e13ef836413d91b6b693f3dee58dc19dd3c33727fd8fa8d1f7aed6ec6df2bfd8ffa87db91b789eddd47430696c9ca287cecf929dd281ee8ec0cddc4df370e43c747e5ec0f44ba731a922450f999f456add7446ff7027a8adedf370f4d0f18c79ac3ad568b89006d5f3737578c6ec0d198f20b8ac448e02d10e54260f9e21163fd43fd4aeb697d965f77de3fd11a70ae5e36f8207163f1b99f968c206a2a149b572d4f11e229ec566578f678beb07c6cfd985a1a968734ebe258f86952dfae0d9f6582e7a60bf1f6a2cde43ae0cd7dbf3f3dfca4e67540d372fcda36af1ecc11ffcf8869317f92f9834ee314515f0f39edc6f77a23f76af6dfa2fb9df1ecd6ab35aaae8ef3dc8707b3defe3c4eb9820e9b2ac49f936092cb36557fa63c0562781e45e6427a82c7e6e5effbddd6afff6e4aef172f31ae5f28b8283afee1c2f6f247fdfde6ed7aec802b7dfb511a4c7cd9f3fe8f26db9fdaef6af8315836687f764b939673f56c5cfe8dbf2e7ad47e58b5b3919dc3517bcf7c5d19c2f2ae367ad67fa1cfdfb75f375b3cd1a5fcdcbedafd70c7a7f1cfdbef1eea0327e06d7d74bcec26eaef195bc9cc1ba41ef93a3b32aec768dad3124355ee9f9b86629b82e6d3773960226e1bb2532c2f11af792cfd6bef76e32c7f38cb58ccf912c395aed5f5314ba364ead3e8e165945fc9cf3b3eb9f038c897f65c92bf9392becda4bc773fa220bc7e7369e753a2bdb95b3e67b95dc7f2ff3c33a7ac9ab7c30465430e01b6c71595b6aa8e86f3ef0903da7c49d2d950ebd60453bb585ae631156ea57ba160c4a6fdc08cf49ddf73ef133e17a0d962d3acc9281bc58289935ad9946b25c52ef55edd4d64872c7be53682fdf8402bcdcd00fd3bf3935af51fe00c7adf657ede89777d72b7f9b12bbd98d719f0dbd41377e8d7fbf2feae08df69c96e743b41c6bdae0e353eaf1d3c1d57f7e6ac2716cda162f7f7ff871433d6b8c02495981b3c6d7ce722bc8108070d01ab4e0869e95686679c64861753b7d121c5097e544705ef4f736c4f3234129b8d678219a92fe2ce3fa3ebdd3e7a7648f96ec045806b6828146320d437f01086116d5015a76c2217ed751c8f958c26794a1a943e968fbcf657aa23a1a758278d6fd6619cec0d5e3bcb2bf9260400485dfc5f212b67c8285da42dd42fc4cf1f05bbde45fa7b5a18e8f0d5ecfa8cdaf4fb340ca17710b62ea6be2d900d73c08c06c4360b6af31e95a64a6f2ac653a6928db4b95fb538f5422667e52a9fe5d03cd16f08bf1352807691c664329e23c740b99d7d818575b57b8dfce2c3fbb53dd6f6f4a5ccdf7d56835333f03e036e265ac680d002e482b6c540def612790858ed06a9b6512afda8f32cbd775ae8252990d83f47739132f777549b9f42e9ab82c999ee8bc7587a664171af0a913e32a75457e7e9492bf554f3a84599ff49a127681e2630fd2108fe7b83e65ac239663dec301e339d643995f21f5ae76708a8e72e895037e9e31228d4e45d35c078eae414d268d506b14ad74e8480f1536d05e7749f749036bf6520da0d8c247f3453a600641f2d4b3c3b310e0890b2333af1b84b68fa6807c68605f5aa379ca5a458c0ba6d8c706f274f3458a9eed40b201ecc3a51e1f26970c9b127ceadd9e14ea327b1252b9c74eadceb95f5775e96444e46763bd2fcbccdfcada03be04c6c1d291cc0ecf61ca279052083723837dfc63f9198dd8b95fd3163ca975c02ff0320f98426ced36afce0e44c5b354785ab7bcd216b8c0b7a1c8c4aa392cf173a1bf2af333c02bb3ccd46e3ceb39b4cf4ee1e64b1f70d98c257a56638367d7373e3680c1b4c93c206e61ec14f4acec40991c74de09d2a2e7785901bbf2ece675cae09d33e95415fae3285994d19435c623bb1c9ac330d7b36b750e26e6c2fd1cd84563ef60899e952ffc9cf330eeb7c6b4e567bd24b48e5e90eb39df43478e9c594da7e3753a566f82e0c44af3319c9cbb9ab9b6b92d0d59d3e0e4c7992c74d0377a760aba75e280126e19cd238865c6100437f44c8b86727c4c561aa010379b2b5db2da341828bf8467b5a06728d964c1b33b7117ecb4c4c5f4b5304b4bfd95b485f43d73a2f88d3487b7b1c17341cf3446e4e3e9f015394a5ac32da4291597f50ce23595fc6a009d4dd9cfcd578b9910b4b90a4c84050b7a8656ab751eb2bf95e33929e2599ea8ce59c47a83fd308999f1290289d7450e70c363b1dbf9fb1101afce7ccc8c7d689dcbfcce5adc3b8f9f356f65508e9109cb1978a65cf8276f4a7851192ee4fa385ad433d68f5dcbcf4bf09c5a3c1b8d97b93b357133d960c4339823ccf36d197e967981855a3ecfb1e5658264217eb67150c9b7262c8ff54d09955591a6f4fe9ad704b1d30fe27011cf6c42749cbc0ecf0e6156499b5ac0b3c4d33cf14e8ee7c2612ed9ed9bb454a4b56411cf589995eebc18cb3ebced733933480a727bc93cc81f0f5dd6088a7a1ee8cd08c812afc4739669df4cbcb3a207c6fdf5efcfd4daa2b78fb4bb81e6cb334f0b761be7a0db522f8dcd810f46f25408481e15f87601cfe4976184dcc134901d36eea546317b5ad6b52be8391d04b98fed303e1b82e786d5ba93ccac97cd1e989689eeef50599b73f2a35ab1639c48d07c201e74c16ed35ba52d340e6a2b50b90f6ee3e77fce7bc7ed79aff9fce4d9fcf917263f86a724af1e6bd3303fbd6ac39363b910f6af5fb8cd27f3d3238e7579227d7ada6bcf4f49a6bd1771535a621d0fb7b9e211c6c02c0b75f4394ef93d51d7b63d3dcc231377de7bd1d7651f672197d211ce01527c5fda3b7e73d5c3e7defcda0c98ca937f6a7ae30ab0df898bf274efcb1dfc4f24dbde6f7f7e4b567b5fc29ffeefa7ffdf72bfc27f77b52bf2a0fe179e3f87f4979e3f8ff43f297a92c78a2a3b3e0000000049454e44ae426082}}{\nonshppict{\pict\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw243\pich61\picwgoal4860\pichgoal1220\macpict\bliptag28590503 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000003d00f3001102ff0c00fffe0000004800000048000000000000003d00f300000000001e0001000a00000000003d00f382000000e8360000000100000000000000000000000000000001000000000000000000000000000040000000000000000000000000000000000000000000003d00f3000003000000000000000056726177200000000000000000000000006170706c000004000000040000f3003d00480000004800000000e79c000100000000000000000000000000000000000000000000000000000000000000000020ffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff66ccccff6699ccff66ccffff6699ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff6699ccff66ccffff6699ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff66ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff66ccccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff3399ccff0066ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccffffffffff6699ccffccccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccffffffffff6699ccff99ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffffffffffffffffffffffffffffffffffff99ccccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccffffffffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffccffffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccffffffffffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff3399ccff0066ccffffffffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccffffffffffffffffffffffffffffffffffccffffff6699ccff99ccffff6699ccff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffccccffffccffffffccccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccffffffffff6699ccff99ccffff6699ccff66ccffffffffffffffffffff6699ccff66ccccff6699ccff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff66ccccff6699ccff99ccffff6699ccff66ccffff0066ccff3399ccff0066ccff66ccccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccffccccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccff6699ccff66ccffff0066ccffffffffff99ccccff66ccffff6699ccff66ccccff6699ccffffffffffffffffffffffffffffffffff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccffccccffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff66ccccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffccffffff99ccffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccffffffffff6699ccff66ccffff6699ccff66ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccff3399ccff99ccccffffffffffffffffffffffffffffffffffffffffff99ccccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccffccffffffccccffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffccffffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccffccffffff99ccccff99ccffff6699ccff99ccffff6699ccff3399ccff6699ccffffffffffffffffffffffffff6699ccff3399ccff0066ccff3399ccffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccccffffffffffffffffffffffffff99ccccffccffffffccccffffccffffff99ccccffccffffffffffffffffffffff99ccccffccffffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffffccffffff99ccccffccffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffffffffffffffffff99ccccffccffffffccccffffccffffff99ccccffccffffffccccffffccffffffffffffffffffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccff6699ccff66ccffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff66ccccff6699ccff66ccffffffffffffffffffff6699ccff66ccffff6699ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff66ccccff0066ccffffffffff0066ccff0066ccffffffffffffffffffffffffffffffffff99ccccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffffffffffffccccffff99ccccffccccffff99ccccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff0066ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff0066ccffffffffffffffffff3399ccff0066ccffffffffff99ccccff66ccccffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff0066ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffffffffff99ccffffccffffff6699ccffccffffffffffffffffffffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccff3399ccff0066ccffffffffffffffffff99ccffff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffff0066ccff3399ccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffff99ccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffffccccffffccffffffccccffffffffffffffffffffccffffffccccffff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff66ccffff6699ccff66ccffff6699ccffffffffff6699ccff99ccffff6699ccff66ccffff6699ccffffffffffffffffffffffffffffffffffccccffff6699ccff66ccffff6699ccff66ccffffffffffffffffffff6699ccff99ccffff6699ccffffffffffffffffffccccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff99ccccffffffffffffffffffffffffffffffffff3399ccff6699ccffffffffffffffffffffffffffffffffff3399ccff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffccccffff99ccccffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffff99ccccff99ccffff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffffccccffff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffff3399ccffffffffffffffffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffffffffffffffffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffccccffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccffffffffffffffffffffffffffffffffffffffffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccffffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccccffffffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffccffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff66ccffff6699ccff66ccccff6699ccffffffffff6699ccff66ccccff6699ccff66ccffff6699ccffffffffffffffffff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff66ccccffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffffffffffffffffffff0066ccff3399ccff0066ccffccccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccffffffffffffffffffffffffffffffffffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffccccffff0066ccff3399ccff0066ccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffccccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff99ccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffff99ccffff99ccffff6699ccff99ccffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffccccffffccffffff99ccffffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccffffccffffffccccffffffffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffffffffffffccccffff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff6699ccff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccffffffffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffffffffffffffffffff6699ccff66ccffffffffffffffffffff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffccccffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffff99ccccffccccffffffffffffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff66ccffff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff0066ccffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffccccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccffffffffff3399ccff6699ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccccffccffffffccccffffccffffff99ccccffffffffffffffffffccffffff99ccccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffffffffffff99ccccffccffffffccccffff99ccffff6699ccffccffffffccccffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccffccccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff6699ccffffffffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff66ccccffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccffffffffffffffffff3399ccff0066ccffffffffff0066ccff0066ccffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffff0066ccff0066ccff0066ccff66ccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffffffffffffffffffff99ccccff3399ccffffffffffffffffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff6699ccffffffffffffffffffffffffff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff0066ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff66ccffffffffffffffffffffffffffff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccffffffffffffffffffffffffff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccffccffffffffffffffffffffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff99ccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffccffffffccccffffccffffff99ccffffccffffffffffffffffffffffffffffffffffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffffccffffff99ccffffccffffffccccffffccffffffccccffffffffffffffffffffffffffffffffffffccffffffccccffffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffccccffffccffffffccccffffccffffffccccffffccffffff99ccffffccffffffccccffffffffffffffffffff3399ccff0066ccffffffffff99ccffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff66ccffffffffffffffffffff6699ccff99ccffff6699ccffffffffffffffffff66ccffff6699ccff66ccccff6699ccff99ccffff6699ccff66ccffff6699ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff66ccffffffffffffffffffff99ccccffccccffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff99ccccffccccffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffccccffff99ccccffccccffff99ccccffccccffff99ccccffccccffff99ccccffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccffffffffffffffffff3399ccff0066ccffffffffff99ccccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff99ccccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff6699ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffff3399ccff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccff99ccffff6699ccffffffffffffffffff99ccffff6699ccff99ccffff6699ccffffffffffffffffffccffffff6699ccff99ccffff6699ccff99ccffff6699ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccffffffffff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccffccccffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffff99ccccffccffffffccccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffffffffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffff99ccccffccffffffffffffffffffffff99ccffffccffffffccccffffccffffff99ccccffccffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccffffffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffff3399ccffffffffff99ccffff0066ccff3399ccff0066ccff3399ccffffffffffffffffffffffffff3399ccffffffffffffffffff0066ccff3399ccffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccffffffffffffffffffffffffff99ccffff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff0066ccffffffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffccffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffff0066ccff3399ccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccff6699ccff66ccffff6699ccff66ccccffffffffffffffffff6699ccff66ccccff6699ccff66ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccffffffffff0066ccff3399ccff0066ccff3399ccff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffccccffff99ccccffccccffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccccffffffffffffffffffffffffff99ccccffffffffffffffffffffffffffffffffffccccffff99ccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccffffffffffffffffff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccffffffffffffffffff3399ccff0066ccff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0066ccffccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff99ccffff6699ccff99ccffff99ccffff99ccffff6699ccff99ccffffffffffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffccffffff99ccffffccffffffccccffffffffffffffffffffccffffffccccffffccffffff99ccffffccffffffccccffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccffccffffff6699ccffffffffffffffffff99ccffff99ccffff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffffccccffff99ccffffffffffff99ccffff6699ccffccffffff99ccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffffffffff99ccffff99ccffff6699ccffccffffffffffffffffffffffffffffffffffffff6699ccff99ccffffccccffff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccffffffffffffffffffffffffffffffffffffffccccffffffffffff99ccffffffffffffffffffffffffffffffffffffccffffffccccffffccffffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffffffffff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffffffffffffffffffffffffffffffffffffffffffff99ccffffffffffffffffffffffffffffffffffffccffffffffffffffffffffffffffffffffffffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccffff99ccffff6699ccff99ccffffccccffffccffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccffffffffffffffffff99ccffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff99ccffffccccffff99ccffffffffffffffffffff6699ccffccffffffffffffffffffffff6699ccff99ccffff99ccffffccffffff6699ccff99ccffffffffffffffffffff6699ccff99ccffff6699ccff99ccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccff99ccffffffffffffffffffffffffffffffffffffffffffffffffffff6699ccffccffffff6699ccffffffffffffffffffffffffffffffffffffffffffffffffff99ccffff6699ccffccffffff6699ccff99ccffff99ccffffccffffffccccffff99ccffff6699ccffccffffff6699ccffccffffff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff0066ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399ccff0066ccff3399cc000700ae00700007000100010003000300040000000d000c001000f300f300f300f300280012004410517569636b54696d65aa20616e642061000028001e004c0d206465636f6d70726573736f720028002a001c1f617265206e656564656420746f20736565207468697320706963747572652e000000a100e007ac00000000000007a86170706c022000006d6e74725247422058595a2007d900020019000b001a000b616373704150504c000000006170706c000000000000000000000000000000000000f6d6000100000000d32d6170706c00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000b64657363000001080000006f6473636d000001780000056c63707274000006e400000038777470740000071c000000147258595a00000730000000146758595a00000744000000146258595a0000075800000014725452430000076c0000000e636861640000077c0000002c625452430000076c0000000e675452430000076c0000000e64657363000000000000001447656e65726963205247422050726f66696c6500000000000000000000001447656e65726963205247422050726f66696c6500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000006d6c7563000000000000001e0000000c736b534b00000028000001786872485200000028000001a06361455300000024000001c87074425200000026000001ec756b55410000002a0000021266724655000000280000023c7a685457000000160000026469744954000000280000027a6e624e4f00000026000002a26b6f4b5200000016000002c86373435a00000022000002de6865494c0000001e00000300646544450000002c0000031e68754855000000280000034a7376534500000026000002a27a68434e00000016000003726a614a500000001a00000388726f524f00000024000003a2656c475200000022000003c67074504f00000026000003e86e6c4e4c000000280000040e6573455300000026000003e874685448000000240000043674725452000000220000045a66694649000000280000047c706c504c0000002c000004a47275525500000022000004d06172454700000026000004f2656e555300000026000005186461444b0000002e0000053e005601610065006f006200650063006e00fd0020005200470042002000700072006f00660069006c00470065006e006500720069010d006b00690020005200470042002000700072006f00660069006c00500065007200660069006c0020005200470042002000670065006e00e800720069006300500065007200660069006c0020005200470042002000470065006e00e9007200690063006f0417043004330430043b044c043d043804390020043f0440043e044404300439043b002000520047004200500072006f00660069006c0020006700e9006e00e9007200690071007500650020005200560042901a75280020005200470042002082725f6963cf8ff000500072006f00660069006c006f0020005200470042002000670065006e0065007200690063006f00470065006e0065007200690073006b0020005200470042002d00700072006f00660069006cc77cbc1800200052004700420020d504b85cd30cc77c004f006200650063006e00fd0020005200470042002000700072006f00660069006c05e405e805d505e405d905dc0020005200470042002005db05dc05dc05d90041006c006c00670065006d00650069006e006500730020005200470042002d00500072006f00660069006c00c1006c00740061006c00e1006e006f00730020005200470042002000700072006f00660069006c666e901a0020005200470042002063cf8ff065874ef64e00822c0020005200470042002030d730ed30d530a130a430eb00500072006f00660069006c0020005200470042002000670065006e0065007200690063039303b503bd03b903ba03cc002003c003c103bf03c603af03bb002000520047004200500065007200660069006c0020005200470042002000670065006e00e9007200690063006f0041006c00670065006d00650065006e0020005200470042002d00700072006f006600690065006c0e420e1b0e230e440e1f0e250e4c002000520047004200200e170e310e480e270e440e1b00470065006e0065006c0020005200470042002000500072006f00660069006c00690059006c00650069006e0065006e0020005200470042002d00700072006f006600690069006c00690055006e006900770065007200730061006c006e0079002000700072006f00660069006c0020005200470042041e04310449043804390020043f0440043e04440438043b044c00200052004700420645064406410020062a06390631064a0641002000520047004200200627064406390627064500470065006e00650072006900630020005200470042002000500072006f00660069006c006500470065006e006500720065006c0020005200470042002d006200650073006b0072006900760065006c007300657465787400000000436f707972696768742032303037204170706c6520496e632e2c20616c6c207269676874732072657365727665642e0058595a20000000000000f35200010000000116cf58595a20000000000000744d00003dee000003d058595a200000000000005a750000ac730000173458595a20000000000000281a0000159f0000b83663757276000000000000000101cd0000736633320000000000010c42000005defffff326000007920000fd91fffffba2fffffda3000003dc0000c06c00a100e000040000000200ff}}}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par ICIS Chemical Business\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  7, 2008\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Land ofdiscovery PARA:: INTRODUCTION:: PARA:: India is pushing into fresh territory by evolving from a commodity-driven drug market into a research-driven development center. But challenges abound PARA::}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Feliza Mirasol\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 FEATURES\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1558  words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PARA:: India's reputation as a hub for pharmaceutical research and development (R&D) is growing. The country's drug industry is famous for its skill in copying products developed elsewhere, but Indian companies, prompted by new patent laws, have begun discovery programs of their own and set their eyes on the global market for innovative drugs.\par PARA::"There are Indian companies that are engaged in the discovery of their own products, and are offe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing these for licensing to third parties, even at very early stages," observes Enrico Polastro, vice president of global management consultancy firm Arthur D. Little. "These types of companies are 'active' in their own di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 covery activities."\par PARA::"There are also other various Indian companies engaged in CRAMS [contract research and manufa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 turing services]," he adds. \par PARA::An interesting move being noticed recently is that some Indian drug companies are spinning off their discovery activities from their manufacturing and marketing operations.\par PARA::"Examples are Nicholas Piramal, Dr. Reddy's Laboratories, and Ranbaxy, which have spun off their discovery divisions in an effort to capture the interest of Western companies. This has been quite fashionable since the end of last year," says Polastro.\par PARA::In addition, there are also service providers that are focusing only on contract development, medicinal chemistry, toxicology, and other narrow areas.\par PARA::"I think most Western generic players are already doing a significant amount of bioavailability studies in India because it's cheaper, and it's easier if you want to do these studies during the period of patent excl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sivity," Polastro says.\par PARA::Innovators that once would source only raw materials from Asia are becoming more comfortable with the region.\par PARA::"Global pharmaceutical companies are increasingly outsourcing early-stage drug discovery to China and India," says UK-based consulting firm Decision Resources. "This trend is not simply a matter of cost. Relocating these functions to China and India helps to gain access to enormous emerging markets."\par PARA::\par PARA::The intellectual challenge\par PARA::However, intellectual property (IP) protection remains a sticky, and often complicated, issue.\par PARA::India's drug industry has historically been driven by the dynamics of the generic drug market. Now it must prove that it can respect patent exclusivity and protect the IP of innovator partners. So far, the results are mixed.\par PARA::"Patents in India are still being overruled in the interest of affordability for the general population," Polastro notes, pointing to Roche's cancer drug Tarceva (erlotinib). The Swiss pharmaceutical company had applied for an Indian patent for Tarceva in 1996. In 2005, Indian regulatory authorities granted Roche the right to market the drug, and in 2007, Roche was granted an Indian patent. So when Mumbai-based }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  launched Erlocip, a generic version of Tarceva, this past January, Roche immediately sued. In March, ho}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ever, the Delhi High Court overruled Roche's Indian patent on Tarceva, clearing the way for the copy. Anot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 er hearing is scheduled for August 6.\par PARA::"The argument [in India] is to make the product more affordable for the general population. As a r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sult, originators are not comfortable with IP in India," Polastro explains. "Another issue is that there is a lot of labor turnover, and this puts IP at risk."\par PARA::The situation is evolving. Regulatory authorities began recognizing drug patents in January 2005 to meet the terms of its membership in the World Trade Organization, (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ) and Indian drug firms increasingly have an interest of their own in the international norms of IP protection.\par PARA::In principle, at least, the country has a new patent plan and a promise to better protect IP rights. In practice, this has been difficult, as the Tarceva example demonstrates.\par PARA::"India's development is entrepreneurial and market-driven [but] it must continue improving IP prote}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion to attract additional global pharmaceutical company investment," says Decision Resources.\par PARA::Indian contract research organizations (CROs) have benefited from trust engendered by the gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment's new IP protection laws. However, each firm on its own will still need to demonstrate that respect for intellectual property is part of its culture and ensured by its systems.\par PARA::"Intellectual property protection in China and India is improving. Both countries are now bound by the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  IP rules, however global pharmaceutical companies (GPCs) continue to face IP hurdles. The deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 opment of local life sciences industries will help to improve the IP environment," says Decision Resources.\par PARA::\par PARA::Attractive shores\par PARA::Pharmaceutical companies have been moving R&D functions and operations to India, as well as Ch}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 na, only in recent years. In some cases, companies began offshoring their business, either relocating internal operations to these countries or establishing joint ventures with Indian or Chinese partners, but they are also outsourcing as well.\par PARA::Driving these choices is the need to improve pharmaceutical R&D productivity and bring a larger number of drugs to market more efficiently, states Decision Resources.\par PARA::Western pharmaceutical companies have typically tapped into CROs in both China and India to pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 form specific tasks in clinical development, data management, and preclinical toxicology studies. Now these CROs are moving upstream in the R&D value chain. They are increasingly offering their services in chemi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 try, assay development and even target identification, according to Decision Resources.\par PARA::"This trend is a consequence of higher government investments in basic research and improved technology transfer between universities and industry," says the consultancy.\par PARA::Both India's and China's governments are striving to create outsourcing opportunities. More i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 portantly, they want to establish domestic high-tech industries and a high-value research base in lucrative therapeutic areas.\par PARA::The nature of the relationship between Western pharmaceutical companies and Indian drug disco}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ery service providers remains tentative, as drug discovery outsourcing to India is still in the early stages.\par PARA::"I think the jury is still out," says Polastro. "And the same applies to China. I think at this stage, ever}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 one is still searching their own way for the best solutions, feeling their way through the R&D dilemma."\par PARA::He adds: "Another issue with IP, for example, is that everybody is moving into new territory, ever}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 body is talking the game, but not many people have actually done it. So it remains somewhat theoretical."\par PARA::Polastro also notes that some companies, such as European-headquartered pharmaceutical r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 search firms Sanofi-Aventis and Novartis, have their own R&D activities in both China and India. "They are setting up shop with their own facilities and their own employees," he says.\par PARA::\par PARA::Who's on the table\par PARA::Leading Indian CROs include GVK Biosciences, Syngene, Sai Advantium and Accutest. Meanwhile, leading Indian hybrid companies - those offering contract services as well as conducting their own internal drug discovery - include Advinus Therapeutics, Avra Laboratories, Dr. Reddy's Laboratories, Jubilant Biosys, Suven Life Sciences and Nicholas Piramal, according to Decisions Resources.\par PARA::GVK grabbed attention when it signed a high-profile outsourcing deal with Wyeth Pharmaceuticals in 2006. The deal was the first large multiyear contract awarded to an Indian company for contract research services, the two companies stated.\par PARA::In May, GVK and Wyeth signed another research agreement to discover and develop drug cand}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 dates from prediscovered targets.\par PARA::Also in May, US-based Merck established an alliance with India's Ranbaxy Laboratories for drug di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 covery and clinical development for new candidates in the antiinfectives therapy market. The deal, which has an initial five-year term, is potentially worth over $100m (\u163\'a364m).\par PARA::In June, Ranbaxy agreed to sell a majority stake to Japan-based Daiichi Sankyo in a transaction va}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ued at roughly $8.5bn. Ranbaxy is known to be in Phase II clinical testing of what some are calling the next important antimalaria drug.\par PARA::Aurigene, Advinus, Nicholas Piramal and Jubilant have all negotiated long-term contracts with Wes}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ern pharmaceutical firms for discovery and development of new chemical entities.\par PARA::The growing outsourcing markets of China and India are attracting Western companies such as Swi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 zerland-based RCC Pharma and US-based Albany Molecular Research, Covance, and Charles River Labo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 atories.\par PARA::Indian players have been getting more play in early drug discovery, giving them an edge over their Chinese peers. India is said to have far more experience from selling generic drugs and from having a track record of meeting the US Food & Drug Administration's standards, lending it a more mature market reput}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion for chemistry and drug discovery activities.\par PARA::"Some Indian companies seeking to enter Western markets are contracting with Western CROs. This situation offers significant opportunities for Western CROs able to comply with US or European regulations," states Decision Resources.\par PARA::\par STARTLIST::LIST::? Sign up for the ICIS fine chemical and pharma e-newsletter: <link>www.icis.com/e-newsletters</link>\par PARA::\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PHARMACEUTICALS INDUSTRY (92%); RESEARCH & DEVELOPMENT (91%); PHARM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 CEUTICAL CHEMISTRY (90%); CHEMICALS RESEARCH (90%); PHARMACEUTICALS PRODUCT D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 VELOPMENT (90%); PRODUCT DEVELOPMENT (90%); DRUG DESIGN & DISCOVERY (90%); PATENT LAW (89%); INTELLECTUAL PROPERTY LAW (89%); PATENTS (89%); INTELLECTUAL PROPERTY (89%); PHARMACEUTICAL PREPARATION MFG (88%); TOXICOLOGY (78%); PRODUCT INNOVATION (78%); MULTINATIONAL CORPORATIONS (78%); EMERGING MARKETS (78%); GENERIC DRUGS (78%); OUTSOURCING (78%); CONSULTING SERVICES (75%); ENTERPRISE GLOBALIZATION (73%); CHEMISTRY (73%); CANCER (73%); CANCER DRUGS (73%); INTERNATIONAL TRADE (71%); MA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AGEMENT CONSULTING (70%) Land ofdiscovery\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ROCHE HOLDING AG (85%); RANBAXY LABORATORIES LTD (55%); DR REDDY'S L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 BORATORIES LTD (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ROG (SWX) (85%); RANBAXY (NSE) (55%); RDY (NYSE) (55%); DRREDDY (NSE) (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (85%); NAICS325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING (85%); NAICS325411 MEDICINAL & BOTAN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 CAL MANUFACTURING (55%); SIC2834 PHARMACEUTICAL PREPARATIONS (55%); SIC2833 MEDIC}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAL CHEMICALS & BOTANICAL PRODUCTS (55%); SIC2835 IN VITRO & IN VIVO DIAGNOSTIC SU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 B}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 STANCES (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 INDIA (96%); CHINA (92%); ASIA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 November 5, 2009\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Magazine\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2008 Reed Business Information Ltd.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda; $10m HIV Drugs Ordered From New Factory Africa News January 28, 2008 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_35}{\*\bkmkstart DOC_ID_35_0}{\*\bkmkstart doc_id_6}{\*\bkmkend DOC_ID_35}{\*\bkmkend DOC_ID_35_0}{\*\bkmkend doc_id_6}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_6"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 6 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 January}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  28, 2008 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Uganda; \par $10m HIV Drugs Ordered From New Factory}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 East African Business Week\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 719 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda's recently commissioned Antiretroviral and anti-malarial drugs plant starts production with a bang as government sets an order for a consignment of ARVs worth Ush17billion ($10US million).\par Uganda's health ministry is raising sh8billion ($4.3 million) and other government departments will fill the r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 maining sh9billion ($5.7million) to buy the drugs, a move that is believed will mark a new era in the manag}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment of HIV/AIDS in the country.\par The ministry of health is handling the procurement of ARVs which will be deployed in the national AIDS treatment programme in which up to 100,000 Ugandans are getting free treatment. \par Statistics indicate despite reaching 42% of the population in need of Antiretroviral therapy (ART) in 2005, the number in need of ART continues to grow each year for example; 129,000 in 2007 and projected to 238,000 in 2012 - far outstripping the capacity of the system to respond.\par The case malaria is equally alarming, making the two mentioned diseases the biggest challenge to Uganda's health care system. Uganda spends $70 million on ARVs and malaria drugs every year.\par The first $10 million consignment covers the first quarter of the year, which implies that government will spend $40 million on ARV treatment throughout the year and will enlist more beneficiaries for the drugs.\par Informed observers say that this is more than half the price that government spends on imported drugs to treat a large portion of the population living with HIV/AIDS.For instance, the Public Service Ministry has re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 istered 10,000 civil servants living with HIV/AIDs and are ready fro ART but have not accessed the service yet.\par Emmanuel Katongole the managing director of the plant, last week said that Ugandan ARVs combination for a monthly subscription will be 30% cheaper than the imported drugs. "We want to focus on addressing the problems of scarcity and affordability of drugs. The triple therapy ARVs cocktail for one month cost $15 to the final consumer but with this factory we are going to sell it at $9," Katongole said. "So we are going to expand access to these drugs."\par The plant, which will in the first phase produce two million tablets per day, is a partnership between the Go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ernment, Quality Chemical Industries, a local company, and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  one of the world's leading generic man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 facturers.\par Minister of state for primary health care Dr. Emmanuel Otaala told East African Business Week that the mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 istry would source the money from donors besides the budget allocations.\par Otaala also confirmed that government has introduced a budget line for HIV/AIDS activities.\par Government has previously been importing ARVs from India which are cheaper than original drugs from E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 rope's giant pharmaceuticals. However, the Indian drugs are still out of reach to the average Ugandan.\par The situation could worsen in the vent of a }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  agreement banning India from exporting relatively cheap generic ARV drugs to third world countries like Uganda.\par The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Trade Related Intellectual Property Rights (TRIPS) agreement which India ratified takes effect this year.\par The TRIPS pact however provided a window for developing countries to access technology which can be used to manufacture the generic drugs locally. Uganda was the first African country to acquire this technol}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gy and set up the factory which will provide a regional market as well.\par But market concerns are at the moment taking second seat as the factory concentrates on the task of ne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tralizing disease burden on the Uganda economy.\par Katongole says that the priority of the company is to satisfy government demand, then private sector and the wider regional market.\par He also said that government is obliged to purchase ARVs from company as part of the agreement which preceded the $30 million investment. Katongole said that export to Rwanda and Tanzania will start at the end of this year.\par Katongole also said that the ARV plant was a big move towards self-reliance in supply of drugs breaking out of the york of depending on donor funding for expensive drugs.\par "Most of the drugs we have are from donor funds, what happens when donor funds dry up," he said. In 2006, government was in a crisis of shortage of ARVs after the Global Fund on Aids, Tuberclosis and Malaria which funds 80% the national ARV requirement suspended the grant over mismanagement of funds.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS & HIV (94%); ANTIVIRALS (93%); AIDS & HIV TREATMENT (92%); PUBLIC HEALTH ADMINISTRATION (90%); MALARIA (90%); ANTI-INFECTIVES (90%); HEALTH DEPARTMENTS (90%); IMPORT TRADE (89%); MANUFACTURING FACILITIES (89%); DISEASES & DISORDERS (78%); PHA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MACEUTICALS INDUSTRY (78%); GENERIC DRUGS (78%); HEALTH CARE POLICY (77%); BUDGETS (77%); HEALTH CARE (75%); CHEMICALS (73%); CHEMICALS MFG (73%); GENERIC PRODUCTS (69%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (51%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (51%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (51%); SIC2834 PHARMACEUTICAL PREPARATIONS (51%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UGANDA (97%); INDIA (79%); EUROPE (79%); EASTERN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 January 28, 2008\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2008 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda; New Factory to Improve Access to Arvs Africa News October 24, 2007 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_36}{\*\bkmkstart DOC_ID_36_0}{\*\bkmkstart doc_id_7}{\*\bkmkend DOC_ID_36}{\*\bkmkend DOC_ID_36_0}{\*\bkmkend doc_id_7}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_7"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 7 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 October}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  24, 2007 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Uganda; \par New Factory to Improve Access to Arvs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 753 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Once the factory is completed, two million tablets will be manufactured in a single day's shift, improving not just availability but affordability of the drugs as well\par Uganda is set to be the first African country to manufacture and produce the full range of Anti-Retrovirals by the end of this year. The fete will be achieved following a partnership between Quality Chemicals Ltd (QCI) and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ltd of India.\par The production of the drugs could not have come at a better time. The chairperson of the Uganda Aids Commission Dr Kihumuro Apuuli raised concern over the emergence of new infections every year which could put a huge burden on finding treatment. Already, Uganda cannot meet the demand of ARVs. \par According to ministry of health official data, only 100,000 people are able to access ARVs out of the 300,000 that require them. The picture is not any different among the children, only 50,000 are on ARV treatment out of the 110,000. \par The situation is however expected to improve once drugs start rolling out of the Luzira-based $36m factory. According to Emmanuel Katongole, QCI's managing director, two million tablets will be manufactured in a single day's shift. "That is enough to cater for Uganda and the region. Therefore there is an export opportun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ty," Mr Katongole said recently.\par However, it would defeat the purpose if the production of the drugs within the country does not result into affordability. Considering that the cost of production for the drugs will be lower than those imported, Mr Katongle said the prices of the drugs will be affordable to the ordinary Ugandan. President Museveni, while inaugurating the factory pledged that the government would buy the drugs from the manufacturers provided the quality is competitive. In turn, the government will avail the drugs to those in need.\par Dr Sam Zaramba, the director general for health services said that the time lag to procure the drugs will si}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nificantly shorten once production starts at the Luzira-based industry. "We shall not have to wait for shi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment," Dr Zaramba said. Shipping of the drugs usually takes close to six months, which according to Dr Z}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ramba can cause problems in case of a shortage as patients cannot go a day without taking the drugs. Uganda has experienced a shortage in the past.\par According to Mr George Baguma, QCI's Director for Marketing, the $36m project was borne of the need to address distortions imposed by India's ratification of the TRIPS agreement of the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ). "The move threatened to deny Africa access to affordable medicines. Indeed the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  recognised the predicament that this agreement would impose on the poor countries and consequently exempted the Least Developed Nations from implementation of the TRIPS accord and encouraged developed countries to transfer technology to LDCs to enable them mitigate a sure catastrophe."\par That is how the manufacturers ended up in Uganda. Dr Zaramba said with the manufacturers within the country, it will make the government's work of monitoring much easier. Uganda's market usually gets flooded with fake drugs especially anti-malarials mainly from India.\par The decline in prices means that more people will be able to access the drugs, which in turn will mean that Uganda will move closer to achieving the United Nations' Millennium goal of increasing access to ARVs and reducing deaths from malaria by 2015. QCI is to also manufacture anti-malarial drugs.\par Malaria is one of the leading causes of death, claiming 320 people in Uganda every day according to the Ministry of Health. That is the number registered at the various health centres, only God knows how many others die without getting to the centres. That figure is expected to reduce with the production of anti-malarial drugs.\par Uganda has also occasionally been hit by a shortage in the supply of ARVs. But with the manufacturers in Luzira, Dr Zaramba said that may not happen again. "The process is a long one which has to be done 2-3 months in advance," he said.\par Mr Baguma said the plant in Luzira will make Uganda self sufficient. "Our aim is to apply the discoveries of pharmaceutical sciences to improve the quality of life of our people. Our commitment is our living strength and its promise for the future," he said.\par The availability of ARVs should however not blur the population to the extent of the HIV scourge. Much as the drugs will be available, behavioural change should also be encouraged, observed Mr Elioda Tu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 wesigye, chairperson of the Parliamentary Committee on HIV/Aids.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 DEVELOPING COUNTRIES (89%); ANTIVIRALS (78%); HEALTH DEPARTMENTS (78%); AIDS & HIV (78%); MANUFACTURING FACILITIES (78%); HEALTH CARE ACCESS (78%); EMERGING MARKETS (77%); TRADE DEVELOPMENT (76%); IMPORT TRADE (74%); DRUG PRICES (73%); CHE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ICALS (72%); PUBLIC HEALTH ADMINISTRATION (70%); EXPORT TRADE (70%); INTERNATIONAL ECONOMIC ORGANIZATIONS (60%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (83%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (83%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (83%); SIC2834 PHARMACEUTICAL PREPARATIONS (83%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UGANDA (94%); INDIA (93%); AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 October 23, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa; Daily HIV/Aids Report Africa News October 9, 2007 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_37}{\*\bkmkstart DOC_ID_37_0}{\*\bkmkstart doc_id_8}{\*\bkmkend DOC_ID_37}{\*\bkmkend DOC_ID_37_0}{\*\bkmkend doc_id_8}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_8"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 8 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 October}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  9, 2007 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Africa; \par Daily HIV/Aids Report}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Kaisernetwork.org\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 3231 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Politics and Policy\par Ministers, Medical Professionals, Lawmakers Gather for Meeting To Discuss HIV/AIDS Issues in Black Community\par [Oct 09, 2007]\par Dozens of ministers from across the country on Monday in New York City gathered with representatives from the National Medical Association, the Congressional Black Caucus and other groups to develop a plan for addressing HIV/AIDS in the black community, USA Today reports.\par During the two-day meeting, convened by the National Black Leadership Commission on AIDS, participants will discuss recommendations from NMA -- which includes about 30,000 black doctors and in August d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 clared HIV/AIDS among blacks a public health emergency -- for fighting the epidemic in the U.S. The confe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ence also aims to educate pastors about how they can combat HIV/AIDS in their communities, such as providing information about the disease and building relationships with social service agencies that can a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sist members living with the disease. Bishop T.D. Jakes of the Dallas-based Potter's House church, who is co-chairing the meeting, said the conference also will demonstrate to 2008 presidential candidates the i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 portance of reaching out to black congregations and supporting HIV/AIDS research and education. \par Comments \par Jakes -- whose church has more than 30,000 members -- said, "We can hold our politicians accountable," adding, "Now is the time for the church to give a clarion call to government that this is one of the issues high on our radar screen." The Rev. Calvin Butts -- senior pastor of the Abyssinian Baptist Church, who is co-chairing the meeting -- said, "Since the movement of the [1960s], we haven't seen a gathering of African-American clergy persons like this around a specific issue," adding, "At that time, it was civil rights and human rights. Now it's a major health crisis which is impacting our community." Butts also said that for "25 years we've been dealing with this crisis, ... but I don't think there's been enough attention paid to it, and I think our efforts have not had the power that they can have because we have not come together as we are doing now."\par NBLCA President Debra Fraser-Howze said, "We have a time bomb on our hands," adding, "I think that the black church will openly admit that they have not done enough in regard to HIV and AIDS. ... This is the time for them to come together to use their collective influence to make a national statement on what needs to happen." According to CDC estimates from 2005, blacks made up about 13% of the U.S. population but a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 counted for 49% of new AIDS diagnoses (Jones, USA Today, 10/8).\par Link to this story.\par Drug Access\par Ugandan President Museveni Commissions Pharmaceutical Plant That Will Produce Antiretrovirals, Antim}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 larials\par [Oct 09, 2007]\par Ugandan President Yoweri Museveni on Monday commissioned a 15-acre pharmaceutical plant in the cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 try that will produce a triple-therapy combination antiretroviral drug, as well as first-line malaria treatments, the New Vision/AllAfrica.com reports. According to New Vision/AllAfrica.com, other African countries -- such as Egypt, Nigeria and South Africa -- have factories that manufacture antiretrovirals but none produces co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 bination therapies (Wendo, New Vision/AllAfrica.com, 10/5).\par The new factory, the first of its kind in Uganda, aims to lower the cost of antiretrovirals by reducing import expenses, BBC News reports. Ugandan pharmaceutical importer Quality Chemical Industries and the Indian pharmaceutical company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  will produce the medications (BBC News, 10/8). The factory will manufacture the antiretroviral combination therapy Triomune, which contains lamivudine, stavudine and nevirapine. In addition, the factory will produce the first-line antimalarial combination treatment Lumartem, which contains artemisinin and lumefantrin.\par According to Emmanuel Katongole, managing director of Quality Chemical Industries, the factory on Monday began trial runs to ensure that factory equipment measures ingredients accurately and produces pills that are uniform in size and concentration. The trial runs are expected to last until November or December, and the factory "should be in position to manufacture for the market" in January 2008, Katongole said.\par Katongole added that the factory initially will produce about two million antiretroviral and antimalarial pills da}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ly, which will later increase to six million daily, or 1.8 billion pills annually. The Ugandan government will be the first client to purchase medications from the factory. About 80,000 of the estimated 150,000 to 300,000 Ugandans in need of antiretrovirals currently receive them, Katongole said, adding that the new factory "should enable [the] government to double that number."\par The factory will export antiretrovirals to neighboring countries after the Ugandan government has purchased its supply. The countries likely will begin to purchase antiretrovirals from the factory beginning in January, Katongole said.\par According to New Vision/AllAfrica.com, African countries beginning in January 2008 will no longer be able to import generic antiretrovirals from India, which has been Uganda's main source of generic antiretrovirals, because of a change in the India's patent laws (New Vision/AllAfrica.com, 10/5).\par Comments\par Leonard Okello of ActionAID International said, "The challenge is to make sure that the production is fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lowed by a good distribution system that makes sure that the drug can reach all corners of the country" (BBC News, 10/8). Jesse Kajimba, Uganda's senior presidential adviser on HIV/AIDS, said that producing a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tiretrovirals locally could give the country greater independence in determining its supply and ensuring quality control.\par Peter Mugyenyi, director of the Joint Clinical Research Centre, added that although local production is the best way to guarantee the availability of antiretrovirals, the factory should aim to produce new antiretroviral combination therapies, such as Atripla (New Vision/AllAfrica.com, 10/5).\par Link to this story.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Receives Notification From Canada Authorizing Generic Drug Company To Produce Combination A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tiretroviral for Rwanda\par [Oct 09, 2007]\par The World Trade Organization on Friday announced it had received notification from the Canadian Intelle}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tual Property Office authorizing Toronto-based generic drug company Apotex to manufacture its fixed-dose combination antiretroviral drug Apo-triAvir for Rwanda, Toronto's Globe and Mail reports (Gandhi, Globe and Mail, 10/6). According to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 , Apo-triAvir now can be manufactured and exported to Rwanda (Higgins, A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sociated Press, 10/5).\par GlaxoSmithKline in August announced that it had given consent to Apotex to use two of GSK's patented a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tiretroviral drugs, lamivudine and zidovudine, to manufacture Apo-triAvir -- a combination of lamivudine, z}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 dovudine and nevirapine. Boehringer Ingelheim agreed in July to allow Apotex to use nevirapine in the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 bination.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  in July in a statement announced that Rwanda plans to override the pharmaceutical patents and import 260,000 packs of Apo-triAvir. Under an August 2003 waiver to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Agreement on Trade-Related Aspects of Intellectual Property Rights, known as the "paragraph 6 system," developing countries with a public health crisis are allowed to import generic drugs when they cannot manufacture the drugs themselves. According to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 , Rwanda is the first country to use the waiver, which would allow it to import generic drugs that are manufactured under compulsory licenses in other countries. The TRIPS waiver submission was made last month by the Treatment and Research AIDS Centre. Rwanda plans to import the 260,000 packets during the next two years (Kaiser Daily HIV/AIDS Report, 8/10).\par Reaction\par Elie Betito, director of public and government affairs for Apotex, said the company is "in the final processes of the development of [Apo-triAvir] now, so we should be in the production stages soon." He added, "If ever}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 thing goes as planned, by mid-December we should have product flowing to Africa."\par According to the Globe and Mail, some HIV/AIDS advocates said the Canadian law that allows authorization of generic drug production needs to be changed if it is going to help other countries in need of generic a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tiretrovirals. "Even though we have the first compulsory license issued, that doesn't mean somehow that there's no problem with the legislation," Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, said, adding, "It took nearly three years to get to this point." It is "unlikely that Apotex, or any gene}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ic manufacturer, will want to go through this process again," Elliott said (Globe and Mail, 10/6).\par Link to this story.\par Media & Society\par Congo Television Pilot Featuring HIV/AIDS Stories in Local Language To Air\par [Oct 09, 2007]\par The first episode of "My Story" -- a television series inspired by people living with HIV/AIDS in the Democratic Republic of Congo -- is scheduled to air this month on Congolese television stations in Lingala, the most common local language, Inter Press Service reports. The series director, Djo Tunda Wa Munga, a Cong}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lese filmmaker who trained at Institut National Superieur des Arts du Spectacle in Brussels, Belgium, said another local program inspired him to create the series. "I was very surprised to see AIDS patients come openly and with uncovered faces to speak of the illness on television," Wa Munga said.\par At the end of 2006, he contacted the people from the show that inspired him and used experiences from their lives to create a fictional series. The pilot, "Papy," is based on the story of Papy Ilunga, a police officer who was rejected by his family after he told them he was HIV-positive. The episode was filmed in Kinshasa, DRC, and professional actors play the characters. "The foundation of reality is very important to my approach. From this, I try to establish story lines," Wa Munga said. According to Inter Press Service, the first episode tries to convey that HIV-positive people need the support of their families to fight the disease.\par Several organizations and governments -- including the International Organisation of La Francophonie, the King Baudouin Foundation, Belgium and Germany -- contributed financially to the filming of "Papy." Wa Munga's project also has the support of UNAIDS Director Peter Piot, Inter Press Service reports. KBF and Belgium gave about $71,000, according to Inter Press Service.\par Gerrit Rauws, health affairs director at KBF, said the foundation had two goals in supporting the series -- "helping a Congolese cinematic project [and] an ambitious project to fight HIV/AIDS." Sabine Ruppol, a tec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nical counselor for Belgian governmental aid, called the film a "strong signal," adding that "each Congolese can recognize themselves in it, and that's proof of success."\par The series is the first HIV/AIDS-related television program to air in Lingala. The pilot also will air on TV5 Monde and will appear at film festivals, including the Fortnight of Francophone Cinema, which begins Friday in Paris. According to UNAIDS data from 2005, there are about one million people living with HIV/AIDS in DRC, including approximately 100,000 children (Walschaerts, Inter Press Service, 10/5).\par A preview of the production can be seen on YouTube.\par Link to this story.\par Science & Medicine\par Philadelphia Inquirer Examines Effect of Merck's Failed International HIV Vaccine Trial on Research and D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 velopment\par [Oct 09, 2007]\par Merck's decision last month to halt its international HIV vaccine trial was not a "definitive blow" to HIV va}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cine research and development, but it created questions about whether research was "careening down the wrong path," the Philadelphia Inquirer reports (Stark, Philadelphia Inquirer, 10/7). Merck announced that it had ended its Phase II trial, which began in late 2004 and involved 3,000 HIV-negative volunteers, after its experimental vaccine failed to prevent HIV infection in participants or prove effective in delaying the progre}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sion of the virus to AIDS. The trial was stopped by the Data and Safety Monitoring Board, an independent overseer.\par Some researchers have theorized that because HIV-positive people who have stronger T-cell responses tend to fight the virus better, a vaccine that simulated a T-cell response might be able to control HIV/AIDS. The Merck vaccine was made from a weakened version of a common cold virus that served as a mode for providing three synthetically produced genes from HIV, known as gag, pol and nef (Kaiser Daily HIV/AIDS Report, 9/24). According to Mark Feinberg, Merck's vice president for Medical Affairs for Vaccines and Infe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tious Diseases, an estimated 90% of vaccine studies were using major elements of Merck's experimental vaccine.\par Some researchers said the trial might prove useful for researchers. "The information is going to help us d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 velop a vaccine in the future," Ian Frank -- director of the HIV Vaccine Trials Unit at the University of Pen}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sylvania, which enrolled 125 people in Merck's trial -- said, adding, "I don't think people should be overly di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 appointed. We're really at the very earliest stages in this process." Gary Nabel, director of NIH's Vaccine R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 search Center, said, "To paraphrase some of my colleagues, the trial shows a failure of a specific product but not a failure of a concept," adding that it would be "truly remarkable" to see an effective vaccine developed in the next 10 years.\par John Shiver, head of Merck's basic research in vaccines, said he believes that no current approaches toward HIV vaccine development are working and that a new approach is needed. The world is spending $759 mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lion annually on HIV vaccine development, up from $150 million annually in the 1990s, Seth Berkley, pres}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 dent of the International AIDS Vaccine Initiative, said. More than 90% of the funding is coming from gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ments, the Inquirer reports (Philadelphia Inquirer, 10/7).\par Related Editorial\par The halt of Merck's HIV vaccine trial is "not the death of the quest; it's an opportunity to bend more strength to it," an Inquirer editorial says. Because of previous research that did not yield an effective HIV vaccine, we know much more about how the "fiendishly well-armed retrovirus associated with AIDS operates," according to the editorial. The Inquirer adds "our failures guide us to our successes" and "failures should spur funders not only to keep backing research and development, but also to step it up." This "quest will need friends in society and government," that is, "if we really care," the editorial concludes (Philadelphia Inquirer, 10/6).\par Link to this story.\par Public Health & Education\par Peace Corps Volunteers To Begin Work on HIV/AIDS Projects in Ethiopia\par [Oct 09, 2007]\par Forty-three Peace Corps volunteers this weekend will begin two-year posts in Ethiopia that will focus on HIV/AIDS-related education and awareness projects, the organization announced last week, the AP/Minneapolis Star Tribune reports. The group of volunteers is the first that Peace Corps has stationed in Ethiopia since 1999, when the organization halted programs during a border war between the country and neighboring Eritrea, the AP/Tribune reports.\par The agency's programs will include working directly with Ethiopia's health ministry on HIV/AIDS programs in western and northern areas of the country, the AP/Star Tribune reports (AP/Minneapolis Star Tribune, 10/4). About 1.4% of Ethiopians ages 15 to 49, or one million people, are HIV-positive, according to the Ethiopia Demographic and Health Survey 2005, which was released in September 2006 (Kaiser Daily HIV/AIDS R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 port, 9/21/06).\par Henry McKoy, Africa director for the Peace Corps, on Wednesday said the organization has been preparing to launch programs in Ethiopia for two years. He added that the new programs will give the Peace Corps a "chance to renew our partnership, to build strong ties" with Ethiopia. The agency plans to have 100 volu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 teers in Ethiopia within one year.\par More than one-third of all Peace Corps volunteers, or about 2,800 volunteers, work in 25 African countries. McKoy said the Peace Corps' return to Ethiopia will not be affected by a bill (HR 2003) that would require the Ethiopian government to improve its human rights record or risk losing U.S. assistance (AP/Minneapolis Star Tribune, 10/4). The House last week by voice vote passed the bill, and it has been referred to the Senate Foreign Relations Committee (HR 2003 bill history, 10/5).\par Link to this story. \par Opinion\par Fight Against HIV/AIDS 'Far From Over,' Should Focus on Prevention, Testing, Opinion Piece Says\par [Oct 09, 2007]\par The fight against HIV/AIDS is "far from over," and the "only way to reverse the spread of" the virus is to "f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cus on prevention," Richard Holbrooke, president of the Global Business Coalition on HIV/AIDS, Tubercul}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sis and Malaria, writes in a Washington Post opinion piece. It is "heartening" that more than two million pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ple living with HIV have access to antiretroviral drugs, Holbrooke writes, adding that "real progress must be measured by the only criterion that ultimately matters: Is the number of people who are HIV-positive decli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing? The answer is a resounding no."\par According to Holbrooke, HIV prevention methods need "immediate emphasis and far, far more resources." He adds that a "viable prevention strategy" should include HIV education and counseling, access to no-cost condoms, efforts to empower women, increased male circumcision efforts and abstinence programs. Ho}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ever, "none of this will work without widespread testing," Holbrooke writes, adding that "[i]n no other medical epidemic in history has detection been such a low priority." Holbrooke writes that during the 19th annual World AIDS Day -- Dec. 1 -- the international health community should admit that it is "still losing" the fight against HIV/AIDS and "[a]dvocate strategies that emphasize prevention and detection, based on the su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cessful 'opt-out' testing system." He concludes, "If current policies are not changed, we will face uncontroll}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ble growth in the costs of" treating a preventable disease (Holbrooke, Washington Post, 10/9).\par Link to this story.\par African Countries Should 'Find Resolve' To Issue Compulsory Licenses 'When They See Fit,' Opinion Piece Says\par [Oct 09, 2007]\par African countries should "find the resolve to follow Thailand's example" and issue compulsory licenses to produce reduced-cost versions of patented antiretroviral drugs "when they see fit," Lara Santoro, who worked as a journalist in Africa from 1997 to 2004, writes in a Los Angeles Times opinion piece (Santoro, Los Ang}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 les Times, 10/9).\par The Thai government in November 2006 and January issued compulsory licenses to produce lower-cost ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sions of Merck's antiretroviral Efavirenz and Abbott Laboratories' antiretroviral Kaletra, respectively. Since then, the government and drug companies have continued negotiations (Kaiser Daily HIV/AIDS Report, 5/16). Santoro writes that "contrary to common perception, Thailand's move was, and remains, in perfect observance of international law." Some countries -- including Kenya, Uganda and South Africa -- "have not only the manufacturing base needed to copy and reproduce drugs for a fraction of their costs, they also have the right" to do so, Santoro writes. She adds that African countries should grant compulsory licenses b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cause by doing so, "they would put an end to a drug monopoly whose human cost brings shame to us all" (Los Angeles Times, 10/9).\par Link to this story.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS & HIV (94%); RACE & RACISM (90%); LEGISLATORS (90%); CONFERENCES & CO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 VENTIONS (90%); DISEASES & DISORDERS (90%); TALKS & MEETINGS (90%); CLERGY & RELIGIOUS (89%); CHRISTIANS & CHRISTIANITY (88%); AIDS POLICY (79%); POLITICAL CANDIDATES (79%); CAUCUSES (79%); AIDS & HIV TREATMENT (78%); AFRICAN AMERICANS (78%); BUSINESS & PR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 FESSIONAL ASSOCIATIONS (78%); PROTESTANTS & PROTESTANTISM (78%); EPIDEMICS (78%); PRESIDENTIAL ELECTIONS (77%); PUBLIC HEALTH ADMINISTRATION (75%); RELIGION (74%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NATIONAL MEDICAL ASSOCIATION (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NEW YORK, NY, USA (88%); DALLAS, TX, USA (79%) NEW YORK, USA (92%); TEXAS, USA (79%) UNITED STATES (95%); UGANDA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 October 9, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda; Country to Begin Producing ARVs Africa News September 21, 2007 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_38}{\*\bkmkstart DOC_ID_38_0}{\*\bkmkstart doc_id_9}{\*\bkmkend DOC_ID_38}{\*\bkmkend DOC_ID_38_0}{\*\bkmkend doc_id_9}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_9"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 9 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 September}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  21, 2007 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Uganda; \par Country to Begin Producing ARVs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 371 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 BEGINNING next month, Uganda will start manufacturing generic Anti-Retroviral drugs, giving hope to many living on the life saving tablets.\par Two companies; Quality Chemicals Ltd and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ltd of India will produce the drugs at their plant in Luzira, Kampala. The firms will also manufacture anti-malarial drugs in a move that has been saluted by the Ministry of Health. \par This will boost access and affordability of anti-retroviral drugs in the country. Dr Sam Zaramba, the director general of health services, told Daily Monitor yesterday that the time taken to procure the drugs will signif}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cantly shorten once production starts.\par "We shall not have to wait for shipment," he said. Shipping of the drugs usually takes close to six months, which according to Dr Zaramba can cause problems in case of shortage as patients cannot go a day without taking the drugs. Uganda has experienced a shortage in the past.\par The prices, Dr Zaramba, said will be competitive as before, but will be cheaper. Currently a monthly dose of ARVs goes for Shs30,000.\par But laboratory and CD4 volume tests, that are a necessary procedure before usage of the drugs, are very expensive. CD4 count shows the status of the body's immunity.\par The decline in prices means that more people would access the drugs, enabling Uganda to move closer to achieving the UN Millennium Goal of increasing access to ARVs and reducing malaria-induced deaths by 2015.\par According to Dr Elizabeth Madraa, the head of the Aids Control Programme, 100, 000 people currently a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cess ARVs as opposed to the 300, 000 that should. Ministry of Health figures show that Malaria on the other hand claims 320 people in Uganda every day.\par According to the Quality Chemicals' Director for Marketing, Mr George Baguma, the $30 million project was borne out of the need to address distortions imposed by India's ratification of the TRIPS agreement of the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ).\par "The move threatened to deny Africa access to affordable medicines. Indeed the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  recognised the pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 dicament that this agreement would impose on the poor countries," he said.\par Dr Zaramba said with the manufacturers now here, the government's work of monitoring the importation of anti-malarials and ARVs would be easier.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS & HIV (90%); GENERIC DRUGS (90%); ANTIVIRALS (90%); CHEMICALS MFG (89%); CHEMICALS (89%); MALARIA (89%); HEALTH DEPARTMENTS (78%); TROPICAL DISEASES (78%); GENERIC PRODUCTS (78%); ANTI-INFECTIVES (78%); PUBLIC HEALTH ADMINISTRATION (77%); HEALTH CARE ACCESS (76%); INTERNATIONAL ECONOMIC ORGANIZATIONS (63%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (93%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UNITED NATIONS (54%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (93%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 KAMPALA, UGANDA (92%) UGANDA (94%); INDIA (93%); AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 September 20, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda; Quality Courts Cipla for Drugs Africa News April 3, 2007 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_39}{\*\bkmkstart DOC_ID_39_0}{\*\bkmkstart doc_id_10}{\*\bkmkend DOC_ID_39}{\*\bkmkend DOC_ID_39_0}{\*\bkmkend doc_id_10}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_10"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 10 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  3, 2007 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Uganda; \par Quality Courts }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955  for Drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 591 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UGANDA is stepping up efforts to manufacture its own life-saving medicines so that it does not have to rely on imports from foreign pharmaceutical companies.\par Quality Chemicals Ltd, a distributor of pharmaceutical products in Uganda has teamed up with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ltd of India, one of the world's leading generic pharmaceutical manufacturers, to put up a world-class plant in the country to manufacture antiretrovirals, drugs used to treat people living with HIV/AIDS.\par This was after President Museveni in particular approached }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Limited and asked them to invest in Uga}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 da. \par According to the World Health Organisation (WHO), the population of people living with HIV/AIDS in the world is approximately 33 million. Of these, 80 per cent are found in Africa (about 26 million people). Further more, 10 to 15 per cent are in need of therapy if they are to stay alive.\par According to WHO, by the end of 2006, only 17 per cent of the 4.7 million people in sub-Saharan Africa in need of anti-retroviral treatment had access to them.\par Despite this, Africa depends on anti-retroviral drug imports from other countries especially India.\par This new Quality Chemicals Anti-retroviral drugs (ARV) / anti-malarial project is borne of the cognisance that India, the biggest source of pharmaceuticals in Africa has ratified the Trade Related Intellectual Property Rights (TRIPS) agreement under the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ) and hence it will soon cease to be a reliable source of relevant, and affordable pharmaceutical products.\par This changed status poses the biggest risk to Uganda and Africa in their effort to contain these killer disea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 es.\par Favours\par Uganda though a signatory to the TRIPS agreement is exempt from implementing the agreement for the next 16 years because it is counted among the Least Developed Countries, which means it can manufacture any patented product without breaking the law.\par Against this backdrop, Quality Chemicals formed a joint venture with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  to locally produce ARVs and anti-malaria drugs at a fraction of the cost of some Western drugs.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  will bring on board its extensive resources and know-how in drug manufacture.\par Construction of the factory is still underway having started at the beginning of July last year. Once comple}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ed, the US$28 million (Shs50.4 billion) plant is likely to increase access to affordable and safe pharmaceut}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cals likely to result into 30 per cent reduction in prices of ARVs and anti-malarial drugs.\par Household incomes\par The Finance Director Quality Chemicals, Fred Mutebi Kitaka, said: "Apart from providing a platform for our local remedies to developed, it will also boost household income through the local production of Artemisinin, a key ingredient in the manufacture of Artemether-based malarial drugs.\par In the past, when Western drug prices have been too high, African countries have traditionally turned to Ind}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 an companies, which have made copies of drugs designed in the West at lower prices.\par At those times, up to 80 per cent of these generic drugs supplied to some African countries including Uganda came from India.\par Constant supply\par Given the uncertainty over the prices of foreign supplies, Mr Mutebi says it is vital to have a constant supply of drugs for those Ugandans already being treated, as well as to meet the future explosion in demand for treatment.\par "It is important for us to be self-sufficient and resourceful," he adds.\par The company says it will take advantage of the fact that under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  rules, the world's poorest countries are able to copy drugs and get away with it without breaking patent laws.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ANTIVIRALS (92%); PHARMACEUTICAL PREPARATION MFG (92%); PHARMACEUTICALS INDUSTRY (91%); AIDS & HIV (91%); CHEMICALS MFG (90%); IMPORT TRADE (90%); CHEMICALS (90%); PHARMACEUTICALS WHOLESALERS (90%); PHARMACEUTICALS TRADE (90%); AIDS & HIV TREATMENT (90%); MALARIA (89%); DRUG PRICES (89%); ANTI-INFECTIVES (89%); INFECTIOUS DISEASE (89%); DISEASES & DISORDERS (78%); HEALTH DEPARTMENTS (78%); GENERIC DRUGS (78%); INTELLECTUAL PROPERTY (78%); POPULATION SIZE (77%); PUBLIC HEALTH ADMINISTR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TION (75%); DRUG SAFETY (73%); DEVELOPING COUNTRIES (72%); INTERNATIONAL ECONOMIC ORGANIZATIONS (71%); PLANT CONSTRUCTION (71%); PATENT LAW (69%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ERTY LAW (69%); PRICE CHANGES (69%); JOINT VENTURES (64%); PATENTS (64%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (96%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD HEALTH ORGANIZATION (90%); WORLD TRADE ORGANIZATION (71%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (96%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (96%); SIC2834 PHARMACEUTICAL PREPARATIONS (96%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AFRICA (95%); UGANDA (94%); SUB SAHARAN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 April 2, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Indian pharma firms go shopping abroad; They are acquiring Western companies to overcome the restrictions of a new patent regime The Business Times Singapore May 25, 2006 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_40}{\*\bkmkstart DOC_ID_40_0}{\*\bkmkstart doc_id_11}{\*\bkmkend DOC_ID_40}{\*\bkmkend DOC_ID_40_0}{\*\bkmkend doc_id_11}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_11"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 11 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  25, 2006 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Indian pharma firms go shopping abroad; \par They are acquiring Western companies to overcome the restrictions of a new patent regime}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Yogi Aggarwal\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 VIEWS AND OPINIONS; BT Comment Others\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1125  words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WHEN the patents regime was changed at the end of 2004 as part of India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  commitments, there were many fears that Indian companies, used to reverse engineering of patented medicines, would not be able to survive in the new environment. This has not happened.\par The new patent regime has accelerated the pace of globalisation of Indian industry, which has responded to the new situation by developing strategies that have taken them to the heart of the developed markets. \par A central part of the new strategy is to buy out existing manufacturers of generic medicines in Europe and the US. 'Indian companies had started thinking of ways to meet the patent challenge some time before the new patent rules began to apply,' says Timmie Kandhari, executive director at the Indian office of Price W}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 terhouseCoopers (PWC), the international consultancy.\par Takeovers of international pharmas by Indian firms increased from $139US million in 2004 to $341US million last year. During the first four months of 2006, takeovers skyrocketed further to $904US million. Takeovers of companies serve to expand the market for Indian companies.\par Other strategies include contract manufacturing or outsourcing the manufacture of pharmaceuticals for fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 eign companies by Indian partners, joint ventures to develop and produce drugs, in-licensing deals where the foreign firms market drugs made by Indian firms under license, and R&D work that includes clinical trials done by Indian companies for their foreign partners.\par While such deals have expanded options for Indian companies after 2004, it is the takeover of foreign co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 panies that is the major step. Until last year the deals were generally small ones, varying from $5US million to $59US million. The biggest deal in 2005 was the $263US million buyout of the Belgian company Docpharma by Matrix labs.\par In the first three months of 2006, two major deals have been struck - the buyout for $572US million of the German generic manufacturer Betapharma by Dr Reddy's from India, and the takeover of the Romanian g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nerics drug company Terapia for $324US million by Ranbaxy, India's largest pharma. Besides these deals, Ranbaxy has bought out Allen SpA of Italy and Ethimed of Belgium for undisclosed sums. And this is just the beginning. Indian pharmas are planning to raise over $2US.5 billion in the international market through co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 vertible bonds.\par Ranbaxy has already raised $400US million and is planning on raising another $1US.1 billion, Wockhardt has got shareholder approval to raise $800US million. Other companies such as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Sun Pharma, Nicolas Piramal and Torrent are also sitting on tidy piles of cash, waiting for the right acquisition opportunity.\par One reason for the aggressive buying is the lack of substantial success and high cost in legally opposing big pharma's extension of their patents on drugs going off-patent. 'Big pharma will fight you every inch of the way,' says Mr Kandhari. So while companies like Ranbaxy also pursue this strategy, it is no longer enough.\par The route of filing abbreviated new drug applications (Anda) is cumbersome and expensive. It takes two to three years to file Anda in the US and Europe and each application could cost a couple of million dollars. D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 spite this, Ranbaxy has over 70 products registered in the US while Dr Raddy's has over a dozen, says D G Shah, secretary general of the Indian Pharmaceutical Alliance (IPA), which represents big pharma comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nies.\par Foreign acquisitions were another route. They mean that the Indian company takes over an established E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ropean company which already has approval to sell several generic drug brands and an established custo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 er base. They also allow the drug to be made at lower cost in India and packaged and sold in the European market.\par Bigger sales base\par 'Whether this translates to a sales increase by a factor of two, three or four is subject to the company cap}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 bilities,' maintains Jayashri Kulkarni, director of healthcare practise at Frost & Sullivan India in an emailed response to questions.\par 'With three of the top five markets in Europe, it is imperative for a company in the pharmaceutical industry to focus on strategies that help it evolve in the region. Acquisitions are a quick boost to Indian companies by providing ready access to a new and growing market.\par 'Secondly, directly selling in the country will allow for growth of the bottom line as well given our cost a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 vantage,' maintains Ms Kulkarni.\par Another reason why European generic companies are preferred is that they are generally smaller than US companies and more affordable. Of course, the deals can really be big as in the $7US.4 billion acquisition last July by the Israeli generics company Teva of Ivax Corporation in Europe.\par An acquisition of a European pharma company also means that it is easier to sell in the other countries of the EU. The total pharma market for the top seven countries in EU is estimated at $162US billion. Of the five biggest pharma markets, three (Germany, France and the UK) are in Europe. While generics only form around one-tenth of the total pharma market in Europe, in these countries it's between 20 per cent and 25 per cent.\par And the generics market is growing more rapidly than any other. Estimates put together by PWC show that the European generics market is growing at a 22 per cent CAGR. It was at $29US.8 billion in 2003, estima}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ed at $54US.2 billion in 2006 and at $80US.7 billion in 2009.\par 'By 2010 we can get 20 per cent of the world generics market,' maintains Mr Shah of IPA. 'Now that India is trying to grow into a global pharma giant,' says Mr Kandhari, 'it makes sense to concentrate on Europe since we are buying into a safe space.' For the Mumbai-based Wockhardt, with 2005 sales of 14.1 billion rupees ($488S million), Europe is already the biggest market, larger than even the domestic Indian market. It has made three acquisitions in Europe so far, Wallis Laboratory and CP Pharmaceuticals in UK, and Esparma GmbH in Germany.\par They are now scouting for acquisitions in the US. 'We look for a strong front-end organisation that will give us market access, we also look for technical capabilities that will compliment ours,' says Habil Khorakiwala, chairman of Wockhardt. 'We should be able to drive faster growth of the acquired asset through our ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 agement.' Mr Khorakiwala is also quite relaxed about the changes in the industry after the new patent r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gime. \par 'Many people were led to believe that Indian companies would be at a disadvantage with the introduction of product patents. But now outsourcing into India has gathered momentum and Indian companies are adapting themselves to integrate their businesses into the global economy. Companies are discovering their strengths and weaknesses with the rest of the world.'\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PATENTS (90%); EDITORIALS & OPINIONS (91%); PHARMACEUTICALS INDUSTRY (91%); TAKEOVERS (90%); PHARMACEUTICALS PATENTS (90%); GENERIC DRUGS (90%); RESEARCH & DEVELOPMENT (90%); GENERIC PRODUCTS (89%); ALLIANCES & PARTNERSHIPS (90%); INTERN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TIONAL TRADE (78%); GLOBALIZATION (78%); OUTSOURCING (78%); PATENT LAW (78%); DRUG DESIGN & DISCOVERY (77%); PHARMACEUTICAL PREPARATION MFG (77%); ENTERPRISE GLOBA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 IZATION (73%); LICENSING AGREEMENTS (73%); PHARMACEUTICALS PRODUCT DEVELOPMENT (71%); MANUFACTURING OUTPUT (70%); SHAREHOLDERS (68%); JOINT VENTURES (66%); BONDS (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PRICEWATERHOUSECOOPERS (70%); RANBAXY LABORATORIES LTD (52%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (58%); RANBAXY (NSE) (52%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS541211 OFFICES OF CERTIFIED PUBLIC ACCOUNTANTS (70%); SIC8721 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 COUNTING, AUDITING, & BOOKKEEPING SERVICES (70%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 JOSEPH C PAPA (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 INDIA (94%); UNITED STATES (79%); GERMANY (77%); BELGIUM (72%); EUROPE (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 May 24, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2006 Singapore Press Holdings Limited\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 U.S. pushes to limit generic drug rights; Agreements seek to extend monopolies in exchange for improvements in trade The International Herald Tribune April 19, 2006 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_41}{\*\bkmkstart DOC_ID_41_0}{\*\bkmkstart doc_id_12}{\*\bkmkend DOC_ID_41}{\*\bkmkend DOC_ID_41_0}{\*\bkmkend doc_id_12}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_12"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 12 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The International Herald Tribune\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  19, 2006 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 U.S. pushes to limit generic drug rights; \par Agreements seek to extend monopolies in exchange for improvements in trade}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Anand Giridharadas\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NEWS; Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1610 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NEW DELHI \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Brian Knowlton in Washington contributed reporting to this article.\par *\par Under global trading rules, the inventors of medicines ordinarily enjoy the right to a 20-year monopoly on their inventions. But five years ago, the United States joined 141 other countries to sign the Doha Declar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion, confirming the right of poor countries to break drug patents and produce cheap generic drugs in the event of contagions like HIV.\par At the time, Thailand was heartened. It had been trying everything in its fight against AIDS. It coined a jingle to promote safe sex. It placed condoms in massage parlors. Most important, it curbed deaths among the poor by giving them generic versions of medicines invented by multinational drug makers. \par So it came as a jolt in January when the United States asked Thailand to sign a free trade agreement that would, on paper, dilute its right to break patents and use generics.\par Washington said the agreement would save lives by spurring innovation and by making multinationals more confident in selling drugs in the country. But Thai officials saw the proposal as a morbid bargain: either r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 fuse the U.S. offer, and thereby scuttle a trade deal with the United States worth billions of dollars, or accept it and lift the price of AIDS drugs beyond the reach of the poor.\par ''Those who require the essential drugs but cannot afford it, they will have to die,'' said Dr. Suwit Wibu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 polprasert, the Thai official who is coordinating the Public Health Ministry's response to the U.S. proposal.\par Thailand is not alone. It is merely the latest target of a quiet worldwide campaign by the administration of President George W. Bush to coax developing nations to barter away their patent-breaking rights in e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 change for lucrative trade benefits, according to public-health experts and government officials from Thailand to Brazil.\par Specifically, Washington is pushing bilateral and regional trade agreements in which countries enact ''supe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 patents'' that prolong U.S. drug makers' monopolies and limit the conditions under which their patents can be broken. These new rules, once they are adopted by developing countries, roll back the patent-breaking rights that were confirmed by the 2001 declaration at World Trade Organization talks in Doha, Qatar.\par In effect, Washington is stitching together its own parallel global patents system. The trade deals, negotiated in secret, attract little notice. But they have already been signed with developing countries battling AIDS, i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cluding six in Central America. And negotiations are beginning with several nations pivotal to the fight against the virus, from Thailand to five southern African countries, including South Africa and Botswana.\par Because of these agreements, India's generics industry, the world's largest, is reining in plans to supply poor countries and refocusing on richer ones, said Dilip Shah, head of the Indian Pharmaceutical Alliance, which represents generic makers.\par "For the Indian pharma industry," he said, "it's not doomed; it will find a way out. But for the patients in the third world, it's bad."\par Public health officials warn of catastrophic consequences if the bilateral deals are applied to AIDS drugs.\par ''If you prevent countries from using generic drugs,'' said Pedro Chequer, the head of Brazil's national AIDS program, ''you are creating a concrete obstacle to providing access to drugs. You are promoting genocide, because you're killing people.''\par First-generation AIDS drugs reached the world's poorest people only when the use of generics cut their cost to $140 a year from more than $10,000. As new drugs emerge to treat patients resistant to first-line med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cines, the trade agreements make a similar drop ''extremely difficult to ensure,'' according to Medecins Sans Frontieres, or Doctors Without Borders.\par Washington maintains that the trade deals are directed toward diseases other than AIDS.\par And Richard Feachem, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, based in Geneva, acknowledged that it was too early to tell whether the bilateral agreements would be used to block access to AIDS drugs.\par ''If we do see this in practice,'' he said, ''we should condemn it. But it really is in the interpretation of these agreements in very particular circumstances.''\par Yet, in defending the bilateral agreements, Bush administration officials often cite the AIDS example to make their case. Stronger patents save lives, the argument goes, by keeping companies confident enough in profit to keep discovering new drugs.\par Dr. Mark Dybul, the second-ranking official in the White House program to fight AIDS, said that because AIDS patients constantly grow resistant to medicines, it is disastrous to widen access today and have no drugs tomorrow.\par ''As an individual physician sitting in front of an individual patient, you will do whatever you need to for that patient now,'' said Dybul, a physician by training. ''When you're a public-health physician, you're not a phys}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cian for one person but for millions of people. And you need to be thinking about whether the action in that single setting, repeated hundreds of thousands of times, will cause a problem for the millions.''\par Spreading the new patents system are U.S. trade negotiators, who some experts believe are assuming the influence that public health experts once had over the Bush administration's AIDS policy.\par Victoria Espinel, an assistant U.S. trade representative, strongly defended the use of trade agreements to promote patents that ''have more in place'' than the patents agreed upon at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  talks in Doha, which she described as merely ''harmonizing minimum standards.''\par ''It is crucial to public health,'' she said, ''to promote the innovation of drugs and to make sure that research and development of drugs continues.''\par As for exempting AIDS drugs from the new accords on patent-breaking, she said, ''I want to emphasize that there is enough flexibility in our free-trade agreements to allow our partners to do what they need to do.''\par An explicit promise to exempt AIDS drugs, however, is not in the agreements, said Wibulpolprasert, the Thai official. And that, experts say, is at the heart of the problem: Nations must take Washington's word for it.\par An examination by the International Herald Tribune of several free-trade accords reveals provisions that a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 pear, on paper, to limit the freedom to use generics.\par Several agreements, for example, prolong a patent monopoly beyond 20 years if the developing country's regulators show ''unreasonable delays'' in approving a patent. This provision, absent from World Trade O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ganization rules, sustains higher prices.\par Many agreements also serve to prolong patents by requiring generics to be retested as if they were new i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ventions. Retesting a drug biologically equivalent to one already approved takes time and may be unethical, since infected patients must be given placebos. The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  rejected this five-year ban on the use by generic makers of the safety data submitted for the original branded drug.\par And while the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  lets countries decide when to break patents, the new U.S. agreements limit this action to special cases to enforce antitrust law, for example, or during emergencies. Experts say the most important use of generics is excluded: to reduce costs by making branded products compete with generics.\par The generics question has also opened a rift in the United States, between Bush and former President Bill Clinton. On a recent visit to New Delhi, Clinton said he had confronted Bush about generics while flying to Rome for the papal funeral last April.\par ''The American position is untenable,'' Clinton recalled saying.\par In an interview, Clinton said Washington was succumbing to the influence of the drug lobby in undermining the Agreement on Trade-Related Aspects of Intellectual Property Rights, or TRIPS, the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  framework on which the Doha Declaration built.\par ''The TRIPS system essentially said there was an exception for life-saving medicine,'' Clinton said. ''And b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sically, the American drug companies and the American government really put the hammer on the bill not to use the TRIPS system.''\par Referring to generic producers, he added: ''If a company develops a new advance in AIDS, TB, malaria, you need large numbers right away and all the people who need it are in poor places. If you don't have }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ranbaxy, Hetero, Aspen in South Africa and other people to step into the breach, how are we going to do that?''\par Last year, when Brazil was faced with upgrading tens of thousands from $140-a-year generics to Kaletra, a patented drug costing more than $3,000 a year, it threatened to break the patent unless given a discount by the U.S. company Abbott Laboratories, Kaletra's inventor. Members of Congress in the United States threa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ened import tariffs in retaliation. Although the Bush administration says it was not involved, Espinel, the a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sistant U.S. trade representative, hinted at how Washington's tacit desires can be enough to make countries fall into line.\par ''Do I think that that would be the best way for a country to go about promoting itself as an innovation player and a destination for foreign investment?'' Espinel said. ''Probably not.''\par Clinton came to Brazil's rescue. His foundation tapped overseas contacts to find a generic drug for about $900 a year a price Brazil used to negotiate with Abbott, which spent $1.8 billion on research in 2005 and reported a profit of $3.4 billion\par Finally, Brazil backed down from its threat to break the patent, and Abbott gave it a discount of about 50 pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cent.\par Abbott is ''gratified to get support'' from ''people in and outside of government,'' said a company spokesman, Brian Kyhos.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GENERIC DRUGS (91%); TRADE TREATIES & AGREEMENTS (90%); AIDS & HIV (90%); TREATIES & AGREEMENTS (90%); PHARMACEUTICALS INDUSTRY (90%); GENERIC PRODUCTS (90%); INTERNATIONAL TRADE LAW (89%); TRADE DEVELOPMENT (89%); PHARMACEUTICAL PREPARATION MFG (89%); PATENTS (89%); INTERNATIONAL TRADE (89%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TRIES (89%); PHARMACEUTICALS PATENTS (78%); AGENCY RULEMAKING (78%); AIDS & HIV TREATMENT (78%); ANTIVIRALS (78%); HEALTH DEPARTMENTS (78%); MULTINATIONAL CORPOR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TIONS (78%); EMERGING MARKETS (78%); INTERGOVERNMENTAL TALKS (77%); FREE TRADE TREATIES & AGREEMENTS (77%); DRUG PRICES (73%); US PRESIDENTS (72%); PUBLIC HEALTH ADMINISTRATION (66%); MASSAGE SERVICES (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GEORGE W BUSH (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NEW DELHI, INDIA (79%) UNITED STATES (99%); THAILAND (93%); INDIA (92%); Q}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TAR (92%); BOTSWANA (79%); AFRICA (79%); CENTRAL AMERICA (79%); SOUTHERN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 April 19, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2006 International Herald Tribune\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 U.S. pushes to limit generic-drug rights in trade pacts The International Herald Tribune April 19, 2006 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_42}{\*\bkmkstart DOC_ID_42_0}{\*\bkmkstart doc_id_13}{\*\bkmkend DOC_ID_42}{\*\bkmkend DOC_ID_42_0}{\*\bkmkend doc_id_13}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_13"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 13 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The International Herald Tribune\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  19, 2006 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 U.S. pushes to limit generic-drug rights in trade pacts}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Anand Giridharadas\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 FINANCE; Pg. 13\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1381 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NEW DELHI \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Brian Knowlton in Washington contributed reporting to this article.\par *\par Under global trading rules, the inventors of medicines ordinarily have the right to a 20-year monopoly on their inventions. But five years ago, the United States joined 141 other countries in signing the Doha Declaration, confirming the right of poor countries to break drug patents and produce cheap generic drugs in the event of contagions like HIV.\par At the time, Thailand was heartened. It had been trying everything in its fight against AIDS. It coined a jingle to promote safe sex. It placed condoms in massage parlors. Most important, it curbed deaths among the poor by giving them generic versions of medicines invented by multinational drug makers. \par So it came as a jolt in January when the United States asked Thailand to sign a free trade agreement that would, on paper, dilute its right to break patents and use generics.\par Washington said the agreement would save lives by spurring innovation and by making multinationals more confident to sell drugs in the country. But Thai officials saw the proposal as a morbid bargain: either refuse the U.S. offer and scuttle a trade deal with the United States worth billions of dollars, or accept it and lift the price of AIDS drugs beyond the reach of the poor.\par ''Those who require the essential drugs but cannot afford it, they will have to die,'' said Dr. Suwit Wibu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 polprasert, the Thai official who is coordinating the Public Health Ministry's response to the U.S. proposal.\par Thailand is not alone. It is merely the latest target of a quiet worldwide campaign by the administration of President George W. Bush to coax developing nations to barter away their patent-breaking rights in e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 change for lucrative trade benefits, according to public health experts and government officials from Thailand to Brazil.\par Specifically, Washington is pushing bilateral and regional trade agreements in which countries enact ''supe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 patents'' that prolong U.S. drug makers' monopolies and limit the conditions under which their patents can be broken.\par These new rules, once they are adopted by developing countries, roll back the patent-breaking rights that were confirmed by the 2001 declaration at World Trade Organization talks in Doha, Qatar.\par In effect, Washington is stitching together a parallel global patents system.\par The trade deals, negotiated in secret, attract little notice. But they have already been signed with developing countries battling AIDS, including six in Central America. And negotiations are beginning with several nations pivotal to the fight against the virus, from Thailand to five southern African countries, including South Africa and Botswana.\par Because of these agreements, India's generics industry, the world's largest, is reining in plans to supply poor countries and refocusing on richer ones, said Dilip Shah, head of the Indian Pharmaceutical Alliance, which represents generic makers.\par ''For the Indian pharma industry,'' he said, ''it's not doomed; it will find a way out. But for the patients in the Third World, it's bad.''\par Public health officials warn of catastrophic consequences if the bilateral deals are applied to AIDS drugs.\par ''If you prevent countries from using generic drugs,'' said Pedro Chequer, the head of Brazil's national AIDS program, ''you are creating a concrete obstacle to providing access to drugs. You are promoting genocide, because you're killing people.''\par First-generation AIDS drugs reached the world's poorest people only when the use of generics cut their cost to $140 a year from more than $10,000. As new drugs emerge to treat patients resistant to first-line med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cines, the trade agreements make a similar drop ''extremely difficult to ensure,'' according to Medecins Sans Frontieres, or Doctors Without Borders.\par Washington maintains that the trade deals are directed toward diseases other than AIDS.\par And Richard Feachem, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, based in Geneva, acknowledged that it was too early to tell whether the bilateral agreements would be used to block access to AIDS drugs.\par ''If we do see this in practice,'' he said, ''we should condemn it. But it really is in the interpretation of these agreements in very particular circumstances.''\par Yet, in defending the bilateral agreements, Bush administration officials often cite the AIDS example to make their case. Stronger patents save lives, the argument goes, by keeping companies confident enough in profit to keep discovering new drugs.\par Dr. Mark Dybul, the second-ranking official in the White House program to fight AIDS, said that because AIDS patients constantly grow resistant to medicines, it is disastrous to widen access today and have no drugs tomorrow.\par ''As an individual physician sitting in front of an individual patient, you will do whatever you need to for that patient now,'' said Dybul, a physician. ''When you're a public health physician, you're not a physician for one person but for millions of people. And you need to be thinking about whether the action in that single setting, repeated hundreds of thousands of times, will cause a problem for the millions.''\par Spreading the new patents system are U.S. trade negotiators, who some experts believe are assuming the influence that public health experts once had over the Bush administration's AIDS policy.\par Victoria Espinel, an assistant U.S. trade representative, strongly defended the use of trade agreements to promote patents that ''have more in place'' than the patents agreed upon at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  talks in Doha, a step she described as merely ''harmonizing minimum standards.''\par ''It is crucial to public health,'' she said, ''to promote the innovation of drugs and to make sure that research and development of drugs continues.''\par As for exempting AIDS drugs from the new accords on patent-breaking, she said, ''I want to emphasize that there is enough flexibility in our free trade agreements to allow our partners to do what they need to do.''\par An explicit promise to exempt AIDS drugs, however, is not in the agreements, said Wibulpolprasert, the Thai official. And that, experts say, is at the heart of the problem: Nations must take Washington's word for it.\par An examination by the International Herald Tribune of several free trade agreements reveals provisions that appear, on paper, to limit the freedom to use generics.\par Several agreements, for example, prolong a patent monopoly beyond 20 years if the developing country's regulators show ''unreasonable delays'' in approving a patent. This provision, absent from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  rules, su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tains higher prices.\par Many agreements also serve to prolong patents by requiring generics to be retested as if they were new i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ventions. Retesting a drug biologically equivalent to one already approved takes time and may be unethical, since infected patients must be given placebos.\par The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  rejected this requirement, a five-year ban on the use by generics makers of the safety data submi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ted for the original branded drug.\par And while the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  lets countries decide when to break patents, the new U.S. agreements limit this action to special cases to enforce antitrust law, for example, or during emergencies.\par Experts say the most important use of generics is excluded: to reduce costs by making branded products compete with generics.\par The generics question has also opened a rift in the United States, between Bush and former President Bill Clinton. On a recent visit to New Delhi, Clinton said he had confronted Bush about generics while flying to Rome for the papal funeral last April.\par ''The American position is untenable,'' Clinton recalled saying.\par In an interview, Clinton said Washington was succumbing to the influence of the drug lobby in undermining the Agreement on Trade-Related Aspects of Intellectual Property Rights, or Trips, the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  framework on which the Doha declaration built.\par ''If a company develops a new advance in AIDS, TB, malaria, you need large numbers right away and all the people who need it are in poor places,'' Clinton said, referring to generics producers.\par ''If you don't have }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ranbaxy, Hetero, Aspen in South Africa and other people to step into the breach, how are we going to do that? I don't understand the apparent obsession with some of the big pharma inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ests in trying to block them off.''\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GENERIC DRUGS (91%); TRADE TREATIES & AGREEMENTS (90%); AIDS & HIV (90%); TREATIES & AGREEMENTS (90%); PHARMACEUTICALS INDUSTRY (90%); GENERIC PRODUCTS (90%); INTERNATIONAL TRADE LAW (89%); TRADE DEVELOPMENT (89%); PHARMACEUTICAL PREPARATION MFG (89%); PATENTS (89%); INTERNATIONAL TRADE (89%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TRIES (89%); PHARMACEUTICALS PATENTS (78%); AGENCY RULEMAKING (78%); AIDS & HIV TREATMENT (78%); ANTIVIRALS (78%); HEALTH DEPARTMENTS (78%); MULTINATIONAL CORPOR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TIONS (78%); EMERGING MARKETS (78%); INTERGOVERNMENTAL TALKS (77%); FREE TRADE TREATIES & AGREEMENTS (77%); DRUG PRICES (73%); US PRESIDENTS (72%); PUBLIC HEALTH ADMINISTRATION (66%); MASSAGE SERVICES (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GEORGE W BUSH (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NEW DELHI, INDIA (79%) UNITED STATES (99%); THAILAND (93%); INDIA (92%); Q}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TAR (92%); BOTSWANA (79%); AFRICA (79%); CENTRAL AMERICA (79%); SOUTHERN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 April 19, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2006 International Herald Tribune\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HIV-Aids and STDs;Global Aids Treatment Drive Takes Off Africa News April 28, 2005 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_43}{\*\bkmkstart DOC_ID_43_0}{\*\bkmkstart doc_id_14}{\*\bkmkend DOC_ID_43}{\*\bkmkend DOC_ID_43_0}{\*\bkmkend doc_id_14}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_14"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 14 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  28, 2005 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 HIV-Aids and STDs;\par Global Aids Treatment Drive Takes Off}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa Renewal\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 3207 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Rapid increase in number of people receiving ARV medicines\par When a reporter first met seven-year-old Bongani in a hardscrabble shantytown near Johannesburg in 2003, it was evident the child was dying. He was too weak for school, stunted and racked by diarrhoea. There was little question that he, like his deceased parents, was infected with the human immunodeficiency virus that causes AIDS. It seemed equally certain that he would soon lie in a tiny grave next to theirs -- joining the 370,000 South Africans who died from the disease that year.\par But when the journalist, Mr. Martin Plaut of the BBC, returned a year later, he found a healthy, laughing Bo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gani poring over his lesson book. "The transformation," Mr. Plaut wrote last December, "was remarkable." \par That transformation -- and the difference between life and death for Bongani and a growing number of pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ple living with HIV and AIDS in Africa -- has resulted from access to anti-retroviral drugs (ARVs) that attack the virus and can dramatically reduce AIDS deaths. For years high costs severely limited their use in Africa. The Joint UN Programme on HIV/AIDS (UNAIDS) estimated that only about 50,000 of the 4 million Africans in urgent need of the drugs were able to obtain them in 2002. But with prices dropping in the face of d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 mands for treatment access and competition from generic copies of the patented medications, the politics and economics of AIDS treatment have finally begun to shift.\par In December 2003, the World Health Organization (WHO) announced an unprecedented drive to put 3 mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lion people living with HIV/AIDS in developing countries on ARV treatment by the end of 2005, the "3x5" campaign. Two months later, the US launched an ambitious programme of its own, the President's Eme}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gency Plan for AIDS Relief (PEPFAR) -- a 5-year, $15 bn initiative to provide ARV therapy to 2 million people and prevent 7 million new infections by 2008 in 15 countries, including 12 in Africa.\par 'Irresponsible' goal now in sight\par The early results are encouraging. In January 2005, WHO, joined by representatives of the US government, UNAIDS and the multilateral Global Fund to Fight AIDS, Tuberculosis and Malaria, announced that the nu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ber of people receiving ARV treatment in developing countries had increased by 75 per cent during 2004 to over 700,000 -- including an estimated 325,000 in sub-Saharan Africa. In the view of many public health e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 perts, the rapid increase vindicates what some critics derided as WHO's "irresponsible" and unrealistic 3x5 pledge.\par The results also seem to belie predictions that the mix of multilateral and bilateral funding and treatment pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 grammes would prove impossible to coordinate and only further burden overstretched health systems in the worst-affected countries. South Africa, Nigeria and India account for over 40 per cent of the total number of people still in need of ARV treatment, and experts say that a focus in those three countries could produce major gains for treatment access in a short time.\par Speaking at a press conference at the World Economic Forum in Davos on 26 January, WHO Director-General Dr. Lee Jong-wook singled out developing countries for much of the credit. "We salute the countries that have now shown us that treatment is possible and can be scaled up even in the poorest settings," he said. "AIDS treatment access is expanding every day thanks to the dedicated work of doctors, nurses, health workers and people living with HIV and AIDS, who are often working under difficult circumstances to turn the dream of universal treatment into a reality." WHO officials assert that at current rates the world is on track to reach the 3x5 goal.\par This upbeat assessment is tempered, however, by an estimated $2 bn shortfall to reach the 3 million mark by the end of this year. That amount is part of the $6 bn in additional resources UNAIDS says is needed in 2005 for the full range of HIV/AIDS programmes in developing regions. The treatment drive in many countries is hampered by severe shortages of trained medical personnel and facilities and by continuing controversies over drug prices and patents. "Unless these and other pressing issues are addressed urgently," declared the non-governmental organization Medecins sans Frontieres (MSF), "many of those living with HIV/AIDS in d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 veloping countries will never get access to life-saving treatment or may not be able to survive once on trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment over the long term."\par MSF and other advocacy groups point out that the 700,000 people in ARV treatment represent only about 12 per cent of the nearly 6 million people in developing countries who need it. With the disease taking 8,000 lives daily, and new infections topping 5 million last year alone, MSF declared that "the global picture is bleak... WHO ... and other institutions should be sounding the alarm."\par 'A tremendous determination'\par Whether one views the pill bottle as half empty or half full, the increased availability of anti-AIDS medicines in Africa is very good news. Although the percentage of Africans currently receiving the life-prolonging drugs remains a low 8 per cent of those requiring it -- ARVs are prescribed only for those in the final stages of the disease -- the continental average masks significant advances in some countries.\par In Botswana, the country with the second-highest HIV-infection rate in the world, an estimated 50 per cent of those in need currently receive ARV drugs. This is due in large part to the government's pioneering decision in 2002 to provide the medications free of charge through the public health system.\par Uganda, whose AIDS prevention campaign is already considered a model for effective programmes, now provides ARV treatment to 40 per cent of the 114,000 people who require it. In Cameroon, reports WHO, strong political leadership combined with increased funding assistance and a sharp drop in drug prices has allowed some 12,000 people to begin ARV therapy. Cameroonian authorities say they will triple that number by the end of 2005.\par Overall, notes WHO in its December 2004 3x5 Campaign Report, anti-retroviral medications are now avail}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ble at more than 700 sites across the region. The study also found that African ARV patients are equally or more likely than patients in developed countries to maintain the drugs' strict daily treatment schedule. This finding has confounded critics who argued that poor adherence rates would accelerate the emergence of drug-resistant strains of the virus.\par WHO also reported that men and women have roughly equal access to ARVs in Africa under the new trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment programmes. This means that women, who make up 57 per cent of Africans living with the virus, are underrepresented in some countries; but the numbers have allayed, at least for now, fears that women would be excluded from national treatment strategies.\par In Botswana, the country with the second-highest HIV-infection rate in the world, an estimated 50 per cent of those in need currently receive ARV drugs.\par The early success of the treatment drive, says UN Special Envoy for HIV/AIDS in Africa Stephen Lewis, r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 flects the coming together of new resources from the Global Fund and the US government, the technical support and momentum of WHO's 3x5 campaign and a new sense of urgency among African governments and civil society. Mr. Lewis, a former Canadian diplomat known for his criticism of responses to the pandemic by both donors and African governments, told Africa Renewal that in recent months "there has been a huge change for the better" among African political leaders and health officials. "It's like night and day. There is tremendous determination to meet those 3x5 targets."\par The reason for the sudden change, he notes, is that in the hardest-hit countries, HIV/AIDS can no longer be ignored. For some leaders "it was the fear that the country was falling apart, the sense that every indicator was being turned back, from life expectancy to levels of poverty to infant and maternal mortality. It made the political leadership say, 'Oh my God, we've got to turn this around.'" In the worst affected regions, "the pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 vasiveness of death is almost unbelievable. They're in a life-and-death battle, and now everybody sees it that way."\par Building capacity\par Despite the progress, obstacles to treatment access remain stubbornly in place. Chief among them is the absence of the public health capacity -- hospitals and clinics, diagnostic and laboratory facilities, trained medical personnel -- to maintain millions of people on the powerful anti-retroviral medications. Although Mr. Lewis estimates that Africa already has the capacity to maintain double the current number of people now on treatment, "the need to increase capacity is huge, and there's a kind of grim, gritted-teeth determination to get it built."\par Part of the problem, notes a recent study by WHO and other international health organizations, is the "fatal flow" of African health professionals to better-paying jobs overseas. The study notes that there are more M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lawian doctors practicing in the UK city of Manchester than in Malawi itself, while Zambia, with one of the highest HIV-infection rates in the world, has lost to foreign employers 550 of the 600 doctors it has trained since independence.\par Malawi and its development partners have responded to the desperate staffing shortage with a programme to improve salaries and working conditions for health professionals and to train a new cadre of health wor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ers able to dispense ARVs and provide basic medical services.\par Rebuilding Africa's threadbare public health systems will take time, however, and for millions of people in the last stages of AIDS, time is running out. "Almost everyone would agree that the largest challenge resides around capacity," says Dr. Mark Dybul, the assistant US global AIDS coordinator and chief medical officer for the PEPFAR programme. The US, the Global Fund and WHO programmes therefore focus on "supporting new people on therapy, but simultaneously building new capacity. I don't think it's correct to say that all [the recent increases] have been done using existing capacity."\par One small PEPFAR-supported clinic in Namibia, he notes, had the resources to treat several hundred pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ple. "Now they have the capacity to treat a couple of thousand people. They're taking people off the waiting list and putting them on the rolls, because they built new capacity at the same time they began treatment."\par Funding support, technical assistance and drugs and equipment could come from outside, Dr. Dybul told A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 rica Renewal. But for the programme to expand, there also needs to be capacity within the country. "And that's got to begin with the national strategy commitment" of the governments and civil societies of affected countries. "What we do is support them... We [all] need to do more, and we're not there yet... but capacity has been expanded over the past year with tremendous success."\par The US programme alone added 155,000 people to the treatment rolls in just eight months in its 15 target countries: Botswana, Cote d'Ivoire, Ethiopia, Kenya, Mozambique, Namibia, Nigeria, Rwanda, Tanzania, Uganda, Zambia, Haiti, Guyana and Vietnam. Dr. Dybul says it is on track to reach the 500,000 mark by June 2006.\par "I think there are a lot of misconceptions about [ARV] drugs," Dr. Dybul adds. "The cost of anti-retroviral therapy is not drugs... The major costs are supporting and training personnel, laboratory capacity and su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 porting those laboratories."\par Dr. Dybul puts the annual cost of ARV treatment in Africa at $1,500- $2,500 per person, with drugs accoun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing for just $300-$600 of the total. "Arguments about the cost of the drugs are for us a red herring," he e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 plains. "That's not the problem right now."\par Patent, pricing controversies\par But controversies over the safety, supply and cost of anti-AIDS drugs have continued. In contrast to Dr. D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 bul's assessment, WHO reported last December that "the high cost of ARV drugs remains a barrier to scaling up HIV treatment and care." Prices for the next generation of anti-AIDS drugs, which will be needed as the virus develops resistance to current medications, "remain prohibitively expensive throughout much of the world," the organization noted. It warned that action is needed now to control future costs.\par For more than a decade after the development of the first anti-retrovirals in the late 1980s, their high cost and the complexity of using them kept the life-prolonging medications out of the hands of all but a few very wealthy or very fortunate people in poor countries. At $10,000-$15,000 per year, ARV treatment was simply unaffordable. Efforts by UNAIDS to negotiate discounted prices for developing countries enjoyed only limited success, and the major Northern pharmaceutical companies generally resisted calls to licence inexpensive generic versions of their patented products.\par In 2001, however, an Indian pharmaceutical firm, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  introduced an innovative generic medication that combined three of the most effective anti-retroviral drugs into a single pill, known as the triple fixed dose combination tablet (FDC). Not only was the drug easier to administer than its patented competitors -- two pills a day compared with six or more of some of the patented formulations -- it was available initially for the unheard-of price of $350 per year. After a two-year investigation by WHO's drug prequalification programme, the triple FDC was certified safe and medically equivalent to the patented originals, and went into wide use. With prices now as low as $140 a year, the triple FDC has emerged as the pharmaceutical backbone of the 3x5 campaign and is credited with making it possible to expand ARV treatment.\par But PEPFAR requires its grantees to use only drugs certified by the US Food and Drug Administration (FDA), a policy that, in practice, has meant the programme buys only patented products, mainly from US suppliers. PEPFAR officials say the policy is necessary to ensure the safety and quality of drugs and note that a number of generic ARVs have been removed from the WHO pre-approval list after problems were di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 covered in the certification documents. They also note that foreign generics producers are welcome to su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 mit their products for FDA approval under a special "fast track" procedure.\par To date, however, none of the triple FDC drugs favoured in international treatment programmes has secured FDA approval. The result, reported the US government General Accounting Office, is that PEPFAR currently pays about twice as much for anti-retroviral medications as treatment schemes using generics. The agency estimates that the costs could potentially run into hundreds of millions of dollars over the five-year span of the PEPFAR initiative, reducing the number of people who can be treated for the same money.\par In late January, the FDA approved its first generic ARV product, a two-pill package taken twice daily, and applications for other generic products, including triple FDCs, are under review. Treatment advocates we}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 come the development but charge that the failure of the US to adopt the preferred triple FDC tablet is forcing participating countries to manage different supply chains and treatment regimes -- complicating the drive to expand treatment.\par Trade rules threaten affordability\par The extension of 20-year patent protections to all but the least developed countries on 1 January 2005, u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 der the World Trade Organization's agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), has also set off alarm bells among advocates and health officials. The agreement makes it more difficult for India and other major exporters of generic drugs to continue to supply developing countries with low-cost ARVs and other vital medicines.\par The current generation of frontline anti-AIDS drugs are exempt from the new patent rules, says Mr. Brook Baker, a professor at Northeastern University in the US and a member of the treatment advocacy group Health Gap. "The problem will be with the next generation of ARVs in the pipeline. TRIPS will prevent the kind of generic competition that has driven prices down in the past."\par In August 2003, the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  TRIPS Council, under pressure particularly from African countries to create a public-health exemption to the new rules, reached an agreement to permit the export of generic drugs for public health emergencies. But the exemption is limited and procedurally complex. To date, no country has attempted to use it.\par Mr. Baker also notes that US negotiators are seeking patent protections in excess of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  requirements in regional and bilateral trade talks. These so-called "TRIPS plus" agreements, Global AIDS Fund head Richard Feacham said last year, have the effect of "either pushing [drug] prices up or preventing their fall," further limiting the availability of affordable medications.\par Canada recently amended its patent laws to permit the pharmaceutical industry to use the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  exemption, but according to Mr. Richard Elliot, the director of legal research and policy at the Canadian HIV/AIDS Legal Network and a member of the government's Ministerial Council on AIDS, its provisions too are complex and restrictive. So far, he told Africa Renewal, no Canadian company has sought an export license under the new law.\par Short on resources, long on needs\par The rapid expansion of AIDS treatment programmes has brought with it equally dramatic demands for new resources. And while the 3x5 campaign and the US programme have short-term targets, they are creating long-term obligations to the millions of people entering treatment, since ARV therapy must continue for life. When UNAIDS was launched in 1996, the organization noted recently, global spending on the full range of HIV/AIDS initiatives in low- and moderate-income countries was $300 mn. Last year, reports the Washin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ton-based Kaiser Family Foundation, spending topped $6 bn.\par But even that impressive figure, notes the UN's Mr. Lewis, is just half the $12 bn UNAIDS estimates is nee}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ed this year to continue expanding treatment programmes and meet education, prevention, counselling and research needs. The Global Fund needs $1 bn this year to cover its commitments, he says. "WHO is short $60 mn for the final vital push on 3x5 and they still don't have it. I don't understand this grudging incrementa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ism by Western countries. We're losing incredible numbers of lives every day."\par UNAIDS estimates that by 2007 $20 bn will be needed for the fight against AIDS, and Mr. Lewis calls on wealthy governments to make major new commitments at the upcoming meeting of the Group of Eight indu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 trialized countries. "We have more money now, but in a few years we'll be fighting desperately for dollars again. Prices for the next generation of drugs are very, very high. They will have to be negotiated down and ways found to make generics."\par "Everywhere we turn we have impediments," he acknowledges. "But we also have a momentum that is u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 stoppable. I see the focus everywhere in Africa. Now the commitment is tremendous."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS & HIV (99%); AIDS & HIV TREATMENT (91%); SEXUALLY TRANSMITTED DISEASE (90%); PUBLIC HEALTH ADMINISTRATION (89%); HEALTH CARE ACCESS (78%); GENERIC DRUGS (78%); ANTIVIRALS (78%); DISEASES & DISORDERS (78%); AIDS POLICY (76%); VIRUSES (76%); M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 LARIA (76%); PHARMACEUTICALS PATENTS (73%); HEALTH DEPARTMENTS (73%); DEVELOPING COUNTRIES (72%); UNITED NATIONS INSTITUTIONS (71%); TUBERCULOSIS (71%); INTERNATIONAL ASSISTANCE (67%); GENERIC PRODUCTS (65%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MARTIN PLAUT (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AFRICA (94%); SOUTH AFRICA (92%); UNITED STATES (92%); SUB SAHARAN AFRICA (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 JOHANNESBURG, SOUTH AFRICA (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (81%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 May 2, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Business Times Singapore April 12, 2005 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_44}{\*\bkmkstart DOC_ID_44_0}{\*\bkmkstart doc_id_15}{\*\bkmkend DOC_ID_44}{\*\bkmkend DOC_ID_44_0}{\*\bkmkend doc_id_15}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_15"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 15 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Is it the end of cheap drugs from India?;\par Medicine prices may soar in a few years as the country can no longer make generic drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  12, 2005 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par Yogi Aggarwal\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 THE Indian pharmaceutical industry is at a cusp. Prices of medicines could start rising sharply in three to five years and Indian companies, which had prospered under the Indian Patent Act of 1970, could see their fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tunes declining as those of the multinationals rise.\par 'What is at stake is the health of the Indian people and even their lives,' says Yusuf Hameid, the Cambridge-educated organic chemist who heads }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 , one of India's largest pharmaceutical companies.\par The earlier legislation only recognised 'process' patents and allowed Indian companies to reverse engineer drugs to manufacture them by another route. It led to India having the cheapest medicine prices in the world, typically less than a tenth of those prevailing in neighbouring Pakistan, which largely imported them. \par While trade minister Kamal Nath assured the Indian Parliament when the Patent Amendment Bill was intr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 duced on March 22 that 'strong safeguards and comprehensive provisions' would check any price increases and availability of medicines, the industry, health workers and many parliamentarians were far from co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 vinced.\par But if the public protest in India was muted, it was more vocal in African countries which heavily rely on Ind}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 an anti-Aids drugs in their public health programmes. A few days before the Bill was to be voted in Parli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment, there were demonstrations in Nairobi and Kampala. Many international health NGOs, including the Geneva based Doctors Without Borders (Medecin Sans Frontiers - MSF) came to India to campaign against the bill.\par Michael Angaga, African Regional Co-ordinator of Network of African People Infected with HIV/Aids, said in a telephone conversation: 'Generic drugs from India are used in public hospitals in Nairobi. People cannot a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ford patented drugs manufactured by MNCs in Kenya or other African countries. We appeal to the Indian Parliament to see this as a humanitarian issue since otherwise millions of people will die in Africa as the pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lic health system will collapse. Patented medicines cost as much as US$100, which is a family's monthly i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 come.'\par This feeling was echoed by the MSF, whose spokeswoman, Ellen Thoen, told The Business Times: 'It is very sad and a matter of great concern that India should no longer have process patents which made medicines so affordable. But we realise that India has obligations under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  and within that we understand the government could not do otherwise. India has modified the earlier ordinance and we take that as a positive signal.'\par While the amended bill as passed is a vast improvement on the ordinance passed by the government in D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cember 2004 (it was formulated by the earlier BJP-led government in 2003) to meet the January 2005 dea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 line under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 , it has not used the full flexibility allowed under the trade-related aspects of intellectual pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 erty rights (Trips) negotiations.\par Concern\par Many of the provisions also make the domestic pharmaceutical industry uneasy. Some of the amended se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tions are worded such that 'they could have been drafted in a multinational company's office' says one o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 server.\par There are several areas of concern. One is whether patents can be extended beyond the stipulated 20 years by some small change. Another relates to whether patented medicines will compulsorily have to be licensed to Indian manufacturers or if the patent holder can retain a monopoly over their supply.\par The backdating of patents from 1995 instead of 2005 has also been criticised, and it is feared that the amb}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 guity in the royalty payable could lead to time consuming and expensive litigation. And while Indian comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nies will be allowed to export some vital drugs to countries which do not have a manufacturing base, they will not be allowed to sell them in India.\par One paradoxical fact is that while less than 25 new molecules have been discovered in the 10 years from 1995 to 2004, there are some seven to eight thousand applications for patents pending or in the 'mailbox' in the Indian patent office. This is because most of them are frivolous and even if 90 per cent are rejected by the office, this still leaves several hundred dubious applications which would have to be opposed, opening a Pandora's box of litigation.\par Spokesmen for drug industry associations concede that while many of their objections to the earlier ord}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nance were met, some were not. Says Dara Patel, secretary general of the Indian Drug Manufacturers Ass}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ciation (IDMA): 'Most of our recommendations were accepted but our suggestions on compulsory license procedure and more powers for the government did not get through.'\par 'We are not against patents, we are against monopoly,' explains Dr Hameid of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 . 'There is an intimate link between monopoly and prices, greater monopoly leading to higher prices'. He poses a vital and painful question: 'Does the globalisation of healthcare imply that we have the means to treat the sick and needy but are at a liberty to make the terrible choice between profits and lives?'\par To answer that, we have to look at how the first world chose to respond to the Aids epidemic. Before }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  started making retroviral drugs for treating Aids, the annual cost of treatment was US$ 2,000, several times the family income of those afflicted by Aids in Africa and Asia. In 2000, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  came out with a formulation which it offered to the international community for US$800 a year and within a year was able to offer an Aids treatment for under US$300 a year.\par There was an international uproar against the looting by big pharma. 'Everyone suddenly knew that effective, affordable anti-Aids drugs were available from Indian generic manufacturers. The monopoly leading to high prices of drugs the patent regime had created stood clearly exposed. Thy were forced to drop prices to US $800. This still allowed a huge profit as the cost was around US$100,' says Dr Hameid.\par Monopoly, and the advantage of controlling knowledge for profit lie at the heart of linking intellectual property rights under Trips to trade negotiations under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 . India had opposed the new IPR first proposed at the Gatt trade negotiations in the early 1990s, but like many other countries, was browbeaten into submission.\par The target of attack is the 1970 Indian Patents Act, which has allowed the Indian pharmaceutical industry to become a force to reckon with. In 1971, drug prices in India were as high as in Pakistan and 33 of the top 50 pharmaceutical companies were multinationals who had a 70 per cent market share of the total industry sales of Rs 3.6 billion. (S$126 million).\par By 1996, the industry sale had grown to 109 billion rupees with multinationals having a market share of 34 per cent. By 2004, the industry had further grown to 354 billion rupees and 37 of the top 50 companies were Indian, while the market share of Indian companies had grown to 78 per cent.\par Exports of drugs from India in 2003-04 touched US$3.18 billion while imports were just US$687 million. The wide use of affordable Indian medicines in Africa and Asia also meant that potentially lucrative markets were being lost to US and European drug companies. This had to change.\par Changes\par The powerful multinational drug companies pushed for the changes evident in the December 2004 Ord}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nance. Though they have had to yield a little ground in the bill as passed recently, the Indian industry is now on the defensive. As new patented molecules start coming into the market from 2008, their prices will be much higher.\par Indian companies will lose ground and market share. The people of India will find themselves paying much more for medicines. Many will not be able to afford them. 'In another 20 years,' muses Dr Hameid, 'we'll be back to where we started in 1970 and a large part of Indian industry will have been acquired by the multin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tionals.'\par Unless, that is, further amendments are made in the bill to ensure that affordable medicines continue to reach the Indian people without hindrance.\par The writer is a Mumbai-based journalist who contributes regularly to BT\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par  DRUG PRICES (92%); EDITORIALS & OPINIONS (91%); PHARMACEUTICALS INDUSTRY (90%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TENTS (90%); LEGISLATION (90%); PATENT LAW (90%); LEGISLATIVE BODIES (90%); GENERIC DRUGS (90%); PHARMACEUTICALS PATENTS (89%); PHARMACEUTICAL PREPARATION MFG (89%); MULTINATIONAL CORPORATIONS (89%); INTELLECTUAL PROPERTY LAW (89%); AIDS & HIV TREATMENT (78%); PRICE INCREASES (78%); AIDS & HIV (78%); MEDICAL CHARITIES (78%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 LECTUAL PROPERTY (78%); NONGOVERNMENTAL ORGANIZATIONS (77%); COMMERCE DEPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MENTS (73%); REVERSE ENGINEERING (72%); PROTESTS & DEMONSTRATIONS (72%); PHYSICIANS & SURGEONS (70%); RELIEF ORGANIZATIONS (70%); HOSPITALS (65%); INTERNATIONAL ASSI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TANCE (65%); \par \par  CIPLA LTD (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 VIEWS AND OPINIONS; BT Comment Others\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1347 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 April 11, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2005 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PanAfrica;New Law in India Drives Up Africa's Cost of Halting Aids Africa News March 29, 2005 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_45}{\*\bkmkstart DOC_ID_45_0}{\*\bkmkstart doc_id_16}{\*\bkmkend DOC_ID_45}{\*\bkmkend DOC_ID_45_0}{\*\bkmkend doc_id_16}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_16"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 16 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  29, 2005 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 PanAfrica;\par New Law in India Drives Up Africa's Cost of Halting Aids}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Business Day\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 752 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 THE Indian government's recent moves to curtail the copying of patented medicines have received a mixed response in SA. Critics warn this threatens the future supply of cheap drugs, but manufacturers hope that India's new patent laws will boost their prospects.\par Last week India amended its 1970 Patent Act to bring it in line with its World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ) obl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gations. The amendments extend the scope of patentable inventions to include products; previously the law only allowed "process patents", which enabled drug makers to copy other firms' products by making small changes in manufacturing. \par "The 1970 law let the Indians reverse engineer, which is what they became very good at," says Jonathan Berger, a researcher at the AIDS Law Project at the University of the Witwatersrand.\par India's generic AIDS drug industry flourished in the absence of patents, and today it supplies drugs to about half of the 700000 people receiving HIV treatment in developing countries, says Marta Darder, the South A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 rican advocacy co-ordinator for Medicines Sans Frontieres, which provides treatment to 2500 patients in SA.\par Cheap, high-quality Indian generics such as those made by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  and Ranbaxy have boosted competition, says Berger, driving the price of generic AIDS drugs down to affordable levels for people in the developing world.\par A month's supply of generic antiretroviral medicines typically costs about $30, or 5% of the price paid in d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 veloped countries.\par Because of a last-minute concession to activists, India's new patent laws do not threaten the supply of gene}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ic drugs already on the market, but critics are worried about the supply of drugs in the pipeline.\par Indian generic firms will have to wait three years before they can apply for licences to produce copies of p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tented drugs. If their application is opposed, litigation in courts could hold up the launch of generic versions for years, says Berger.\par The new laws also say that generic companies must pay "reasonable royalties" to a patent holder which grants them manufacturing licences, but doesn't set a limit.\par Critics fear this will drive up the price of generics, making them too expensive for many patients.\par "It's disappointing to see that India didn't follow recent international trends and set a royalty limit of 4%-5%," says Tenu Avafia, a researcher at the Trade Law Centre for Southern Africa.\par Europe's biggest drug maker, GlaxoSmithKline, tried to charge royalties of 45% for a licence to make copies of its AIDS drugs in SA before it reached a settlement with activists and the Competition Commission, which set royalties at 5%.\par India's new patent laws include provisions for the issuing of "compulsory licences" in a public emergency, effectively cancelling a drug maker's patent rights and allowing India to export drugs to countries unable to manufacture them.\par But its ambiguous provisions mean that litigation concerning compulsory licenses could be lengthy and co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 plicated, says Avafia. So far no developing country lacking the capacity to manufacture essential medicines has made use of a special }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  mechanism designed to assist them issue compulsory licenses to import such drugs.\par Afavia suggests that South African consumers are in a slightly more fortunate position than many of their African counterparts, as there is a strong local generics industry. Aspen Pharmacare is Africa's largest g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 neric drug maker and will supply a large number of the AIDS drugs provided in government clinics. But wit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 out competition from other generic companies, prices may eventually rise, he says.\par The National Association of Pharmaceutical Manufacturers, which represents South African generic drug makers, is optimistic.\par The new patent laws will level the playing field between Indian and local firms, and increase competition, says association chairman Muhammad Bodhania.\par He says the nature of the Indian generics industry is set to change significantly, with firms likely to shift their attention to medicines that are no longer protected by 20-year patents. This is the market segment South African firms such as Aspen and Adcock Ingram focus on, because SA has strong patent laws.\par Bodhania says local firms that import raw materials from Indian drug makers already comply with South Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 can patent laws, and so their supplies should not be affected by last week's developments. But he concedes that in the long term there might be problems if the Indian raw materials industry dwindles.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PATENTS (93%); GENERIC DRUGS (92%); ANTIVIRALS (91%); AIDS & HIV TREATMENT (91%); AIDS & HIV (91%); GENERIC PRODUCTS (90%); PHARMACEUTICALS PATENTS (90%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 LECTUAL PROPERTY LAW (90%); PHARMACEUTICALS INDUSTRY (90%); PATENT LAW (90%); PHARMACEUTICAL PREPARATION MFG (89%); ROYALTIES (89%); DRUG PRICES (89%); LEGISL}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TION (89%); DRUG DESIGN & DISCOVERY (78%); INTERNATIONAL TRADE LAW (77%); EMERGING MARKETS (77%); DEVELOPING COUNTRIES (77%); TRADE DEVELOPMENT (76%); INTERNATIONAL TRADE (76%); EXPORT TRADE (76%); PHARMACEUTICALS PRODUCT DEVELOPMENT (75%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TERNATIONAL ECONOMIC ORGANIZATIONS (73%); EXPORT CONTROLS (72%); LICENSES & PE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MITS (68%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (90%); GSK (NYSE) (84%); GSK (LSE) (84%); RANBAXY (NSE) (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%); SIC2834 PHARMACEUTICAL PREPARATIONS  (84%); N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ICS325411 MEDICINAL & BOTANICAL MANUFACTURING (55%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 JONATHAN BERGER (62%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANIZATION  (83%); WORLD TRADE ORGANIZATION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 INDIA (98%); AFRICA (93%); EUROPE (79%); SOUTHERN AFRICA (79%); SOUTH AFRICA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANIZATION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 March 29, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Zambia;India's Cheap Medicines Africa News March 29, 2005 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_46}{\*\bkmkstart DOC_ID_46_0}{\*\bkmkstart doc_id_17}{\*\bkmkend DOC_ID_46}{\*\bkmkend DOC_ID_46_0}{\*\bkmkend doc_id_17}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_17"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 17 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  29, 2005 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Zambia;\par India's Cheap Medicines}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Post\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 776 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 INDIA'S enactment of a law making it illegal for their pharmaceutical companies to make generic copies of patented drugs will certainly deprive millions of people across the world of inexpensive life-saving medicines.\par This law was enacted in compliance with India's commitment to the World Trade Organisation's Agreement on Trade-related Aspects of Intellectual Property Rights, or TRIPS.\par This law is very difficult to accept for us who believe that the highest level of political and economic thought was reached when some people became aware that no people and no human being had the right to exploit others, and that the fruits of the efforts and intelligence of each human being should reach all others; that man really had no need to be a wolf, but could be a brother to man.\par And although the Indian Congress Party government has pledged to its leftist allies and other opposition lawmakers that the new law won't push up the medicine prices in the country, we don't see how this will be guaranteed, especially for the export market. \par India's pharmaceutical market has thrived in the last three decades because the country's law had allowed patented drugs to be copied, as long as a different manufacturing process is used to make them. The co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 panies were legally producing generic versions of medicines that were under patent elsewhere, including the much in demand low-cost AIDS drugs for 50 per cent of nearly one million HIV patients taking antiretroviral medicines in developing countries.\par Some of the AIDS drugs made by reputable Indian companies cost about 5 per cent of the price of similar drugs sold by United States and European Union pharmaceutical companies.\par We know that the news of the new Indian law is honey to the ears of international pharmaceutical companies but this law will spell doom for the access to medicine in poor and developing countries by sky-rocketing the drug prices, making them unaffordable.\par Indian pharmaceutical majors like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  and Ranbaxy were spearheading making AIDS drugs and exporting them to African nations at a very low cost as compared to multinational pharmaceutical majors. All this seems to be changing now.\par This new law spells long-term disaster for India and other Third World countries in health. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  had virtually become a household name in African countries, as its generic or chemically similar AIDS drugs took on mu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tinational companies selling in the market.\par In Africa, exports by Indian companies, helped nose-dive the annual price of antiretroviral treatment down from US $14,000 a decade ago to about $200. They also simplified the therapy by making pills containing three AIDS drugs.\par Generics made up about 15 per cent of India's $10 billion pharmaceutical industry that has 300 large and moderate-sized firms, plus 10,000 small companies, making 8 per cent of the world's drugs. According to pharmaceutical industry statistics, nearly 70 per cent of production is by the top 100 companies and about a third of that is exports, which were rising by 25 per cent a year. Indian companies will no longer be able to make copies of over-priced western drugs, which will affect poor countries around the world.\par But the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  obligation does not require India to grant patents on new uses of known drugs, or combinations of known drugs. However, Indian lawmakers have included double-usage patents in their law. A drug like AZT, which was used against cancer in the mid '70s and now used for HIV, can be patented simply on the grounds of new usage.\par And five cancer drugs such as Gefitinib, Temozolomide, Zoledronic acid, Letrozole and Ganciclovir are set to see a multi-fold increase in prices, as a result of this new law. Prices on these drugs will increase between two and 12 times.\par And simply because India is one of the world's biggest producers of generic drugs, this law will have a s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 vere ripple effect on many developing countries which depend on imported generic drugs from India.\par Under the agreement on intellectual property at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 , India had to introduce amendments to its existing patent Act by January 1, 2005. Unfortunately, the Indian government waited until the very last minute and then rushed it through the parliament, leaving no space for democratic debate and consideration of wider public health implications.\par We are deeply disturbed and concerned that the Congress Party government has failed to listen to the voi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 es of so many people who have entrusted them with their welfare. And it is difficult to accept the Indian go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ernment's assurance that it has enough safeguards to protect the interests of the poor. How?\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PHARMACEUTICALS INDUSTRY (91%); PHARMACEUTICAL PREPARATION MFG (90%); GENERIC PRODUCTS (90%); PHARMACEUTICALS & BIOTECHNOLOGY REGULATORY COMPLIANCE (90%); PHARMACEUTICALS PATENTS (90%); AIDS & HIV TREATMENT (90%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ERTY LAW (90%); GENERIC DRUGS (90%); AIDS & HIV (90%); ANTIVIRALS (89%); DRUG PRICES (89%); INTERNATIONAL TRADE (89%); EXPORT TRADE (89%); LEGISLATION (89%); DEVELOPING COUNTRIES (89%); LEGISLATORS (78%); PATENT LAW (78%); MULTINATIONAL CORPORATIONS (77%); EXPORT PRICES (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (58%); RANBAXY (NSE) (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (58%); SIC2834 PHARMACEUTICAL PREPARATIONS (58%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ING (52%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANIZATION  (58%); WORLD TRADE ORGANIZATION (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 INDIA (95%); AFRICA (93%); ZAMBIA (92%); UNITED STATES (79%); EUROPEAN UNION MEMBER STATES (53%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANIZATION (60%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 March 29, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PanAfrica;Goodbye to Cheap Indian Aids Drugs? Africa News November 26, 2004 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_47}{\*\bkmkstart DOC_ID_47_0}{\*\bkmkstart doc_id_18}{\*\bkmkend DOC_ID_47}{\*\bkmkend DOC_ID_47_0}{\*\bkmkend doc_id_18}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_18"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 18 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  26, 2004 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 PanAfrica;\par Goodbye to Cheap Indian Aids Drugs?}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Inter Press Service\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1225 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 As India moves to meet a New Year's Day deadline to comply with the Trade Related Aspects of Intellectual Property Rights (TRIPS) regime of the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ) the cheap, generic anti-AIDS drugs that this country is famed for could be a thing of the past.\par On Nov.19, the World Health Organisation (WHO) announced that the Hyderabad-based pharmaceutical Hetero Drugs Limited, had voluntarily withdrawn all six of its generic antiretroviral (ARV) drugs from the world body's list of approved drugs following concerns about their laboratory tests.\par ARVs are substances used to kill or inhibit the multiplication of retroviruses such as HIV.\par It was the third time since June that an Indian company has removed anti-AIDS drugs following WHO inspe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tions which claimed that bioequivalence tests -- meant to show the drugs have the same effect as the original patented brands - were faulty. And this has deeply upset those involved in fighting the global HIV/AIDS ep}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 demic. \par Earlier this month Indian pharmaceutical giant Ranbaxy pulled its AIDS drugs off the WHO's list after the global body also claimed there were discrepancies in the equivalency tests. It followed the removal by India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  of two HIV/AIDS drugs in June for similar problems..\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  is the Indian company credited with introducing the 'dollar-a-day' treatment that dramatically tran}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 formed drug access for HIV-infected people around the world.\par But the fact of the matter remains.\par Both Ranbaxy and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  were able to prove to WHO, before the voluntary pull-off, that their ARVs met the global body's bioequivalence standards -- though not before their world business had taken a knock that benefited the manufacturers of costlier patented drugs.\par That initially led to charges from non-governmental organisations (NGOs) that the world health body was acting at the behest of western pharmaceutical giants.\par However, things, now, have become more complicated.\par Why did the two Indian pharmaceutical companies pull their ARVs from the market, if they had insisted all along that their drugs met WHO pre-qualification standards?\par "We are concerned over the withdrawals. Earlier it was WHO which dropped the drugs. This time the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 panies are doing it own their own. We may ask the Drugs Controller of India (DCGI) to look into the issue," a senior health official told IPS.\par WHO's pre-qualification list was created to guide procurement by aid agencies and donors interested in fighting the global HIV/AIDS epidemic and includes more than 60 ARVs made by both patented and generic drug manufacturers.\par According to the internationally-known drug policy expert, Mira Shiva, the actual culprit in the whole debacle involving Hetero, Ranbaxy and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  was actually the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  and not WHO.\par Shiva who is attached to the Voluntary Health Association of India (VHAI), a leading health NGO, said Indian pharmaceutical companies that specialise in cheap generics drugs could face legal action, initiated by the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 , if they continued to manufacture and sell them after Jan. 1, 2005.\par "The TRIPS regime (in the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  structure) has been identified as one of the worst international trade r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gimes and resistance to it in developing countries has come from farmers, public interest and human rights minded social action groups, as well as drug and health activists," Shiva told IPS.\par TRIPS agreement, introduced in the late 1990s, defines how products can be protected from piracy. A major criticism has been that in its current form, intellectual property rights regimes (IPR) -- like TRIPS -- serve to stifle competition. For poor nations it makes developing their own industries independently more costly, if at all possible.\par "Excessively high levels of intellectual property protection required by TRIPS have shifted the balance away from the public interest, towards the monopolistic privileges of IPR holders," said Martin Khor of the Mala}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sia-based Third World Network. "This undermines sustainable development objectives, including eradicating poverty, meeting public health needs, conserving biodiversity, protecting the environment and the realisation of economic, social and cultural rights."\par Shiva pointed out that a TRIPS review was due in 2000 but was never carried out although the WHO was both aware and concerned about the effect the regime would cause to drug prices and access especially in the developing countries.\par So far, India's pharmaceutical business has followed the fiercely nationalistic India Patents Act of 1970 that fostered the phenomenal growth of the industry that came to be hailed by the United Nations Council for Trade and Development (UNCTAD) as a model for developing countries.\par According to a World Bank study in the mid-1990's prices for four typical drugs were ten times more expe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sive in neighbouring Pakistan, 17 times more expensive in Britain and 37 times more expensive in the United States than in India.\par The Indian law has safeguards for both inventors as well as users but recognizes process patents as against the product patents regime required by TRIPS/}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 .\par An amendment to the Act, designed to meet the WHO deadline is slated to be tabled by the government du}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing the winter session of the Indian Parliament next month. If the government fails to get a consensus, it is expected to resort to an ordinance.\par India signed the relevant }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  agreement on the issue in 1995 as part of its economic liberalisation under a Congress government but the party lost the elections in the following year because of widespread public pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ception that globalisation had benefited only a small elite.\par The Congress party had to wait eight years before it could return to power in May on a promise to pursue liberalisation "with a human face." But Kamal Nath its current minister for commerce and industry said the country could not avoid taking at least "credible steps" to fulfill its multi-lateral obligations.\par Political opposition to the bill that would amend the Indian Patents Act has come from the major communist parties united as the Left Front, which provides critical support to the Congress-led coalition government.\par "The Jan. 1 deadline should not be used as a plea to rush through legislation for which the country may have to pay a heavy price later," said D. Raja, National Secretary of the Communist Party of India (CPI).\par In the meanwhile Poornima Mane, director for social mobilisation and communication at UNAIDS, the U.N. body charged with fighting HIV/AIDS said patients should continue using Ranbaxy and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  drugs that are available in the market.\par "We want to clarify this so that patients do not panic. This (the voluntary withdrawals) does not mean that the drugs are not good. The worst thing will be if people stop using these drugs and develop resistance," she said.\par But Mane said both UNAIDS and WHO were monitoring the situation in India "since this country will have to follow the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  restrictions coming up next year and also because it is the biggest producer of generic drugs."\par India itself has 5.1 million people afflicted with HIV according to the 'AIDS Epidemic Update', an annual r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 port prepared by UNAIDS and WHO and released here this week. Globally, the number of the HIV-afflicted people has reached 39.4 million up from the 36.6 million estimated in 2002.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS & HIV TREATMENT (94%); AIDS & HIV (94%); ANTIVIRALS (92%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); INTERNATIONAL TRADE (90%); PHARMACEUTICAL PREPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TION MFG (89%); EPIDEMICS (89%); NONGOVERNMENTAL ORGANIZATIONS (89%); INTELLECTUAL PROPERTY LAW (89%); PHARMACEUTICALS INDUSTRY (89%); GENERIC DRUGS (89%); PUBLIC HEALTH ADMINISTRATION (89%); DISEASES & DISORDERS (89%); RELIEF ORGANIZATIONS (89%); PUBLIC POLICY (78%); PHARMACEUTICALS & BIOTECHNOLOGY REGULATORY COMPLIANCE (78%); PHARMACEUTICALS PATENTS (77%); PRESCRIPTION FORMULARIES (77%); HEALTH DEPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MENTS (77%); VIRUSES (75%); GENERIC PRODUCTS (72%); DRUG POLICY (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (92%); RANBAXY (NSE) (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (92%); SIC2834 PHARMACEUTICAL PREPARATIONS (92%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ING (72%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MIRA SHIVA (74%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANIZATION  (91%); WORLD TRADE ORGANIZATION (91%); WORLD HEALTH ORGANIZATION  (90%); WORLD HEALTH ORGANIZATION (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 INDIA (94%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ANDHRA PRADESH, INDIA (73%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYDERABAD, INDIA (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HETERO DRUGS LTD (66%);  WORLD TRADE ORGANISATION (84%);  HETERO DRUGS LTD (72%); RANBAXY LABORATORIES LTD (55%);  WORLD TRADE ORGANIZATION  (91%); WORLD HEALTH ORGANIZATION  (90%); WORLD HEALTH ORGANIZATION (90%); WORLD TRADE ORGAN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ZATION (84%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 November 29, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2004 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PanAfrica;Daily HIV/Aids Report Africa News July 13, 2004 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_48}{\*\bkmkstart DOC_ID_48_0}{\*\bkmkstart doc_id_19}{\*\bkmkend DOC_ID_48}{\*\bkmkend DOC_ID_48_0}{\*\bkmkend doc_id_19}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_19"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 19 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  13, 2004 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 PanAfrica;\par Daily HIV/Aids Report}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Kaisernetwork.org\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 11362 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Bangkok Daily Update\par Discussion at XV International AIDS Conference Focuses on How To Provide Antiretroviral Drugs to Deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 oping World\par [Jul 13, 2004]\par Delegates and speakers at the XV International AIDS Conference in Bangkok, Thailand, on Tuesday called for broader accessibility to antiretroviral treatment, as access to HIV/AIDS medications continues to elude millions around the world. Jim Kim, who heads the World Health Organization project tasked with scaling up treatment -- the <a ="http://www.who.int/3by5/about/en/">3 by 5 Initiative</a> -- expressed shame over the six million people who have died of AIDS since the conference last met two years ago. "By these measures of human life, the ones that really matter, we have failed and we have failed miserably to do enough in the precious time that has passed since Barcelona," he said.\par Protestors agreed, arguing that the availability of cheap generic drugs would remove the largest barrier to access. But first, advocates said that brand-name pharmaceutical companies must forgo their patents for certain drugs in developing countries. Hank McKinnell, CEO of <a ="http://www.pfizer.com/">Pfizer</a>, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gued that forgoing patents will dry-up innovation. "People living with HIV are going to need a steady stream of new therapies as this virus mutates and currently available treatments fail patients. If 'Access for All' is all that we do in the first sense, access for those needing medicines today, then the theme of future IAS confe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ences will surely be 'Why are treatments failing patients?'" \par However, maintaining research and development should not keep needed medications from people who cannot afford them, according to Walden Bello from the University of the Philippines. "R&D for HIV drugs and other essential medicines is no longer efficient within a corporate context. Big pharma is more interested in protecting its 20% margin, provided by monopolistic pricing based on patents, than in providing drugs to people with little purchasing power."\par Neither side denies there is a need to provide these medications; they just disagree on the best way to get them to the millions of people who need them (Jill Braden, Kaiser Daily HIV/AIDS Report, 7/13).\par Video highlights of the day's events are available <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1178">online</a>.\par Bangkok Notebook\par Kaiser Family Foundation Senior Visiting Fellow Jackie Judd Discusses XV IAC Events With Science R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 porter Jon Cohen\par [Jul 13, 2004]\par Kaiser Family Foundation Senior Visiting Fellow Jackie Judd each day during the <a ="http://www.aids2004.org/">XV International AIDS Conference</a> is interviewing Science magazine corr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 spondent Jon Cohen about news coming out of the conference. On Monday, Jon discussed an opening ce}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 emony that did not go as planned, and on Tuesday he talked about the bold admission by World Health O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ganization HIV/AIDS Program Director Jim Kim, who said that the world has "failed miserably" to provide treatment to HIV-positive people worldwide. The interviews are available <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1181">online</a> from ka}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sernetwork.org (Kaiser Daily HIV/AIDS Report, 7/13).\par Global Challenges\par Costs for Antiretroviral Drug Treatment, HIV Prevention, AIDS Orphan Care in Developing Countries Will Be $12B by 2005, UNAIDS Report Says\par [Jul 13, 2004]\par The cost of providing antiretroviral drug treatment, care for AIDS orphans and HIV prevention in services in developing countries is expected to reach $12 billion by 2005 and could reach $20 billion by 2007, according to a report released Monday by UNAIDS, the <a ="http://sfgate.com/cgi-bin/article.cgi?f=/c/a/2004/07/13/MNG2B7KGJQ1.DTL">San Francisco Chronicle reports. The bulk of the increase reflects the cost of expanding treatment from fewer than 500,000 people to six million HIV-positive people by 2007, as well as the provision of essential services, according to the report (Russell, San Franci}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 co Chronicle, 7/13). According to the report, titled "Financing the Expanded Response to AIDS," funding for next year is still anticipated to fall short by $6 billion in 2005, even though total global spending to combat HIV/AIDS increased from $1.2 billion in 2000 to $6 billion in 2004. UNAIDS researchers used new data from 78 countries on "actual costs" for prevention, care, treatment, orphan support, policy, advocacy and admini}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 trative programs to complete the report. Bilateral support for the efforts to combat the HIV/AIDS pandemic has increased 64% among leading donor countries between 2000 and 2002. UNAIDS predicts that bilateral spending will reach $1.3 billion by the end of 2004, according to a UNAIDS <a ="http://www.unaids.org/NetTools/Misc/DocInfo.aspx?LANG=en&=http%3a%2f%2fgva-doc-owl%2fWEBcontent%2fDocuments%2fpub%2fMedia%2fPress-Releases02%2fPR_Funding-BKK_12Jul04_en%26%2346%3bpdf">release</a>.\par U.S. Spending\par According to the report, the United States is the leading bilateral donor "in terms of absolute dollars," the r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lease said (UNAIDS release, 7/12). The House Appropriations Committee on Friday approved by voice vote a $19.4 billion foreign aid spending bill for fiscal year 2005, <a ="http://www.reuters.com/newsArticle.jhtml?type=topNews&storyID=5633849">Reuters</a> reports. The foreign aid bill provides $2.2 billion for HIV/AIDS, tuberculosis and malaria initiatives. Some critics have called the amount "inadequate" compared with the funding provided for the war on terror and post-war Iraq, Reuters reports (Willard, Reuters, 7/9). Although the approved funding -- most of which will go to AIDS pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 grams -- meets President Bush's request for FY 2005, an appropriations subcommittee allocated a larger portion of the money to the <a ="http://www.theglobalfund.org/en/">Global Fund to Fight AIDS, Tuberculosis and Malaria than Bush had requested. Bush's proposed FY 2005 budget, which is $1.9 billion more than the total amount the subcommittee approved, includes $2.8 billion for international HIV/AIDS, TB and malaria programs. That amount includes $1.45 billion for the <a ="http://www.state.gov/">State Department</a> <a ="http://www.state.gov/s/gac/">Office of the Global AIDS Coordinator, which will administer the <a ="http://www.state.gov/s/gac/rl/or/c11652.htm">President's Emergency Plan for AIDS Relief, and $200 mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lion for the Global Fund. Because the draft spending bill would double the requested Global Fund contrib}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion to $400 million, less money would go to PEPFAR. The $2.2 billion approved by the House subcommittee combined with an anticipated $600 million in funding from the Labor-HHS-Education appropriations bill would bring overall global AIDS, TB and malaria spending to $2.8 billion for FY 2005 (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24395">Kaiser Daily HIV/AIDS Report, 6/24).\par Funding Gap Getting Worse?\par UNAIDS Director of Evaluation Dr. Paul De Lay said, "Unless more resources are directed toward the global response, the gap between the need and available resources will grow significantly in coming years" (U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS release, 7/12). The situation could be worsened by a lack of inexpensive second-line treatments for HIV-positive people who develop resistance to first-line drugs, according to the Chronicle. Because about 10% to 20% of people living with HIV/AIDS who take antiretroviral drugs develop resistance, some adv}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cates predict the costs for providing second-line treatments to cause a "sort of balloon payment down the road," the Chronicle reports.\par Global Fund\par Advocates are "step[ping] up their campaign" for wealthy countries to increase their donations to the Global Fund. Richard Feachem, executive director of the fund, said that it would not be possible to reach the fund's 2005 $3.5 billion goal if wealthy countries do not increase contributions, according to the Chronicle (San Francisco Chronicle, 7/13). U.N. Special Envoy for HIV/AIDS in Africa Stephen Lewis said that funding co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cerns have put efforts to combat HIV/AIDS "on the knife's edge of the chasm," adding, "Either we continue the flow of funds and continue to increase treatment and make people feel there's hope, or we suffer a dreadful setback in responding to the pandemic." Ambassador Randall Tobias, head of the State Department Office of the Global AIDS Coordinator, said that the United States is "certainly going to continue to contribute to the Global Fund," but he added, "We need to put more emphasis on getting [the money already contribu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ed to the fund] put to work." <a ="http://www.globalaidsalliance.org/">Global AIDS Alliance</a> President Paul Zeitz said that the funding situation amounts to a "battle between a U.S. go-it-alone approach and mult}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lateralism" (Nakashima, Washington Post, 7/13).\par Abstinence Best Way To Prevent HIV/AIDS, Ugandan President Museveni Says\par  [Jul 13, 2004]\par Abstinence is the best way to curb the spread of HIV/AIDS, Ugandan President Yoweri Museveni said during a plenary session on the first full day of the XV International AIDS Conference in Bangkok, Thailand, <a ="http://www.reuters.co.uk/newsPackageArticle.jhtml?type=topNews&storyID=545616A\u223\'a7ion=news">Reuters</a> reports (Schuettler, Reuters, 7/12). Museveni has said that the country's HIV prevention slogan, "ABC" -- Abstinence, Be faithful, use Condoms -- could be used elsewhere in Africa to stem the spread of HIV. M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 seveni said that the "C" is meant to be a "fallback position," a "means of last resort" if a person "cannot ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 age A and B." Museveni also has said that the country has the funding, supplies and infrastructure in place to begin treating the 60,000 HIV-positive people in the country who need antiretroviral drugs (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24461">Kaiser Daily HIV/AIDS Report, 6/29). Museveni said, "I look at condoms as an improvisation, not a solution," adding that he favors "optimal relationships based on love and trust instead of institutional mistrust which is what the condom is all about" (Reuters, 7/12). Museveni said that in some societies, sexual intercourse "is so elaborate that co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 doms are a hindrance" (<a ="http://www.ajc.com/news/content/news/0704/12aids.html">AP/Atlanta Journal-Constitution, 7/12). "Let the condom be used by people who cannot abstain, cannot be faithful, or are e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tranged," he added (BBC News, 7/12). Museveni's comments contradict the opinion of some health experts who support condom use as a first-line defense against HIV infection, according to Reuters (Reuters, 7/12).\par Reaction\par International AIDS Society President and conference Co-Chair Joep Lange said, "Condoms are effective, but you have to look at different cultures in each country." Dr. Tim Brown, director of the UNAIDS Collaborating Center at the <a ="http://www.eastwestcenter.org/">East-West Center</a> in Hawaii, said that condoms, in addition to abstinence, are an "essential component" of HIV/AIDS prevention campaigns, Reuters reports. Brown said, "We need to move our prevention programs back to prevention science, and the one thing that is very clear for young people is that the best programs are those that provide full information," including info}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 mation on abstinence, sexually transmitted diseases and condoms (Reuters, 7/12). <a ="http://www.ippf.org/">International Planned Parenthood Federation</a> Director-General Steven Sinding said, "The religious-focused or oriented groups denigrate condoms, and believe that serious efforts to control [HIV] can be successful without recourse to condoms, and we don't believe that" (BBC News, 7/12). Rep. Barbara Lee (D) -- the only member of Congress to attend the conference -- said that the Bush administr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion uses "ideology, not science, to dictate policy," according to Reuters (Reuters, 7/12). "In an age where five million people are newly infected each year and women and girls too often do not have the choice to a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 stain, an abstinence until marriage program is not only irresponsible, it's really inhumane," Lee said (Joshi, <a ="http://www.washingtontimes.com/world/20040712-094622-5261r.htm">AP/Washington Times, 7/13). She added, "Abstaining from sex is oftentimes not a choice, and therefore their only hope in preventing HIV infection is the use of condoms" (Reuters, 7/12).\par BBC's "<a ="http://www.bbc.co.uk/worldservice/programmes/worldupdate/">World Update" on Monday r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ported on abstinence as a method of preventing HIV/AIDS. The segment includes comments from Sinding (Hogg, "World Update," BBC, 7/12). The complete segment is available <a ="http://www.bbc.co.uk/worldservice/ondemand/rams/wup28014__2004.ram">online</a> in RealPlayer.\par Fight Against HIV/AIDS Hindered by Duplicated Efforts, XV International AIDS Conference Participants Say\par [Jul 13, 2004]\par The duplication of efforts by donors in the fight against AIDS is leading to waste and inefficiency and slowing the fight against the disease, a panel of experts at the XV International AIDS Conference said on Monday, the <a ="http://www.nytimes.com/2004/07/13/international/asia/13aids.html">New York Times reports. In a session titled "Funding the Response to HIV/AIDS: Why Are Donors Not Working Together?" moderator Hank McKinnell, CEO of Pfizer, said that the donor community is "pledging, moving and disbursing funds and materials at unprecedented rates." However, an overall "lack of agreement on approaches and key issues among the donors themselves has ... led to delays or problems in program implementation and coordin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion," Dr. Biziwick Mwale, executive director of the National AIDS Commission in Malawi, said. The partic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 pants agreed that standardized measures to monitor the costs and effectiveness of prevention efforts as well as the adoption of U.N. recommendations on using resources efficiently are needed to improve coordination among donors and developing countries. However, participants offered no formal proposals, saying that it would "take more time to resolve the complexities involved in the relationships between donors and recipient countries," according to the Times (Altman, New York Times, 7/13).\par A kaisernetwork.org webcast of the session is available <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1193">online</a>.\par Chinese Premier Wen Jiabao Appeals to Government, Public for Help in Fighting HIV/AIDS\par [Jul 13, 2004]\par Chinese Premier Wen Jiabao on Saturday ahead of the <a ="http://www.aids2004.org/">XV International AIDS Conference</a> in Bangkok, Thailand, released a public appeal for "all levels of government and the entire society [to] attach great importance to preventing and controlling AIDS," London's <a ="http://www.guardian.co.uk/aids/story/0,7369,1259101,00.html">Guardian</a> reports (Boseley, Guardian, 7/12). The Chinese government estimates that there are 840,000 HIV-positive people in the country and that 80,000 people have AIDS; however, some experts believe that those figures are an underestimate. The United Nations estimates that there are at least one million HIV-positive people in China (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24484">Kaiser Daily HIV/AIDS Report, 6/30). Wen said that the rural areas where most of the population lives presented the greatest cha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lenge because of "backward hygiene and medical conditions" and because people in rural areas "are not well educated about legal and health issues" (Agence France-Presse, 7/9). Wen's statement, which was pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lished on the front page of Chinese newspapers, called on Chinese scientists to "work hard to develop new drugs and optimize therapies" and said that prevention would be a "long-term, arduous task." In addition, Wen said that the country would invest more in the fight against the disease (Guardian, 7/12). Wen also called for expanded HIV testing -- 90% of HIV-positive people in the country are unaware of their status, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cording to government figures (Agence France-Presse, 7/9). UNAIDS Executive Director Peter Piot on Mo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 day at a session on nongovernmental AIDS organizations in China said that Wen's statement showed that "China means business when it comes to AIDS." However, he said that the country must address AIDS-related stigma and other social issues, such as injection drug use, commercial sex workers and their clients and men who have sex with men (Associated Press, 7/12).\par Medical Students\par China plans to send 1,300 medical students to rural areas to help with HIV/AIDS prevention programs during their summer break, <a ="http://story.news.yahoo.com/news?tmpl=story&cid=571&ncid=751&e=5&u=/nm/20040710/hl_nm/aids_china_dc">Reuters</a> reports (Reuters, 7/12). The program is part of the country's AIDS education campaign that 12 government departments, ministries and organizations launched on Saturday. In addition, the go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ernment will distribute millions of posters on AIDS prevention to rural villages, urban communities, univers}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ties and schools throughout the country. The education campaign also will include "face-to-face" AIDS ed}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cation for women ages 15 to 49 in 51 counties. Khalid Malik, U.N. resident coordinator in China, said that the program is one of the biggest HIV prevention initiatives in the world (Xinhua News Agency, 7/10).\par ABCNews' "<a ="http://abcnews.go.com/Sections/Nightline/">Nightline</a>" on Monday focused on HIV/AIDS in Russia and China, two countries where HIV prevalence rates are "exploding." The segment on China examines the unsafe blood collection practices that facilitated HIV transmission in the country and the stigma HIV/AIDS patients experience. The segment includes comments from UNAIDS Executive Director Peter Piot (Wright, "Nightline," ABCNews, 7/12). The segment on Russia examines the lack of needle-exchange programs in cities with high rates of injection drug use and profiles an orphanage serving HIV-positive children. According to "Nightline," Russian President Vladimir Putin has spoken exactly one se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tence about HIV/AIDS (Litke, "Nightline," ABCNews, 7/12). A video excerpt of the segment on China is avai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 able online in RealPlayer.\par Most Global Fund Grant Programs Performing as Expected, Some Underperforming, Fund Report Says\par [Jul 13, 2004]\par Twelve of the first 25 programs that received funding from the <a ="http://www.theglobalfund.org/en/">Global Fund to Fight AIDS, Tuberculosis and Malaria more than one year ago are either on schedule or ahead of schedule for meeting their goals, according to a report released on Monday at the XV International AIDS Conference, <a ="http://www.guardian.co.uk/international/story/0,3604,1258976,00.html">London's Guardian reports (Boseley, Guardian, 7/12). The report analyzed the first 25 grants for HIV, TB and malaria programs in operation for one year between May 1, 2003, and April 30, 2004 (Global Fund <a ="http://www.theglobalfund.org/en/media_center/press/pr_040711b.asp">release</a>, 7/11). The report, t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tled "A Force for Change: The Global Fund at 30 Months," also says that eight programs that received grants from the Global Fund are below target and five programs are underperforming. Of the five programs consi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ered to be underperforming, two are in Sri Lanka, two are in Senegal and one is in Tanzania, according to the report (Guardian, 7/12). Other countries -- such as Honduras, which placed nearly twice as many people on antiretroviral treatment as planned -- are "substantial overachievers," according to the release. The 25 programs have provided interventions such as testing, treatment and care to 2.3 million people and trained 340,000 people to administer antiretroviral drugs, according to the report. Sixty percent of Global Fund grants go to AIDS programs, through which about 12,000 people have received antiretroviral drugs, the r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 port says, according to the Guardian. Global Fund Executive Director Richard Feachem said that in five years, more than 1.6 million people are expected to be receiving antiretroviral treatment through programs receiving fund money (Guardian, 7/12). He added, "We hope this report is an indication that the innovative ways in which the Global Fund works are beginning to make the impact envisioned at its creation 30 months ago. The systems work and the Global Fund is ready to dramatically expand funding to countries fighting the three pandemics" (Global Fund release, 7/12).\par More Funding Needed\par Any delay in funding from major donors to the Global Fund will affect the group's efforts to fight the three di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 eases, especially HIV/AIDS, Feachem said, Thailand's Nation reports. The Global Fund needs $1.65 billion to fund projects through this year and an additional $3.56 billion in funds next year, according to Feachem (Arthit, Nation, 7/12). The Global Fund has approved grants to nearly 300 programs in 130 countries thus far; 25 of them have been running for more than one year, according to the Guardian (Guardian, 7/12). The group is planning to launch the fifth round of grants in November and the sixth round in the middle of 2005, but it will not be able to proceed without the necessary funds, according to the Nation. Donations to the Global Fund are expected to peak at $3 billion per year by 2008, with more than half of the total dedicated to AIDS programs (Nation, 7/12).\par Kaisernetwork.org on Tuesday webcasted a Global Fund <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1222">session</a> and a <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1193">session</a> on cooperation among donors in the fight against AIDS. The webcasts and other coverage are available <a ="http://www.kaisernetwork.org/aids2004/kffsyndication.asp?show=portal.html">online</a>.\par More Than 35 M Working-Age Adults Living with HIV/AIDS, International Labor Organization Report Says\par [Jul 13, 2004]\par About 36.5 million adults of working age are HIV-positive and about 28 million working-age adults have died from AIDS-related causes since the beginning of the epidemic, according to a report released on Sunday by the International Labor Organization at the <a ="http://www.aids2004.org/">XV International AIDS Confe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ence</a> in Bangkok, Thailand, <a ="http://www.voanews.com/article.cfm?objectID=A5A874E1-ED77-47DA-8B61D9FAC9FF1190&title=ILO%20Says%20HIV%2DAIDS%20Takes%20Heavy%20Toll%20%20at%20%20Workplace&catOID=45C9C786-88AD-11D4-A57200A0CC5EE46C&categoryname=Health%20%26%20Medicine">VOA News reports. ILO surveyed workers between the ages of 15 and 64 in 50 countries and found that HIV/AIDS is "one of the biggest cau}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 es of mortality in the working world," according to VOA News. The report, titled "<a ="http://www.ilo.org/public/english/protection/trav/aids/publ/global_est/index.htm">HIV/AIDS and Work: Global Estimates, Impact and Response," shows that if access to antiretroviral drug treatment is not i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 creased, the number of workers who die from AIDS-related causes will increase to 48 million by 2010 and 74 million by 2015, according to the report. In addition, about two million people by 2005 and four million by 2015 will be too ill to work and will have "dropped out of the labor force," Odile Frank, the report's author, said. The loss of workers at their most productive stage in life costs the world approximately $25 billion a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nually, according to the report (Schlein, VOA News, 7/1). In addition, young women -- who are usually r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sponsible for caring for family members with HIV and other family members in addition to often being r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sponsible for subsistence farming -- account for the largest increases in HIV-prevalence rates worldwide, the report says, according to <a ="http://news.xinhuanet.com/english/2004-07/12/content_1591227.htm">Xinhuanet</a>. The combination of these factors "jeopardizes their capacity" to provide food for the household and care for family members, Xinhuanet reports (Xinhuanet, 7/11). ILO D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 rector-General Juan Somavia said, "HIV/AIDS is not only a human crisis, it is a threat to sustainable global, social and economic development," adding that the loss of life from AIDS-related causes and the "debilitating effects of the illness will lead not only to a reduced capacity to sustain production and employment, reduce poverty and promote development, but will be a burden borne by all societies -- rich and poor alike" (Xinhua News Agency, 7/11).\par 'Brain Drain' of African Health Workers Slowing Fight Against AIDS, Physicians for Human Rights Report Says\par [Jul 13, 2004]\par A "brain drain" of health care workers from Africa is "further crippling ... already fragile" health care infrastru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tures throughout the continent, as it "struggl[es]" to provide HIV/AIDS drugs and treatment to hundreds of thousands of people, according to a <a ="http://www.phrusa.org/">Physicians for Human Rights</a> report to be released Thursday, the <a ="http://www.nytimes.com/2004/07/13/international/africa/13afri.html?pagewanted=all">New York Times r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ports. The report, titled "An Action Plan to Prevent Brain Drain," proposes specific measures to slow the m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gration of African health care workers to wealthier nations and increase staff in African health care facilities. Recommendations include calling upon developed nations to:\par Reimburse African countries for the loss of African-educated health professionals;\par Combat their own health care worker shortages by training more people domestically rather than recruiting workers from developing countries; and\par Work with international organizations to directly support higher salaries or other forms of reimbursement for underpaid African health professionals.\par The report advocates limiting recruitment of African health professionals by developed countries and private organizations, saying, "The balance will be best achieved when policies that make it more difficult for health professionals to emigrate, such as restrictions on recruitment, are implemented in the context of improving working conditions, fairer salaries and other advances in health professionals' ability to enjoy their rights." However, the report recognizes the difficulty in accomodating both the rights of African health care workers to seek better living conditions and the rights of African patients to receive adequate health care, according to the Times. "Everyone says it's not sustainable to pay salaries. But we're facing the worst health crisis in human history. Let's do things outside the box," Holly Burkhalter, PHR's U.S. policy director, said (Dugger, New York Times, 7/13).\par France Criticizes United States for 'Pressuring' Developing Countries To Give Up Producing Generic Drugs, Including Antiretrovirals\par [Jul 13, 2004]\par French President Jacques Chirac in a written statement to the <a ="http://www.aids2004.org/">XV Intern}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tional AIDS Conference</a> said on Tuesday that the United States is "pressuring" developing countries to give up the right to make generic drugs -- including antiretroviral drugs -- in exchange for free trade agre}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ments, the <a ="http://www.kansascity.com/mld/kansascity/news/world/9142736.htm">AP/Kansas City Star reports. Chirac said that U.S. methods concerning generic drugs in free trade negotiations have been "ta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tamount to blackmail." Mireille Guigaz, France's global ambassador on AIDS, said, "The United States wants to put pressure on developing countries who try to stand up for their own industries." A U.S. official, speaking on condition of anonymity, called Chirac's allegations "nonsense," and said that trade agreements entered into by the United States would be consistent with <a ="http://www.}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 wto.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 org/">World Trade Organization</a> rules that allow developing countries to produce generic drugs (Joshi, AP/Kansas City Star, 7/13).\par Australia Pledges To More Than Double Funding To Fight AIDS in Asia-Pacific Region\par [Jul 13, 2004]\par Australian Foreign Minister Alexander Downer announced on Sunday at the Second Asia-Pacific Ministerial Meeting on HIV/AIDS in Bangkok that Australia would more than double to $437 million its funding to fight HIV/AIDS in the Asia-Pacific region, the <a ="http://smh.com.au/articles/2004/07/11/1089484229581.html?oneclick=true">Sydney Morning Herald r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ports (Pollard, Sydney Morning Herald, 7/12). Downer did not specify whether the funding would go toward the <a ="http://www.theglobalfund.org/en/">Global Fund to Fight AIDS, Tuberculosis and Malaria or ind}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 pendent programs, saying only that the money "will mostly be spent" in the Asia-Pacific region, the Associa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ed Press reports (Associated Press, 7/11). Australia also will provide $2.2 million to the <a ="http://www.ausaid.gov.au/hottopics/hivaids/aplsf.cfm">Asia-Pacific Leadership Forum on HIV/AIDS, Dow}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 er said (Sydney Morning Herald, 7/12). Downer also announced the appointment of Annmaree O'Keeffe, a senior official with Australia's Agency for International Development, as the country's first special represent}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tive on HIV/AIDS, the Sydney Daily Telegraph reports (Sydney Daily Telegraph, 7/12). "[HIV/AIDS] is not just a health issue; it is a human security issue, it is an issue that can tear apart the fabric of societies and cause deep economic damage," Downer said (Sydney Morning Herald, 7/12). He added that Australia's main co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cern was for Papua New Guinea and Cambodia. Downer said, "We do have strong HIV/AIDS programs that we are running in Papua New Guinea. But I think the growth in the problem there is serious" (Associated Press, 7/12).\par Several U.S. and international broadcast programs reported on strategies for fighting HIV/AIDS in Thailand and the South Pacific:\par Australian Broadcasting Corporation's "<a ="http://www.abc.net.au/ra/asiapac/default.htm">Asia Pacific</a>": The segment includes comments from World Health Organizations's Dr. Jack Chow; <a ="http://www.unaids.org/en/default.asp">UNAIDS</a> Executive Director Peter Piot; and Relaki Ngawu, an HIV-positive AIDS advocate from Nigeria (Lloyd, "Asia Pacific," ABC, 7/13). The complete segment is avail}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ble <a ="http://www.abc.net.au/ra/asiapac/programs/m914586.asx">online</a> in Windows Media.\par NPR's "Talk of the Nation": The segment will examine how to maintain political will in fighting HIV/AIDS (Neary, "Talk of the Nation," NPR, 7/13). The complete segment will be available <a ="http://www.npr.org/programs/totn/">online</a> in RealPlayer and Windows Media after the broadcast. E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 panded NPR coverage is available <a ="http://www.npr.org/healthscience/aids2004/">online</a>.\par Xtra Broadband News: The segment includes comments from Dr. Kathleen Cravero, deputy executive dire}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tor of UNAIDS; Helen Leslie, a New Zealand government official; and Rachael Le Mesurier of the <a ="http://www.nzaf.org.nz/">New Zealand AIDS Foundation</a> (Glennie, Xtra Broadband News, 7/13). The complete segment is available online in Windows Media.\par Vietnam Population Policy Should Highlight Reproductive Health, HIV/AIDS Initiatives, Official Says\par [Jul 13, 2004]\par Le Thi Thu, minister of Vietnam's <a ="http://www.danang.gov.vn/home/view.asp?id=79&id_theloai=392&id_tin=3288">Committee for Population, Family and Children, on Friday at a meeting marking World Population Day called for the nation to work t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gether to implement a population policy, including HIV/AIDS initiatives and reproductive health care for ad}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lescents and pregnant women, BBC News reports. The government should focus on developing reproductive health and HIV/AIDS policies, in addition to raising awareness about contraception and providing medical services in inaccessible areas. Le said that population growth in Vietnam could impede the plan's impleme}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tation, according to BBC News. The number of women who reach reproductive age each year is three times higher than the number of women who are outside of that age range (BBC News, 7/11).\par USA Today Profile\par <a ="http://www.usatoday.com/news/health/2004-07-11-vietnam-aids_x.htm">USA Today on Monday pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 filed HIV/AIDS initiatives in Vietnam, which is the only country outside of Africa and the Caribbean eligible for funds under the five-year, $15 billion <a ="http://www.state.gov/s/gac/rl/or/c11652.htm">President's Eme}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gency Plan for AIDS Relief (Sternberg, USA Today, 7/12). Although there are currently about 200,000 HIV-positive people in Vietnam, some analysts predict that number could increase eightfold to one million people by 2010. Senior Bush administration officials said that the administration "considers that Vietnam is a place where the American people's money can really make a tremendous impact because it is on the brink of a very explosive epidemic" (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24636">Kaiser Daily HIV/AIDS Report, 7/9). According to Ambassador Randall Tobias, head of the State Department's <a ="http://www.state.gov/s/gac/">Office of the Global AIDS Coordinator, the HIV/AIDS epidemic in Vietnam is concentrated among high-risk groups such as injection drug users and commercial sex workers. Currently, fewer than 300 of the approximately 130,000 HIV/AIDS patients in Vietnam receive treatment, and there is only one doctor for every 11,250 HIV/AIDS patients in the country. With the additional $10 million in funding from PEPFAR, Vietnam plans to provide HIV/AIDS treatment to more patients nationwide; establish preve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion, treatment and care programs in walled rehabilitation camps where tens of thousands of commercial sex workers and drug addicts -- half of whom are HIV-positive -- are "warehoused"; and enlist several faith-based organizations to become active in HIV/AIDS initiatives, according to USA Today. Tobias said that the United States will not finance needle-exchange programs in Vietnam. Tim Brown, senior fellow at the <a ="http://www.eastwestcenter.org/">East-West Center</a>, in Bangkok on Sunday criticized the administr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion's restriction on needle exchange programs as well as its reluctance to promote condom use (USA T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 day, 7/12).\par XV International AIDS Conference\par Protestors Demanding Increased Antiretroviral Drug Access 'Disrupt' Events During XV International AIDS Conference\par [Jul 13, 2004]\par Protestors demanding increased antiretroviral drug access on Tuesday "disrupted" several events during the XV International AIDS Conference in Bangkok, Thailand, Agence France-Presse reports. Approximately 30 AIDS advocates "stormed" the main debating arena at the conference while Pfizer CEO Hank McKinnell was preparing to speak, according to Agence France-Presse. The demonstrators carried banners saying, "Patient rights, not patent rights" and chanted "Free the people, break the patents." Some AIDS advocates have crit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cized developed countries for not giving sufficient funding to fighting HIV/AIDS and have blamed some pharmaceutical companies for the high price of antiretrovirals, according to Agence France-Presse. Me}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 bers of the French AIDS advocacy group <a ="http://www.actupparis.org/">ACT UP-Paris</a> on Tuesday "jeered" French Minister for Development and Cooperation Xavier Darcos as he was preparing to deliver a speech on behalf of French President Jacques Chirac, according to Agence France-Presse. The protestors chanted, "10,000 deaths [from AIDS-related causes] per day, Darcos wants more." In his speech on behalf of Chirac, Darcos said that France would like to see $3 billion annually from Europe, the United States and ot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 er donors to the <a ="http://www.theglobalfund.org/en/">Global Fund To Fight AIDS, Tuberculosis and Mala}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ia, according to Agence France-Presse (Agence France-Presse, 7/13). Some AIDS advocates also said that the conference's Global Village community, an area set aside for community gatherings and activities, was an "insincer[e ]" effort by conference organizers to recognize HIV-positive people because it was "completely ignored" by the world leaders and celebrities attending the conference, according to Thailand's Nation. Pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 son Suwannawong, chair of the Thai Treatment Action Group, said, "How could the organizers say we come here to learn from one another when those big names didn't even bother to show up where we are," adding, "Didn't they say they want to learn from people really living with the disease?" Princess Zulu, an AIDS adv}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cate from Zambia, said, "You just invited us to be tokens to make your conference look good," adding, "If you want to fight AIDS, you have to listen to us because the virus is in our veins" (Nantiya, Nation, 7/13).\par Five Pharmaceutical Companies Close Booths During Protest\par Five pharmaceutical companies -- <a ="http://www.gsk.com/index.htm">GlaxoSmithKline</a>, <a ="http://www.bms.com/landing/data/index.html">Bristol-Myers Squibb</a>, Merck, <a ="http://www.abbott.com/">Abbott Laboratories</a> and <a ="http://www.roche.com/">Roche</a> -- closed their booths on the conference's exhibition floor when a group of protestors arrived to ask the companies to sign a "Treatment Access Pledge" that would commit the companies to "stand down" from patent enforc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment in developing countries, according to an AIDS Healthcare Foundation release. Two pharmaceutical companies -- <a ="http://www.gilead.com/wt/home">Gilead</a> and <a ="http://www.boehringer-ingelheim.com/corporate/home/home.asp">Boehringer Ingelheim -- kept their booths open and addressed the protestors, according to the release. The protestors who presented the pledge included AIDS advocates from South Africa, the United States, Thailand and Uganda. Michael Weinstein, AHF president, said, "We want to acknowledge and thank both Boehringer Ingelheim and Gilead for being willing to hear our concerns and engage in discussion," adding, "Some are in agreement with our position on patent enforcement in the developing world, particularly a company like Gilead, which doesn't even register drug patents in many r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 source-poor countries" (AHF release, 7/13).\par The <a ="http://www.abc.net.au/news/newsitems/200407/s1153170.htm">Australian Broadcasting Corpor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion on Tuesday reported on the protests about drug prices and the lack of HIV/AIDS funding. The audio r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 port includes an interview with McKinnell (Lloyd, ABC, 7/13). The complete segment is available <a ="http://www.abc.net.au/reslib/200407/r25247_62453.ram">online</a> in RealPlayer and <a ="http://www.abc.net.au/reslib/200407/r25247_62454.asx">online</a> in Windows Media.\par Drug Access\par Brazil, Seven Other Countries To Form Alliance To Share Antiretroviral Drug Manufacturing, Technology I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 formation\par [Jul 13, 2004]\par Brazil and seven other countries plan to establish an alliance aimed at improving the manufacture of drugs -- including antiretroviral drugs -- by sharing information on technologies, the Associated Press reports. Brazil, Russia, China, India, South Africa, Ukraine, Thailand and Nigeria are set to formally announce the partne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ship during the <a ="http://www.aids2004.org/">XV International AIDS Conference</a> in Bangkok, Thailand, through July 16, according to the Brazilian <a ="http://portal.saude.gov.br/saude/">Ministry of Health</a>. In a statement, the health ministry said that the alliance will focus on two issues: "investments for the produ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion of new drugs, and the improvement of the capacity of local production of generics." In addition, the all}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ance will help bolster negotiations for low-cost antiretrovirals and "speed up the dissemination of new tec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nologies," according to the Associated Press (Radowitz, Associated Press, 7/10). Brazil's <a ="http://www.aids.gov.br/indexpingl.htm">National STD/AIDS Programme, which is considered to be one of the most progressive in the world, manufactures and distributes generic versions of antiretrovirals to HIV-positive people. Although the health ministry has recorded 310,310 AIDS cases, experts estimate that there are 600,000 HIV-positive people in the country (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=23957">Kaiser Daily HIV/AIDS Report, 5/28). The country also managed to negotiate discounts with pharmaceutical companies "simply by threatening to break the rules if treatments became too costly" when it entered the World Trade Organization -- which mandates compliance with trademark rules, according to the <a ="http://www.billingsgazette.com/index.php?id=1&display=rednews/2004/07/06/build/health/35-aids-drug.inc">AP/Milwaukee Journal Sentinel. Brazil's drug program has cut the number of AIDS-related deaths in half in four years and has kept approximately 100,000 HIV/AIDS patients alive, the AP/Journal Sentinel reports. The country spends $175 million a year -- or 1.5% of its health budget -- on antiretrovirals alone (A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tor, AP/Milwaukee Journal Sentinel, 7/12). Jarbas Barbosa, secretary of sanitary vigilance for the Ministry of Health, said, "If India or China have a product that isn't protected by patents, we will use the agreement to transfer technology and vice versa." Brazilian officials also plan to meet with British health officials at the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ference to discuss the HIV/AIDS epidemic in Bolivia, according to the Ministry of Health statement, the Ass}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ciated Press reports (Associated Press, 7/10).\par Lack of Doctors, Health Workers in Developing Countries Hinders Fight Against AIDS, TREAT Asia Report Says\par [Jul 13, 2004]\par Shortages of doctors, nurses and health care workers in developing countries are hindering efforts to distri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ute antiretroviral drugs to people living with HIV/AIDS in the most-affected areas, according to a <a ="http://www.amfar.org/cgi-bin/iowa/asia/about/index.html?record=15">report</a> released by the American Foundation for AIDS Research and the <a ="http://www.amfar.org/cgi-bin/iowa/asia/index.html">Therapeutics Research, Education and AIDS Training in Asia at this week's <a ="http://www.aids2004.org/">XV International AIDS Conference</a>, in Bangkok, Thailand, the Asian Wall Street Journal reports (Chase/Efrati, Asian Wall Street Journal, 7/13). The report includes a table that co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 pares the number of trained doctors to HIV-positive people in 13 Asian countries. Researchers found that Japan had the best ratio with one doctor for every 24 HIV-positive people, followed by Taiwan, Hong Kong, Singapore and the Philippines. Vietnam had the worst ratio with one doctor for every 11,250 HIV-positive people, followed by Thailand with one doctor for every 6,700 HIV-positive people, Indonesia with one doctor for every 4,630 HIV-positive people and China with one doctor for every 4,200 HIV-positive people, the r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 port says. There are fewer than 200 doctors in China who are trained to administer antiretroviral treatment, the report says (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24617">Kaiser Daily HIV/AIDS Report, 7/8).\par Deep Roots\par This shortage of health care workers in developing countries has "deep roots," including illiteracy, lack of e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ucation, poverty and famine, according to the Wall Street Journal (Chase/Efrati, Wall Street Journal, 7/13). "The race is to scale up the infrastructure," Kevin Frost, TREAT Asia director, said, adding, "Hand in hand with the availability of treatment is the need to provide it safely." Dr. Patrick Li, principal investigator for TREAT Asia in Hong Kong, said that it is important for HIV-positive people to receive counseling and instru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tions on when and how to take antiretroviral treatments because "[i]f the complicated regimen is not adhered to, the patients may become resistant to the drugs and it will be even harder to treat them later." (Mitchell, <a ="http://www.reuters.co.uk/newsArticle.jhtml?type=healthNews&storyID=5647425A\u223\'a7ion=news">Reuters</a>, 7/12). Without counseling and instruction, "desperate" patients are self-treating, taking incorrect doses, sharing medications with HIV-positive family members or "just dropping out of treatment," the Journal reports (Wall Street Journal, 7/13). Physicians, nurses and "a range" of other health care professionals and comm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nity volunteers should be recruited and trained in affected countries, Helene Gayle, director of <a ="http://www.gatesfoundation.org/GlobalHealth/HIVAIDSTB/">HIV/AIDS and TB and <a ="http://www.gatesfoundation.org/GlobalHealth/ReproductiveChildHealth/">Reproductive and Child Health at the Bill & Melinda Gates Foundation, said, the Asian Wall Street Journal reports. UNAIDS Executive Director Peter Piot said that some young U.S. and European doctors are also "filling some gaps," according to the Asian Wall Street Journal (Asian Wall Street Journal, 7/13).\par Politics and Policy\par Kerry Calls for Doubling of U.S. Funding for Global HIV/AIDS Efforts, Ending Ban on Immigrants With HIV\par [Jul 13, 2004]\par Presumptive Democratic presidential nominee Sen. <a ="http://www.johnkerry.com/front/splash.html">John Kerry</a> (Mass.) on Saturday said that if elected he would double U.S. funding for global HIV/AIDS pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 grams and would seek to lift a U.S. ban on HIV-positive immigrants, Agence France-Presse reports. In a statement released to coincide with the opening of the XV International AIDS Conference, which is being held in Bangkok, Thailand, Kerry said, "I will turn up the diplomatic pressure to seek similar increases from our partners. I will provide rapid distribution of quality medicines, including generic affordable, safe and effe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tive drugs" (Agence France-Presse, 7/10). "We cannot fight AIDS without adequate weapons to prevent new infections and without providing treatment for the millions already living with HIV and AIDS. "The Bush a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ministration has hampered U.S. efforts with policies created to appease its political constituencies, putting ideology before science," Kerry said in the statement(Kerry campaign <a ="http://www.johnkerry.com/pressroom/releases/pr_2004_0710.html">release</a>, 7/10). President Bush last year annouced his five-year, $15 billion <a ="http://www.state.gov/s/gac/rl/or/c11652.htm">President's Emergency Plan for AIDS Relief, which some AIDS advocates have criticized for its slow response and e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 phasis on abstinence-only education (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24409">Kaiser Daily HIV/AIDS Report, 6/25). Kerry said he also would "work with Congress to lift the immigration ban on HIV-positive pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ple that has prohibited the United States from hosting" the International AIDS conference. The United States tests all new immigrants for HIV, and if an immigrant tests positive for the disease, he or she generally is d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nied admission, according to Agence France-Presse (Agence France-Presse, 7/10). "As president, I will work side by side with our international partners, faith-based, nongovernmental, affected communities and private sector groups in order to strengthen the capacity for sustained response by those on the front lines," Kerry said, adding, "A 'go it alone' approach to the war on AIDS is not how we will succeed; only in partnership can we have a chance of defeating this deadly disease" (Kerry campaign release, 7/10).\par Science & Medicine\par USA Today Examines Efforts To Develop AIDS Vaccine\par [Jul 13, 2004]\par USA Today on Tuesday examined efforts to develop an HIV/AIDS vaccine, which researchers at the XV I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ternational AIDS Conference in Bangkok, Thailand, on Monday said is "all but starting over" after two de}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ades of work (Sternberg, USA Today, 7/13). According to a report by the International AIDS Vaccine Initiative released Monday, the effort needs almost a doubling of funds, and researchers might have to start over if the current approach fails. More than 30 vaccines are in clinical trials, compared with a handful two years ago, according to the IAVI report. However, of the 30 vaccine candidates being researched in 19 countries, only one has reached the final testing phase, according to the IAVI report. IAVI has called for $1.3 billion in fun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing for vaccine development. IAVI President and CEO Seth Berkley said that annual spending on vaccine research is about $650 million -- less than 1% of the total spending on all HIV/AIDS product development (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24674">Kaiser Daily HIV/AIDS Report, 7/12). According to USA Today, AIDSVAX, the only AIDS vaccine to complete two large-scale clin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cal trails, "proved a flop." In addition, most of the 30 vaccine candidates are "relatively untested" and "so si}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ilar that if one fails, they all might fail," USA Today reports. Further, conducting human clinical trials of va}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cine candidates could prove "challenging" because the countries with the largest numbers of HIV-positive people lack the resources to study thousands of patients, according to USA Today reports (USA Today, 7/13).\par New York Times Examines 'Growing Interference From Conservatives' in Sexual Health Research\par [Jul 13, 2004]\par The New York Times on Sunday examined what some sexual health experts believe is a "growing interfe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ence from conservatives in and out of government with their work in research, education and disease pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 vention." According to the Times, such interference has consisted of reduced financing for sexual health pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 grams and an "overall chilling effect" on research in the field. "Programs almost have to hide what they do," Richard Parker, a professor at the Mailman School of Public Health at <a ="http://www.mailman.hs.columbia.edu/index.html">Columbia University</a> and co-chair of the International Working Group on Sexuality and Social Policy, said. IWGSSP in June released a report that cited what it called "sex policing" by the Bush administration as well as inquiries by members of Congress regarding NIH research grants, the Times reports (Navarro, New York Times, 7/11). Earlier this year, conservative House members questioned at least 10 NIH research grants, including grants for studies on emergency contrace}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion, Asian sex workers in San Francisco and women's response to pornography. NIH staff were required to review the grants to determine whether the projects "were relevant to the public health needs of our country," used methodology that was "scientifically and ethically appropriate," had been "properly reviewed and funded by NIH" and received funding that was proportional "relative to the burden of sexually related diseases as compared to other diseases" (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=21951">Kaiser Daily HIV/AIDS Report, 1/30). Andrea Lafferty, executive director of the Traditional Values Coalition, said that her group is challenging research grants that "don't pass the ... test," adding, "There's an arrogance in the scientific co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 munity that they know better than the average American" (New York Times, 7/11).\par Public Health & Education\par HIV Prevention Programs Emphasizing 'Ethnic Pride, Communication Skills' Increase Condom Usage, Study Says\par [Jul 13, 2004]\par Sexually active African-American teenage girls, who are at high risk for contracting HIV, were less likely to engage in sex without a condom after taking part in an HIV prevention program that "emphasiz[ed] ethnic pride and communication skills," according to a study published in the July 14 issue of the <a ="http://jama.ama-assn.org/cgi/content/abstract/292/2/171">Journal of the American Medical Association, which focuses on HIV/AIDS, and presented Sunday at the XV International AIDS Conference in Bangkok, Thailand, <a ="http://www.newsday.com/news/health/ny-hsteen113888258jul11,0,1711920.story">Long I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 land Newsday reports (Rabin, Long Island Newsday, 7/11). Ralph DiClemente of Emory University's <a ="http://www.sph.emory.edu/">Rollins School of Public Health</a> and colleagues from December 1996 to April 1999 studied 522 sexually active black girls between the ages of 14 and 18. About half of the partic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 pants were separated into an intervention group, which offered information on ethnic and gender pride, communication skills, HIV/AIDS, condom use and healthy relationships. The other half of the participants were offered information on exercise and nutrition. Researchers evaluated the intervention program on the basis of different behavior change factors, including condom use and number of sexual partners, according to the <a ="http://www.washingtontimes.com/national/20040710-113547-2629r.htm">Washington Times. Researchers did not evaluate the program based on an increase in sexual abstinence because "they thought the goal was unrealistic," the Times reports (Howard Price, Washington Times, 7/11). After 12 months, 73% of the 251 girls in the intervention program reported using condoms regularly in the previous 30 days, co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 pared with 56% of the participants in the control group. The girls in the intervention group also were more likely to turn down unsafe sexual advances; slightly less likely to start sexual relationships with new partners; slightly less likely to report pregnancies; and had more favorable attitudes toward condoms, according to the study, Newsday reports (Long Island Newsday, 7/11). Researchers concluded that it is "compellingly urgent" to develop new HIV prevention programs that target high-risk groups (Washington Times, 7/11).\par Kaiser Daily HIV/AIDS Report Summarizes Features on HIV/AIDS Among Blacks in United States\par [Jul 13, 2004]\par Several newspapers this week published features on HIV/AIDS among blacks in the United States to coi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cide with the opening of the <a ="http://www.aids2004.org/">XV International AIDS Conference</a> taking place this week in Bangkok, Thailand. Summaries of the features appear below:\par "AIDS: Darkening in America," <a ="http://www.usnews.com/usnews/issue/040712/health/12wilson.htm">U.S. News & World Report: U.S. News & World Report on Monday profiled <a ="http://www.blackaids.org/">Black AIDS Institute</a> Founder Phill Wilson. Although the development of effective antiretroviral therapy in 1996 caused a shift in the pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ception of HIV/AIDS from an epidemic of young, white, gay men, to an epidemic centered on Africa, the Ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ibbean and Eastern Europe, the "constant epidemic in people of color" -- which is "having a devastating e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 fect in black communities" in the United States -- has been "ignored," Wilson said. Over the last five years, Wilson has worked to obtain support from civil rights leaders, the black media, seven black fraternities and sororities and historically black colleges and universities to make HIV/AIDS education a priority. According to Wilson, individuals and local organizations must "bridge the gap" between the "overwhelmingly white" med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cal community and the "increasingly black" HIV community, adding, "We are faced with the worst health di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 aster that our community has seen in the last century. What I do is ordinary. It's only extraordinary because we're not all doing it" (Brink, U.S. News & World Report, 7/12).\par "Black Church Has Vital Role in Fighting AIDS," <a ="http://www.chicagotribune.com/news/printedition/chi-0407120205jul12,1,2064933.column">Chicago Tribune: HIV/AIDS is a "reality about which everybody needs to be concerned," and African-American churches are starting HIV/AIDS prevention programs "not a moment too soon," the Tribune reports. Although black churches historically have avoided addressing HIV/AIDS or issues of sexuality, HIV/AIDS education and outreach is "particularly important" in light of recent studies showing an increase in HIV incidence among black male college students. Trinity United Church of Christ's HIV/AIDS ministry, which started in 1992, includes workshops on prevention, treatment options and living with HIV/AIDS, as well as a youth sexuality project that includes HIV/AIDS education (Turner Trice, Chicago Tribune, 7/12).\par "Danger on the Down Low," Houston Chronicle: African-American women who remain faithful to their sexual partners and have no history of injection drug use but who contract HIV from their husbands or boyfriends are "part of a troubling trend" in new HIV infections, the Chronicle reports. Some observers say that the i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 crease in the number of HIV cases linked to heterosexual sex among black women stems from men "on the down low" -- black men who have sex with men but do not mention their male relationships to their female sex partners, friends or family members -- but researchers do not know whether the phenomenon is to blame. CDC spokesperson Karlie Stanton said that although researchers know the phenomenon is a factor, "we don't know how big a factor it is" (Kever, Houston Chronicle, 7/10).\par "HIV Alarm for Mid-Age Blacks," New York Post: An increasing number of black men between the ages of 40 and 54 are testing HIV-positive, according to a study by New York City health officials presented Monday at the conference. City officials, who began collecting and reporting data on HIV in 2000, found that out of the more than 75,000 HIV-positive people in the city, one in 15 is a black middle-aged man and one in 10 is fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 eign-born, primarily in the Caribbean, Africa or South America. Of the city's 11,039 black, middle-aged, HIV-positive men, 1,523 men had developed AIDS at the time of diagnosis, which city scientists said indicates that many were "long infected but not tested until symptomatic" (Edozien, New York Post, 7/12).\par "Inequities in Health, Race? Among African Americans, Disease Rates Are Higher and Care Is Inferior," <a ="http://www.philly.com/mld/inquirer/9121368.htm?1c">Philadelphia Inquirer: The "tragic phenomenon" that blacks suffer higher rates of diseases -- including HIV/AIDS -- and the issue of minority health disparities in rates of illness and quality of care "finally seems to have hit the mainstream," the Inquirer reports. According to the Inquirer, "pressure is mounting" on researchers, health care providers, lawmakers, insurance comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nies and other businesses to address "what is arguably one of the nation's worst public health crises." The "uncomfortable but unavoidable" conclusion that health care workers "like everyone else, bring their biases to work" have led some researchers to believe that a potential long-term solution to minority health disparities is to increase the number of minorities in medicine, academia and other areas that influence research, fun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing and policy, the Inquirer reports (Smith, Philadelphia Inquirer, 7/10).\par The Black AIDS Institute has <a ="http://www.blackaids.org/bangkok/">additional conference coverage</a> relating to blacks and AIDS.\par Media & Society\par Kaiser Daily HIV/AIDS Report Summarizes Media Coverage of International HIV/AIDS Issues\par [Jul 13, 2004]\par Several U.S. and international broadcast programs have included features on HIV/AIDS in response to the XV International AIDS Conference in Bangkok, Thailand, from July 11-16. Summaries of the coverage a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 pear below.\par Australian Broadcasting Corporation's "<a ="http://www.abc.net.au/ra/asiapac/default.htm">Asia Pacific</a>": The segment reports on the world's AIDS orphans and includes comments from Carol Bellamy, executive director of UNICEF (Thompson, "Asia Pacific," ABC, 7/13). The complete segment is available <a ="http://www.abc.net.au/ra/asiapac/programs/m914590.asx">online</a> in Window Media.\par BBC's "<a ="http://news.bbc.co.uk/2/hi/talking_point/talking_point_programme/default.stm">Talking Point": The segment includes comments from Dr. Jim Kim, director of WHO's HIV/AIDS program and Jack Summe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 side, head of health promotion at the Terrence Higgins Trust. Complete video of the program in RealPlayer is available <a ="http://www.bbc.co.uk/newsa/n5ctrl/progs/talkingpoint/04/11jul.ram">online</a>. A complete audio version of the program is available <a ="http://www.bbc.co.uk/newsa/n5ctrl/progs/talkingpoint/04/11jul_audio.ram">online</a> in RealPlayer. In addition, an interactive discussion board about abstinence is available <a ="http://news.bbc.co.uk/2/hi/talking_point/3870335.stm">online</a>.\par NPR's "Day to Day": The segment will examine how gender inequality in South Africa is contributing to the spread of HIV/AIDS ("Day to Day," NPR, 7/13). The complete segment will be available online in RealPlayer and Windows Media after the broadcast. Expanded NPR coverage is available <a ="http://www.npr.org/healthscience/aids2004/">online</a>.\par NPR's "Morning Edition" on Tuesday profiled the Indian drug company <a ="http://www.}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 cipla.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 com/">}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 </a> and the debate over drug makers that produce generic versions of brand-name antiretroviral drugs to treat people with HIV/AIDS in developing countries (Wilson, "Morning Ed}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion," NPR, 7/13). The complete segment is available <a ="http://www.npr.org/dmg/dmg.php?prgCode=ME&showDate=13-Jul-2004&segNum=13&mediaPref=RM">online</a> in RealPlayer. Expanded NPR coverage is available <a ="http://www.npr.org/healthscience/aids2004/">online</a>.\par PBS' "NewsHour with Jim Lehrer": The segment profiles Botswana's HIV testing and antiretroviral drug pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 grams. The segment includes comments from Dr. Ernes Darkoh, director of Botswana's antiretroviral pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gram; Richard Holbrooke, former U.N. ambassador and president of the <a ="http://www.businessfightsaids.org/">Global Business Coalition on HIV/AIDS; Dr. Banu Kahn, head of the Botswanan HIV/AIDS program; Botswanan President Festus Mogae; and Thai Sen. Mechai Viravaidya (de Sam Lazaro, "NewsHour with Jim Lehrer," PBS, 7/12). The complete transcript is available <a ="http://www.pbs.org/newshour/bb/health/july-dec04/botswana_7-12.html">online</a>. The complete se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment is available <a ="http://audio.pbs.org:8080/ramgen/newshour/expansion/2004/07/12/fl28.rm?altplay=fl28.rm">online</a> in RealPlayer. Expanded PBS coverage of the conference is available <a ="http://www.pbs.org/newshour/health/aids/aids2004/">online</a>.\par WAMU's "The Diane Rehm Show": The NPR-syndicated show in the first hour of the broadcast will include a panel discussion of research findings and policy debates from the conference. Guests on the program will include Dr. Kathleen Cravero, deputy executive director of <a ="http://www.unaids.org/en/default.asp">UNAIDS</a>; Dr. Anthony Fauci, director of the NIH <a ="http://www.niaid.nih.gov/">National Institute of Allergy and Infectious Diseases; David Gartner, policy dire}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tor for the <a ="http://www.globalaidsalliance.org/">Global AIDS Alliance</a>; and Dr. Joseph O'Neill, deputy coordinator and chief medical officer in the <a ="http://www.state.gov/">State Department</a>'s <a ="http://www.state.gov/s/gac/">Office of the Global AIDS Coordinator</a> (Page, "The Diane Rehm Show," WAMU, 7/13). The complete segment will be available online in RealPlayer after the broadcast.\par Opinion\par Kaiser Daily HIV/AIDS Report Summarizes Editorials, Opinion Pieces on Global HIV/AIDS Epidemic\par [Jul 13, 2004]\par Several newspapers have published editorials and opinion pieces focusing on HIV/AIDS-related issues to mark the XV International AIDS Conference, which began on Sunday in Bangkok, Thailand, and runs through July 16. Summaries of some of the editorials and opinion pieces appear below:\par <a ="http://www.azcentral.com/arizonarepublic/opinions/articles/0712mon1-12.html">Arizona Republic: While the "threat" of the global AIDS epidemic "has never been higher," the world's "ability to control it has never been greater," a Republic editorial says. Education, prevention, outreach and treatment strategies, along with increased funding commitments to global initiatives, are the most effective ways of controlling the spread of HIV/AIDS, the editorial concludes (Arizona Republic, 7/12).\par <a ="http://www.chicagotribune.com/news/opinion/chi-0407120187jul12,1,1440465.story?coll=chi-newsopinion-hed">Chicago Tribune: Because the HIV/AIDS epidemic "keeps outpacing efforts to contain it," more needs to be done to distribute antiretroviral drugs -- including reconsidering FDA's policy to retest g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 neric drugs that have already been vetted by the <a ="http://www.who.int/en">World Health Organiz}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion</a>, a Tribune editorial says. The double-processing is "unwarranted and only delays delivery of esse}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tial medicines," the Tribune concludes (Chicago Tribune, 7/12).\par <a ="http://www.latimes.com/news/opinion/editorials/la-ed-aids12jul12,1,1201813.story?coll=la-news-comment-editorials">Los Angeles Times: Without better training on how to teach health care workers HIV prevention methods, children are "more likely to repeat the mistakes of their parents and continue to spread the disease," a Times editorial says, concluding, "[T]he war on AIDS can be won only with a fight on many fronts, not just by giving poor countries more cash to buy drugs" (Los Angeles Times, 7/12).\par <a ="http://www.miami.com/mld/miamiherald/news/opinion/9133199.htm?ERIGHTS=-5144001735320941980miami::kennedyb@advisory.com&KRD_RM=8ooxsrrtwrqouwtqwwqooooooobN">Miami Herald: The "fundamental barrier" to stemming the HIV/AIDS epidemic is not ability but will, a Herald ed}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 torial says. While counseling, outreach and public-awareness campaigns provide knowledge and expertise, financial commitments on the part of wealthy nations -- including the United States -- ultimately make preve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion and treatment measures effective, the editorial says, concluding, "The United States should -- and easily can do its share" (Miami Herald, 7/12).\par <a ="http://www.startribune.com/stories/561/4872618.html">Minneapolis Star Tribune: Because the global HIV/AIDS epidemic has worsened since the 2002 International AIDS Conference in Barcelona, Spain, HIV/AIDS advocates must continue to "hammer away at the trilogy of what works": education and awareness programs, prevention and treatment while wealthy nations must financially "fully support" global initiatives, a Star Tribune editorial says (Minneapolis Star Tribune, 7/13).\par <a ="http://www.nj.com/opinion/ledger/editorials/index.ssf?/base/news-2/1089445905139970.xml">Newark Star-Ledger: Both the successes and failures of the continuing fight against the HIV/AIDS epidemic provide "a lesson to learn" -- HIV/AIDS can be contained with resources and leadership that require an adequate and sustained financial commitment from the United States and other wealthy nations, a Star-Ledger editorial says (Newark Star-Ledger, 7/10).\par Salt Lake City Deseret Morning News: AIDS is "more than a global health crisis" because it creates the p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tential for the development and proliferation of terrorism worldwide, a Morning News editorial says. Global HIV/AIDS initiatives therefore would save lives and "stem the spread of terrorist activities," the editorial co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cludes (Deseret Morning News, 7/11).\par Opinion Pieces\par Enriqueta Bond, <a ="http://www.washingtonpost.com/wp-dyn/articles/A43460-2004Jul11.html">Washington Post: The global HIV/AIDS epidemic has recently overshadowed the "accelerating" malaria epidemic that has affected more people in the past two decades than HIV/AIDS, Bond, president of the <a ="http://www.bwfund.org/">Burroughs Wellcome Fund</a>, writes in a Post opinion piece (Washington Post, 7/12).\par Jane Eisner, <a ="http://www.philly.com/mld/inquirer/news/editorial/">Philadelphia Inquirer: It is a "shame" that the United States has to choose between funding prevention initiatives and treating people living with HIV/AIDS, Inquirer columnist Eisner writes in an opinion piece. Because both approaches are necessary, the United States should be "compassionate enough to do more than one," Eisner concludes (Philadelphia I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 quirer, 7/11).\par Desmond Tutu, <a ="http://www.guardian.co.uk/business/story/0,3604,1259032,00.html">Guardian</a>: Even the "greatest speeches do not save lives ... [a]id does," Tutu, former archbishop of Cape Town, South Africa, says in a London Guardian opinion piece. To combat global HIV/AIDS and poverty, wealthy nations should "tak[e] action" on international trade regulations and debt owed by developing countries and "[d]ramatically" increase aid to "heal not only the physical suffering of the poor south, but also the moral su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 fering of the rich north," Tutu concludes (Guardian, 7/12).\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS & HIV (94%); ANTIVIRALS (92%); PHARMACEUTICAL PREPARATION MFG (90%); AIDS & HIV TREATMENT (90%); PHARMACEUTICALS INDUSTRY (90%); RESEARCH & DEVELOPMENT (89%); PATENTS (87%); GENERIC DRUGS (78%); PRESCRIPTION DRUGS (78%); DEVELOPING COUNTRIES (78%); HEALTH CARE ACCESS (77%); FOUNDATIONS (76%); HEALTH DEPARTMENTS (73%); PUBLIC HEALTH ADMINISTRATION (72%); RESEARCH (70%); GENERIC PRODUCTS (67%); MONOPOLIZATION (61%); UNITED NATIONS INSTITUTIONS (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PFZ (LSE) (58%); PFEB (BRU) (58%); PFE (NYSE) (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (58%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (58%); SIC2834 PHARMACEUTICAL PREPARATIONS (58%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 KAISER DAILY HIV (96%); JON COHEN (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD HEALTH ORGANIZATION  (57%); WORLD HEALTH ORGANIZATION (57%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 THAILAND (92%); PHILIPPINES (78%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 BANGKOK, THAILAND (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD HEALTH ORGANIZATION (63%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 July 13, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2004 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS;Daily HIV/Aids Report Africa News July 7, 2004 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_49}{\*\bkmkstart DOC_ID_49_0}{\*\bkmkstart doc_id_20}{\*\bkmkend DOC_ID_49}{\*\bkmkend DOC_ID_49_0}{\*\bkmkend doc_id_20}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_20"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 20 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  7, 2004 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 AIDS;\par Daily HIV/Aids Report}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Kaisernetwork.org\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 4531 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Global Challenges\par Number of New HIV Cases Increases Worldwide, Many Concentrated in Asia, UNAIDS Report Says\par [Jul 07, 2004]\par The 2004 UNAIDS Report of the Global AIDS Epidemic released by UNAIDS on Tuesday in advance of the XV International AIDS Conference illustrates "daunting trends" and an increasing "need for assistance" in the world's fight against the pandemic, the Boston Globe reports (Donnelly, Boston Globe, 7/7). According to the report, which for the first time includes revised HIV prevalence for previous years based on improved met}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 odology and more comprehensive country surveillance data, five million new HIV cases were reported worldwide last year -- the most cases reported in any single year since the beginning of the epidemic. The report shows that the number of people living with HIV increased from 35 million in 2001 to 38 million in 2003. The report also shows that nearly three million people died from AIDS-related causes in 2003. In add}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion, almost 50% of new HIV cases worldwide were among people ages 15 to 24, and women comprised almost 50% of people living with HIV, the report says (Kaiser Daily HIV/AIDS Report, 7/6). \par Asian Crisis\par Although sub-Saharan Africa remains the most affected region in the world with about 25 million HIV-positive people, the report shows that Asia could "face an AIDS catastrophe" if the region does not make bigger strides in combating the disease, the Financial Times reports (Dyer/Marcelo, Financial Times, 7/6). Asia, which accounts for 60% of the world's population, has 7.4 million HIV-positive people and has experienced some of the "sharpest" increases in numbers of HIV cases, the report says. In Asia, the epidemic is still "largely concentrated" among injection drug users, men who have sex with men, commercial sex workers and clients of sex workers and their sexual partners, according to the report (Kaiser Daily HIV/AIDS Report, 7/6). However, the Asian epidemic is "fast moving into the general population," Kathleen Cravero, deputy executive director of UNAIDS, said. The report shows that of the five million new HIV cases reported in 2003, nearly 1.2 million occurred in Asia, the New York Times reports. In addition, China, Indonesia and Vietnam account for 50% of the Asian population and are seeing "rapidly ... expanding" epidemics, the report says. HIV epidemics are "much harder to stop" after HIV prevalence begins to exceed 1% -- the prevalence level that most epidemiologists use to define a generalized HIV epidemic -- than before prevalence reaches 1%, according to Cravero, the Times reports. Because "many countries [in Asia] have prevalence rates less than 1%, and some are hovering around 1%," there is a "small window of opportunity" to curb the spread of HIV in Asia, Cravero said. "If we miss it, it will slam shut forever," and "we will see an epidemic the likes of which we never imagined," Cravero said, adding, "You either drive [the Asian HIV/AIDS epidemic] down now through maximum scaling up of prevention or you spend exponentially more money and energy trying to drive it down" (Altman, New York Times, 7/7).\par India\par India has 5.1 million people living with HIV, up from about four million in 2002, according to the Globe (Bo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ton Globe, 7/7). The epidemic in India, which now ranks second behind South Africa for the most HIV/AIDS cases in the world, stems from "widespread ignorance" about HIV, according to the Chicago Tribune. In add}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion, the "down low" phenomenon -- in which men have sex with men but do not mention their male relatio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ships to their female sex partners, friends or family members -- is an "emerging concern," the Tribune r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ports. NIH National Institute of Allergy and Infectious Diseases Director Anthony Fauci said that although only a small percentage of the India's population of one billion is HIV-positive, "you're talking tens of millions of additional infections" if the number of cases doubles or triples, the Tribune reports. He added that he is concerned that "several Asian countries [have] a gross underestimate, not only of what is actually going on but what the potential is" for the HIV/AIDS epidemic, adding, "You have the potential for an explosion that, given the numbers of people who live in Asia, could potentially dwarf what we're seeing in Africa" (Graham, Chicago Tribune, 7/7). However, the Indian government has said that the rate of increase in the number of HIV cases in 2003 "had slowed" compared with statistics for 2002, according to the Financial Times. India's National AIDS Control Organization Director Meenakshi Datta Ghosh said, "There is no galloping AIDS ep}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 demic in India" (Financial Times, 7/6).\par Prevention, Treatment Among Women\par To help curb the spread of HIV in Asia and elsewhere, countries must "vastly increase" prevention and treatment efforts, Cravero said, according to the Times. However, prevention and treatment programs in Asia "largely miss" women and girls, who often do not have the option of abstaining from sex and have "little co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 trol" over whether their partners use condoms or remain faithful, according to Cravero, the Times reports (New York Times, 7/7). However, the epidemic's "feminization" is most apparent in sub-Saharan Africa, where 57% of HIV-positive adults are women and 75% of young people living with HIV are female, the report says, according to AFP/Yahoo! News. In the region's "male-dominated culture," women are the caregivers and therefore "bear the largest AIDS burden," the report says, according to AFP/Yahoo! News (AFP/Yahoo! News, 7/6). UNAIDS Executive Director Peter Piot said that the "ABC" model of prevention -- Abstinence, Be faithful, use Condoms -- is "pretty irrelevant" for women in Africa. Many women in the region face "violent, nonconsensual sex," according to the Mail & Guardian (Mail & Guardian, 7/7). He added that teenage girls in the region often have their first sexual experience with a man who is five to 15 years older, which "introduces extremely high-risk situations to girls, who are already more vulnerable" (Maugh, Los Angeles Times, 7/7). Cravero said, "Most of the women and girls, as much in Asia as in Africa, don't have the option to abstain [from sex] when they want to," adding, "Women who are the victims of violence are in no position to negot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ate anything, nevermind faithfulness and condom use" (Nakashima, Washington Post, 7/7). Piot said that "[t]o ensure women become less infected, we have to target men," adding, "We are getting into a need for quite fundamental and long-ranging behavior change. We have to change norms in society" (Mail & Guard}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 an, 7/7).\par NBC's "Nightly News" on Tuesday reported on the study. The segment includes comments from Dr. Wafaa El-Sadr, a professor of epidemiology at Columbia University's Mailman School of Public Health and Piot (B}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 zell, "Nightly News," NBC, 7/6). The complete segment is available online in Windows Media.\par Thailand to Launch Revitalized HIV/AIDS Awareness Campaign Aimed at Nation's Youth\par [Jul 07, 2004]\par Thailand at the close of the XV International AIDS Conference next week will launch a revitalized HIV/AIDS awareness campaign to promote condom use among the nation's youth, Thai Public Health Minister Sudarat Keyuraphan said Tuesday, the Bangkok Post reports. The campaign will target young people between the ages of 14 and 25, an age group whose "ignorance" about condom use has become a "prime concern" for Thai health officials, Sudarat said, according to the Bangkok Post. Approximately one-third of sexually active young people are not using condoms, primarily because of confidence in their partners, according to Health Ministry surveys. Health officials fear that such high-risk behavior could make young people increasingly at risk for HIV. "They worry about getting pregnant more than AIDS," Sudarat said (Bangkok Post, 7/7). Tee}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 agers and young adults worldwide are at the greatest risk of HIV infection, especially female teenagers, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cording to a UNAIDS report released Tuesday, Xinhua News Agency reports (Xinhua News Agency, 7/7). As part of the new campaign, the government will install more condom vending machines throughout the cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 try, especially near secondary schools, Charal Trinvuthipong, director general of the Disease Control D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 partment, said. Seven thousand machines already have been installed nationwide, including 5,000 in Ban}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 kok, which offer condoms for about 12 cents each -- one-tenth the price of condoms sold at drug and co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 venience stores. Local singers also will be asked to take part in the campaign to promote condom use and inform teenagers about the risks of HIV/AIDS (Bangkok Post, 7/7).\par Increased Risk\par Teenagers are increasingly at risk because they are too young to have learned from the public education campaigns the government launched a decade ago, Hakan Bjorkman, U.N. deputy resident for HIV/AIDS programs in Thailand, said (VOA News, 7/6). Thailand was one of the first "hard hit" countries to recognize and address HIV/AIDS in the early 1990s. The country initiated programs to encourage condom use, esp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cially among commercial sex workers, and implemented antiretroviral drug programs to prevent mother-to-child HIV transmission (Kaiser Daily HIV/AIDS Report, 7/6). HIV/AIDS cases in the country decreased from 140,000 in 1991 to 21,000 in 2003, according to UNAIDS (Bangkok Post, 7/7). "Young people, the really young people, they come on the scene, so to speak, become sexually active -- they weren't around in the early '90s when this big campaign was going on," Bjorkman said, adding, "So they come out, they don't use condoms, they experiment with drugs ... they're very vulnerable" (VOA News, 7/6). Thai Sen. Mechai V}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ravaidya, who is known as the "condom king" for spearheading the national condom promotion initiative 10 years ago, said that Thailand has become complacent about HIV education in recent years, Reuters reports. "In the last two or three years, we have fallen into a state of hibernation in terms of public education," Mechai said, adding, "A new generation hasn't heard much about HIV. They think it's gone" (Schuettler, Reuters, 7/6).\par A kaisernetwork.org video feature -- prepared by Fred de Sam Lazaro, who also is a correspondent for the "NewsHour with Jim Lehrer" -- includes interviews with people who are on front lines of efforts to fight HIV/AIDS in Thailand. The video is the fourth in a series of spotlights from kaisernetwork.org on local efforts around the world to combat the HIV/AIDS epidemic. The other features -- which examine HIV/AIDS in Haiti, Brazil and India -- also are available online.\par South Asia Lacks Leadership, Strategy for Fighting HIV/AIDS, World Bank Officials Say\par [Jul 07, 2004]\par South Asia lacks the leadership and strategy necessary for confronting the region's HIV/AIDS epidemic, World Bank officials last week said at a news conference ahead of the XV International AIDS Conference, the Taipei Times reports (Taipei Times, 7/5). Asia accounts for 60% of the world's population and has exp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 rienced some of the sharpest increases in numbers of HIV cases, according to the 2004 UNAIDS Report of the Global AIDS Epidemic. Asia has 7.4 million HIV-positive people, the report said (Kaiser Daily HIV/AIDS Report, 7/6). Although the World Bank has set aside $380 million annually to address AIDS in the region, much of the money has not been spent because of a lack of programs, World Bank Vice President for South Asia Praful Patel said. The officials said that political leaders have "wasted time arguing" about the number of people with the disease instead of implementing programs to address it, according to the Times (Taipei Times, 7/5). "We are facing exactly the same situation in South Asia now where this disease has gained a foothold and absolutely there is no serious strategy to address it," Patel said. There are approximately 4.6 million HIV-positive people living in India, almost two-thirds of South Asia's total number of infected individ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 als, and the epidemic has progressed from being concentrated in high-risk groups to a generalized epidemic in six of the country's 28 states (Agence France-Presse, 6/30).\par Women, Other Groups\par The epidemic is also increasingly affecting women, previously considered a low-risk group, according to I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 dia's National AIDS Control Agency's Project Director Meenakshi Datta Ghosh, VOA News reports. "We used to believe that for every eight men getting the infection maybe one woman will get it," Ghosh said, ad}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing, "But now we believe that is not so. For every eight men getting (HIV) maybe three women will be getting it" (VOA News, 7/6). Other countries in the region, such as Pakistan, Bangladesh and Nepal, have low HIV prevalence among the general population but high prevalence among injection drug users and commercial sex workers. However, the size of these subpopulations is "frightening," and could lead to an increase in HIV prevalence in the region, Patel said. For example, although HIV prevalence among the general population of Nepal is 0.5%, the prevalence among injection drug users is as high as 68% (Agence France-Presse, 6/30). The lack of leadership in fighting the disease could be a setback in the economic development of the region, Jean-Louis Sarbib, World Bank vice president for development, said. The epidemic could reduce economic growth by as much as 1% and could lead to a 1% to 3% increase in health expenditures, according to World Bank estimates (Taipei Times, 7/5).\par HIV-Positive Employees Still Face Discrimination in Thai Business Sector, Nation Reports\par [Jul 07, 2004]\par Thailand's business leaders have not fulfilled a promise to reduce discrimination against HIV-positive e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ployees in the country's business sector, Thailand's Nation reports. Thai business leaders attending an inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 national summit in 2001 agreed to take steps to reduce discrimination in the work force. However, recent complaints received by the country's Centre for AIDS Rights show that Thai employers have asked job appl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cants to submit blood for HIV tests, have screened employees during annual medical exams and fired HIV-positive employees. A recent survey conducted by the Thailand Business Coalition on AIDS of 510 bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nesses found that the percentage of companies conducting compulsory pre-employment HIV testing fell from 27% in 2001 to 12% in 2004, TBCA Executive Director Anthony Pramualratana said, according to the Nation. The survey also found that the percentage of companies that said they would not terminate HIV-positive e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ployees has decreased from 64% in 2001 to 41% currently, the Nation reports.\par Reaction\par CAR program officer Sathien Tanprom said that although companies claim they do not discriminate on the basis of HIV status, many companies do so in practice, the Nation reports. CAR and the Thai AIDS Access Foundation say that discrimination against HIV-positive employees amounts to a violation of human rights that "fl[ies] in the face" of the country's commitment to ensuring that at least 50% of companies establish HIV/AIDS-friendly policies by 2003, according to the Nation. Sathien said, "Although many employers verba}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ly promised to stop preventing the hiring of workers with HIV, none dared make it a formal company policy." Only a "handful" of companies in Thailand have adopted all of the HIV-friendly workplace policies, Anthony said, according to the Nation. These policies include anti-discrimination training, prevention programs and workplace support networks. Ignorance among upper management is largely responsible for the lack of HIV-friendly programs, according to Anthony, the Nation reports (Nation, 7/5). However, the Thai government after the XV International AIDS Conference plans to launch a campaign focused on employers and creating better job opportunities for HIV-positive employees, the Bangkok Post reports. The campaign aims to e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 courage factories to employ more HIV/AIDS patients and includes an educational campaign about how HIV is transmitted (Bangkok Post, 7/7).\par Social Welfare\par Advocates also are criticizing the Thai government for denying people living with HIV/AIDS equal access to antiretroviral drugs, the Bangkok Post reports. The government's requirement that HIV/AIDS patients who receive public health services through the country's Social Welfare Fund pay extra for antiretrovirals that cost more than $120 per month is "unacceptable" because they already contribute part of their income to the fund, AAF Director Nimit Tien-udom said, according to the Nation. All workers must contribute 5% of their monthly salaries to the fund, and employers contribute an equal amount per employee. Unlike the National Health Care Program -- which allows HIV/AIDS patients access to generic antiretrovirals for 75 cents per month -- workers covered by the Social Health program pay the difference in cost for any drug treatment re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 imen that exceeds the fund's budget (Bangkok Post, 7/7).\par U.S., Thai HIV/AIDS Advocates To Protest Opening of XV International AIDS Conference\par [Jul 07, 2004]\par More than 1,000 HIV/AIDS advocates and HIV-positive people in Bangkok, Thailand, on Sunday are pla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ning to protest at the opening of the XV International AIDS Conference, to call for improved access to a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tiretroviral treatment for people living with HIV, among other issues, Thailand's Nation reports. Nimit Tien-udom, director of Thailand's AIDS Access Foundation -- which is organizing the protest with U.S.-based Health GAP and the Thai Network of People Living With HIV/AIDS -- said that he wants the conference to "live up to its theme" of "Access for All," according to the Nation (Nantiya, Nation, 7/7). Demonstrators plan to protest "failures of government worldwide" to take sufficient steps to combat the HIV/AIDS pandemic, Agence France-Presse reports. The advocates said that "government inactivity, ... political obstruction and free trade pacts" could worsen the HIV/AIDS pandemic, according to Agence France-Presse. Health GAP Director Asia Russell said that the United States and other countries seem to be "backtracking" on funding pledges while the amount of money needed to effectively combat the disease is increasing, Agence France-Presse reports. She added that President Bush is requesting a reduction in AIDS funding from fiscal year 2004 to FY 2005, according to Agence France-Presse (Agence France-Presse, 7/6). The House Foreign Operations Appropriations Subcommittee in June by voice vote approved a $19.4 billion draft foreign aid spending bill for FY 2005, including $2.2 billion for global AIDS, tuberculosis and malaria programs. Although the approved funding -- most of which will go to AIDS programs -- meets Bush's request for FY 2005, the subcommittee allocated a larger portion of the money to the Global Fund to Fight AIDS, Tuberculosis and Malaria than Bush had requested. Bush's proposed FY 2005 budget, which is $1.9 billion more than the total amount the subcommittee approved, includes $2.8 billion for international HIV/AIDS, TB and malaria pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 grams, including $1.45 billion for the State Department Office of the Global AIDS Coordinator, which will a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 minister the President's Emergency Plan for AIDS Relief, and $200 million for the Global Fund (Kaiser Daily HIV/AIDS Report, 6/24).\par Access for All?\par Russell also said that the advocates were concerned about the high cost of registration for the conference, according to the Nation (Nation, 7/7). The early registration fee for the conference was $800 and standard registration was $900; however, after May 1 the fee rose to $1,000, which comes to $1,250 including Thai tax. Although the conference fees include access to all conference sessions and copies of related doc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ments and reports, meals and accommodations are not included in the price (Kaiser Daily HIV/AIDS Report, 6/29). Russell said, "To tackle HIV/AIDS is partly about an exchange of information between scientists and infected people. But such a high price damages opportunities for an open exchange." Nimit said that the price of registration could provide a person living with HIV in Thailand with antiretroviral treatment for about three years, according to the Nation (Nation, 7/7). Kamol Upakaew of the Thai Network of People Living With HIV/AIDS said that although the conference theme of Access for All is an "admirable goal," it is not likely to happen, according to the Associated Press (Associated Press, 7/6). Russell said that in the two years since the 2002 International AIDS Conference in Barcelona, Spain, six million people have died from AIDS-related causes and another 10 million have tested HIV-positive, adding, "The lessons that the international comm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 nity has been unwilling to learn in countries in Africa we appear to be poised to relive" elsewhere (Agence France-Presse, 7/6).\par Webcasts and other coverage of the XV International AIDS Conference will be available online at kaiserne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 work.org/aids2004. Kaisernetwork.org will serve as the conference's official webcaster.\par San Francisco Chronicle Continues Five-Part Series Examining AIDS in India\par [Jul 07, 2004]\par In advance of the XV International AIDS Conference in Bangkok, Thailand, next week, when "[w]orld atte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion will focus on the threat AIDS poses to Asia," the San Francisco Chronicle on Sunday began a five-part series on AIDS in India. Experts believe that the "key" to HIV/AIDS trends in Asia lie with India, the most populous nation in the world, according to the Chronicle. Other articles in the series focused on women and AIDS; AIDS among the country's commercial sex workers; and prevention campaigns at truck stops (Kaiser Daily HIV/AIDS Report, 7/6). A summary of the fourth article in the series appears below:\par "Drugs for a Few: Disease Strikes Five Million--Only the Lucky Get Medicine, Government's Slack Taken up by Tireless Informal Network:" Although there are more people living with HIV in India than in any other cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 try besides South Africa, HIV/AIDS prevention is "underfunded, treatment is spotty" and access to brand-name drugs is a "luxury saved for the wealthy or the lucky," the Chronicle reports. However, India's "best weapon" against AIDS may be its "vast network" of "mom-and-pop" nongovernmental organizations that a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 dress the disease, according to the Chronicle.\par Chronicle medical writer Sabin Russell traveled to India for five weeks earlier this year as part of a fellowship from the Kaiser Family Foundation (Russell, San Francisco Chronicle, 7/7).\par Drug Access\par World Trade Organization Generic Drug Deal Not Being Implemented, Leaving Developing Countries Wit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 out Antiretrovirals, UNAIDS Says\par [Jul 07, 2004]\par Some countries have not taken steps to implement a World Trade Organization agreement that allows d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 veloping countries to waive patent laws to import generic drugs, including antiretroviral drugs, UNAIDS E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ecutive Director Peter Piot said, Reuters reports (Reuters, 7/6). }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  negotiators in August 2003 reached an agreement to allow developing countries to issue a compulsory license in order to import generic drugs if the country confirms that it cannot domestically manufacture them (Kaiser Daily HIV/AIDS Report, 5/24). Only Mozambique, Malaysia and Canada have adopted legislation to implement the agreement, Piot said on Tuesday (Reuters, 7/6). The Canadian Parliament in May adopted a bill (C-9) that would would amend the country's patent laws to permit the government to order the override of patents to allow certain pharmaceut}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cal manufacturers to produce and export generic drugs -- including antiretrovirals -- for use in developing countries (Kaiser Daily HIV/AIDS Report, 5/13). Although the price of antiretrovirals in developing countries has decreased by more than 90%, only 440,000 of the six million people in the developing world that need treatment have access to the drugs, Reuters reports. Piot also said that it is important to ensure that the quality of generic antiretroviral drugs matches that of brand-name drugs. "We don't only want and need cheap drugs, we need top quality medicines," Piot said, adding, "There is no compromise possible on quality ... that would be immoral" (Reuters, 7/6).\par The San Francisco Chronicle on Wednesday profiled Indian pharmaceutical company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  which produces the generic fixed-dose combination antiretroviral Triomune and other antiretrovirals (Russell, San Francisco Chronicle, 7/7). Triomune combines three different medicines into one pill that is taken twice a day and costs as little as $140 per person per year (Kaiser Daily HIV/AIDS Report, 4/29). The full article is available online.\par Lack of Political Will, Drug Shortages Impede South African AIDS Drug Program, Study Says\par [Jul 07, 2004]\par A lack of political will and a shortage of antiretroviral drugs have impeded the rollout of South Africa's natio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 al antiretroviral drug program, according to a report released on Saturday by the South African treatment a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 vocacy group Treatment Action Campaign and the AIDS Law Project of Johannesburg, South Africa's Witw}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tersrand University, AFP/Independent Online reports. TAC and ALP compiled the report -- the "First Monito}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing Report of the Antiretroviral Rollout," which is the first to measure progress since the plan was announced in November 2003 -- using information from provincial health departments and from the South African D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 partment of Health (AFP/Independent Online, 7/3). Officials expect 50,000 HIV-positive people to be on a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tiretroviral drugs by the end of the year and 1.4 million people to be on the drugs by 2009, at a total cost of $700 million (Kaiser Daily HIV/AIDS Report, 4/27). However, the report says that during the seven months after the plan was announced, less than 10,000 people have started treatment (AFP/Independent Online, 7/3). Sibani Mngadi, a spokesperson for South African Health Minister Manto Tshabalala-Msimang, said that the number of people currently receiving antiretroviral treatment is less than 5,000, AFP/Yahoo! News r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ports. Mngadi also said that there are slightly more than 30 health facilities that provide antiretrovirals throughout South Africa, according to AFP/Yahoo! News (AFP/Yahoo! News, 7/6). Although the district and provincial governments have put a "great deal of effort" into implementing the program, the national gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ment has not "matched" the effort, the report said. In addition, the report said that communication about the plan was "extremely weak," adding that the health department "violate[d] the right to access health care se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 vices by operating secretly and refusing to make important information available" (Health-e News, 7/5). For example, although lists of approved treatment sites are available on the internet and to the media, the list of treatment sites has not been published for "ordinary South Africans who have some access to radio, telev}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sion and/or newspapers," the report said, adding that television advertisements about the program have "disappeared" ("First Monitoring Report of the Antiretroviral Rollout," 7/3).\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS & HIV (96%); EPIDEMICS (90%); AIDS & HIV REPORTING (90%); DISEASE REPOR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ING (89%); EPIDEMIOLOGY (89%); DISEASES & DISORDERS (89%); POPULATION SIZE (79%); TRENDS (78%); POPULATION & DEMOGRAPHICS (76%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS511110 NEWSPAPER PUBLISHERS  (82%); SIC2711 NEWSPAPERS: PUBLISHING, OR PUBLISHING & PRINTING (82%); NAICS511110 NEWSPAPER PUBLISHERS (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 KAISER DAILY HIV (97%); KATHLEEN CRAVERO (76%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (94%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ASIA (96%); CHINA (79%); AFRICA (79%); INDONESIA (79%); SUB SAHARAN AFRICA (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 FINANCIAL TIMES LTD (65%);  CHICAGO TRIBUNE (61%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 July 7, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2004 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Business Times Singapore June 7, 2004 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_50}{\*\bkmkstart DOC_ID_50_0}{\*\bkmkstart doc_id_21}{\*\bkmkend DOC_ID_50}{\*\bkmkend DOC_ID_50_0}{\*\bkmkend doc_id_21}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_21"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 21 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Indian drug firms stand to gain much from }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955  talks;\par Potential to carve out slice of US$15b US generics market}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 June}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  7, 2004 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par Yogi Aggarwal in Bombay\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 A HUGE opportunity awaits Indian pharmaceutical companies - if India plays its cards right during the u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 coming World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ) negotiations.\par A research report by investment bankers JM Morgan Stanley says Indian companies have opportunities in the US$15 billion generics market in the US, and can also expect to capture a part of the US$33 billion ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ket in challenging patents for drugs that have been unduly extended by US and European companies.\par Other segments where Indian companies could score is in novel drug delivery systems and subcontracting much of the research to develop new drugs.\par In a document called Vision 21, global consulting firm McKinsey & Co estimated the total market for Indian companies to be around US$25 billion by the end of the decade, up from around US$7 billion now. \par T R Gopalakrishnan, assistant secretary general of the Indian Drug Manufacturers Association, the leading industry body, said: 'Everything boils down to the patent regime that is coming.\par 'If there are balanced patent laws that allow Indian companies to export freely as per the Doha Declaration (of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ) under conditions agreed upon under Trips (trade-related intellectual property rights), the going will be good. But non-trade barriers should not be allowed to distort trade.'\par Under the 1970 Indian Patent Act, pharmaceutical companies in India used 'reverse engineering' to man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 facture drugs to bypass US patent laws. This has enabled them to manufacture drugs for the Indian market at less than one-tenth the cost in the West.\par But multinational companies have vigorously opposed Indian companies' attempts to develop cheaper drugs, including anti-Aids drugs. Indian companies like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  could sell an anti-Aids drug in Africa for as little as US$250 for a year's treatment, compared to a cost to the patient of US$15,000 a year using Western form}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lations.\par William Haddard, a US expert on generic drugs, commented: 'The poor nations of the world now look to India to provide them with safe, effective and affordable medicines. But it is ironic that India, with enormous pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lems of its own, should be the hope of the Third World.'\par US and European pharmaceutical companies, meanwhile, have been furious at the enormous loss in profits, and the matter has not yet been fully settled despite the acrimony. With the rules of the game changing in 2005 - when patent laws are to be more strictly enforced - the fine print of the new rules will become more important.\par Some points of contention are compulsory licensing to manufacture drugs in developing countries in times of emergency, and whether the cut-off date for allowing the manufacture of patented drugs by third countries is 1995 or 2005.\par If India handles its case at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  well, there could be tremendous opportunities after 2005. Drugs with an annual sale of some US$55 billion to US$65 billion are going off patent in the next five years. But the patent holders can be counted on to try all manner of stratagems to extend the patent periods.\par Despite a price erosion to around one-forth the original price, the market is still worth around US$15 billion, and Indian companies should be able to capture at least part of this potential.\par Indian companies could also be a subcontractor for the testing of a new drug. It costs some US $600 million to US$900 million to develop a new molecule, much of this cost in testing. A McKinsey & Co. report says I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 dian companies could get a chunk of this by conducting clinical trials.\par Bioinformatics is also a very promising area with a market potential of US$2 billion. While India has been lax in exploiting the potential of its indigenous herbal systems of medicine, this could change in the next decade.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par  PHARMACEUTICALS INDUSTRY (94%); PHARMACEUTICAL PREPARATION MFG (93%); PATENTS (91%); TRADE DEVELOPMENT (91%); PHARMACEUTICALS ASSOCIATIONS (90%); PATENT LAW (90%); INTELLECTUAL PROPERTY LAW (90%); INTERNATIONAL TRADE (90%); PHARMACEUTICALS PATENTS (89%); GENERIC PRODUCTS (89%); INTERNATIONAL ECONOMIC ORGANIZATIONS (89%); AIDS & HIV TREATMENT (78%); DRUG DELIVERY SYSTEMS (78%); DRUG DESIGN & DISCOVERY (78%); EXPORT TRADE (78%); ENGINEERING (78%); MULTINATIONAL CORPORATIONS (78%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TELLECTUAL PROPERTY (78%); GENERIC DRUGS (78%); DEVELOPING COUNTRIES (78%); INVES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MENT BANKING (77%); CONSULTING SERVICES (74%); REVERSE ENGINEERING (71%); \par \par  CIPLA LTD (90%); MCKINSEY & CO INC (83%); MORGAN STANLEY (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 THE NEWS; South Asia\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 632 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 June 6, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2004 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Business Times Singapore September 2, 2003 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_51}{\*\bkmkstart DOC_ID_51_0}{\*\bkmkstart doc_id_22}{\*\bkmkend DOC_ID_51}{\*\bkmkend DOC_ID_51_0}{\*\bkmkend doc_id_22}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_22"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 22 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955  drug deal to spark competition}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 September}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  2, 2003 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par By RAVI KANTH IN GENEVA\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 THE landmark agreement to override patent provisions for addressing HIV/Aids, tuberculosis, and malaria in poor countries reached among 146 members of the World Trade Organization on Saturday is expected to result in intense competition among leading generic drug producers, analysts said.\par The historic deal will help poor countries avoid being drowned in complying with complex patent rules that provide monopoly-marketing rights to pharmaceutical giants such as Pfizer, Merck, and GlaxoSmithKline Wellcome.\par It would provide political and legal clarity to the use of what is called the compulsory-licensing instrument in the trade-related intellectual property rights , said Faisal Ismail, the South African trade envoy to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 . \par Under the agreement - in which Singapore's Ambassador to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 , Vanu Gopala Menon, played a major role - poor developing countries lacking manufacturing facilities to produce latest patented drugs could issue a compulsory licence to a third government that would enable its generic producers to supply the much-needed drug at affordable prices.\par Leading global generic drug producers in Canada, India, Brazil, Israel, the United States and Switzerland are expected to jump into fray once poor countries in Africa declare their intention to issue compulsory licences to manufacture the latest drugs for HIV/Aids, said a Geneva-based trade analyst. The compulsory licence allows }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  members to revoke the rights of a patent holder to address serious public health problems, but the existing law says that production under compulsory licensing must be predominantly for domestic co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sumption.\par To overcome this provision for poor countries with insufficient facilities to manufacture pharmaceutical pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ucts, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  members had to struggle hard for almost two years to arrive at Saturday's agreement.\par Asked whether Canadian generic companies would export medicines under this route, the Canadian amba}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sador to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 , Sergio Marchi, said he would imagine all generic producers would be able to compete for any compulsory licence issued under Paragraph 6 mechanism of the Doha Trips (trade-related intellectual pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 erty rights) and Public Health agreement.\par Intense competition between generic producers could lead to downward pressure on prices of most of the important life-saving drugs needed to combat HIV/Aids, an Indian pharmaceutical industry analyst said.\par Significantly, shares of leading India generic drug companies like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ranbaxy and Reddy Labs have ri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 en steadily over the last few days in anticipation of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  agreement.\par Rich countries such as the US, Japan, Canada, and the EU members cannot use this agreement as impor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ers, while nations like South Korea, Hong Kong, and Singapore among others voluntarily said they would not use it except in grave public health emergencies.\par However, Oxfam and MSF (Medicines sans Frontiers) criticised the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  agreement saying it watered down the goals set out in the Doha declaration and would make the implementation ineffectual.\par With tightened safeguards, the agreement would not help achieve the objective of letting poor countries gain easy access to cheap copies of patented medicines, said a representative of the Penang-based Third World Network.\par 'We do not agree with this, and we are confident that we could use the compulsory licensing provisions wit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 out much hindrance,' said Mr Ismail of South Africa.\par Until now, many countries found it difficult to use compulsory licence when faced with serious public health crisis because of arm-twisting by the US administration and its pharmaceutical companies, said a Geneva-based patent law analyst.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par  PHARMACEUTICALS INDUSTRY (91%); PHARMACEUTICAL PREPARATION MFG (91%); PATENTS (90%); LICENSING AGREEMENTS (90%); PATENT LAW (90%); AIDS & HIV (90%); INTELLECTUAL PROPERTY LAW (90%); GENERIC DRUGS (90%); DEVELOPING COUNTRIES (90%); INTERNATIONAL TRADE (90%); MALARIA (90%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); AIDS & HIV TREATMENT (89%); PHARMACEUTICALS PATENTS (89%); TRADE TREATIES & AGREEMENTS (89%); PUBLIC HEALTH ADMINISTRATION (89%); INDUSTRY ANALYSTS (89%); INTELLECTUAL PROPERTY (89%); EMBASSIES & CONSULATES (89%); BUSINESS FORECASTS (89%); INTERNATIONAL TRADE LAW (89%); TUBERCULOSIS (78%); EXPORT TRADE (78%); TREATIES & AGREEMENTS (78%); PHARMACEUTICALS TRADE (78%); IMPORT TRADE (78%); CONTROLLED SUBSTANCES CRIME (77%); GENERIC PRODUCTS (77%); PHARMACEUTICALS & BIOTECHNOLOGY REGULATORY CO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PLIANCE (76%); RELIEF ORGANIZATIONS (73%); EUROPEAN UNION (73%); MANUFACTURING FACI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ITIES (68%); CONSUMPTION (64%); \par \par  PFIZER INC (90%); GLAXOSMITHKLINE PLC (90%); CIPLA LTD (57%); RANBAXY LABORATORIES LTD (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 THE NEWS; World\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 610 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 September 1, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2003 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Cheap drug plan founders The Globe and Mail (Canada) August 30, 2003 Saturday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_52}{\*\bkmkstart DOC_ID_52_0}{\*\bkmkstart doc_id_23}{\*\bkmkend DOC_ID_52}{\*\bkmkend DOC_ID_52_0}{\*\bkmkend doc_id_23}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_23"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 23 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Globe and Mail (Canada)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  30, 2003 Saturday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Cheap drug plan founders}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WARREN GILES, Bloomberg News\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 REPORT ON BUSINESS: INTERNATIONAL; Pg. B6\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 544 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GENEVA \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  A U.S.-backed compromise meant to boost poor countries' access to inexpensive medicines threatened to unravel yesterday after the Philippines and as many as two dozen other nations put up last-minute obstacles.  \par  Philippine and other negotiators demanded "modifications" to a World Trade Organization agreement that would increase sales of generic drugs from countries such as India to the poorest nations in Africa and Latin America so that they could fight diseases such as AIDS and malaria. \par  "I'm very, very disappointed," }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  secretary-general Supachai Panitchpakdi said after negotiations broke off. Officials from the 146-nation }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  met late yesterday afternoon to try to resolve their differences, on the last day before they were scheduled to return to their individual capitals. \par  The impasse casts a shadow over broader }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  talks to give the global economy an $800-billion-a-year (U.S.) boost by lowering trade barriers on financial services and products from cars to chocolate. A deadlock over drugs may jeopardize progress on issues such as reducing rich nations' farm subsidies when trade mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 isters meet next month in Cancun, Mexico. \par  The compromise was meant to limit the ability of companies in larger poor nations, including India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ltd., to profit on sales to the poorest nations, such as Zambia or Bolivia, of drugs patented by companies such as Pfizer Inc. The Philippines said it objected to this restriction. \par  Carlos Perez del Castillo, Uruguay's ambassador to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  and the chairman of the governing council, said he's still aiming for an accord before the Cancun gathering. \par  "My bet is that there will be [an agreement] either before or at Cancun," European Union Trade Commi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sioner Pascal Lamy told French radio Station Europe 1. \par  Observers said that the compromise that the United States worked out with India, Kenya, South Africa and Brazil this week represented a reversal for the Bush administration from December, when the United States was the sole holdout to an agreement. \par  "We're back to the December text," said James Love, director of the Washington-based Consumer Project on Technology, which has lobbied for lower drug prices. "A lot of developing countries think this is the best deal they're going to get." \par  Negotiators are scheduled to return to their capitals this weekend, before travelling to the Mexico meeting, which begins Sept. 10, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  spokesman Keith Rockwell told reporters. \par  An agreement would clear the way for the poorest nations, such as Bolivia and Zambia, to buy cheap copies of medicine to fight health epidemics. Sub-Saharan Africa is home to almost 30 million of the 42 million pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ple worldwide with AIDS or HIV. \par  Even as it held out in December, the Bush administration had pledged not to oppose at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  any use by poor nations of patent infringement to treat medical emergencies and says it wants a deal that both helps the poor and protects the investments of the pharmaceutical companies. \par  American drug makers including Pfizer and Merck & Co. Inc. had feared that any loosening of patent rules could be interpreted to allow nations such as Brazil to override patents on medicines for non- infectious di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 eases such as asthma or cancer, and flood European and U.S. markets with cheap generics. \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 INTERNATIONAL ECONOMIC ORGANIZATIONS (92%); TRADE DEVELOPMENT (90%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TERNATIONAL TRADE (90%); AGRICULTURAL TRADE (90%); DEVELOPING COUNTRIES (90%); DI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 EASES & DISORDERS (89%); COMMERCE DEPARTMENTS (89%); AIDS & HIV (89%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 CALS PATENTS (78%); PHARMACEUTICALS INDUSTRY (78%); GENERIC DRUGS (78%); INTERN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TIONAL TRADE LAW (77%); MALARIA (76%); EPIDEMICS (76%); GENERIC PRODUCTS (76%); GLO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 B}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ALIZATION (75%); TRADE DISPUTES (75%); DRUG PRICES (73%); BANKING & FINANCE (72%); TRE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TIES & AGREEMENTS (72%); EUROPEAN UNION (71%); INTELLECTUAL PROPERTY LAW (70%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TENTS (70%); LOBBYING (68%); PATENT INFRINGEMENT (65%); GOVERNMENT GRANTS & SUBS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 DIES (57%); AGRICULTURAL SUBSIDIES (52%) trade; policy; drugs\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PFIZER INC (84%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANIZATION (94%) World Trade Organization\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PFZ (LSE) (84%); PFEB (BRU) (84%); PFE (NYSE) (84%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (84%); NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (84%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (84%); SIC2836 BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES (84%); SIC2834 PHARMACEUTICAL PREPARATIONS (84%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PASCAL LAMY (56%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UNITED STATES (95%); INDIA (94%); MEXICO (94%); PHILIPPINES (93%); AFRICA (93%); LATIN AMERICA (92%); ZAMBIA (92%); URUGUAY (79%); KENYA (79%); BRAZIL (79%); SUB SAHARAN AFRICA (79%); EUROPEAN UNION MEMBER STATES (77%) United States; Third World\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 September 16, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Illustration\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2003 The Globe and Mail, a division of CTVglobemedia Publishing Inc.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Business Times Singapore August 29, 2003 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_53}{\*\bkmkstart DOC_ID_53_0}{\*\bkmkstart doc_id_24}{\*\bkmkend DOC_ID_53}{\*\bkmkend DOC_ID_53_0}{\*\bkmkend doc_id_24}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_24"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 24 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Proposed }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955  deal set to bring hope to poorer nations;\par It calls for relaxing patent provisions, issuing of licences to producers in poorer nations}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  29, 2003 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par Ravi Kanth\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PREPARATIONS are set for a final and long delayed humanitarian deal at the World Trade Organization to allow poor countries to relax patent provisions on latest medicines and issue licences to generic producers in India and Brazil to supply them at affordable prices.\par 'We are hoping to have a deal by the end of the day,' said the architect of the proposed deal, Singapore A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 bassador to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Vanu Gopala Menon.\par Ensuring poorer states unable to manufacture medicines can import cheap generic drugs when they need to is seen as vital to beating major killers such as Aids and malaria. But it also means setting aside patent laws protecting multinational firms. \par Agreement is crucial for the success of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  current Doha Round of free trade talks, which is due to be discussed at a major summit in the Mexican city of Cancun next month.\par Over the last five months, Mr Menon, who now heads the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Intellectual Property Council, quietly worked behind the scenes to resolve the differences between the key players such as the US, the European Union, India, Brazil, and South Africa for implementing the Doha Agreement on trade-related intellectual property rights (TRIPS) and Public Health.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  members are expected to endorse the statement that Mr Menon had prepared to bring the US on the board.\par The leading US pharmaceutical companies, particularly Pfizer, were unhappy with the proposed agreement and forced their government to block the deal last year on the ground that it would be abused by generic producers like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  and Ranbaxy in India to produce cheap copies of Viagra and other profit-making drugs.\par Except for the US, the entire }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  membership had approved a draft deal last year to implement the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 plex 'paragraph six' mechanism requiring countries lacking manufacturing facilities to transfer their compuls}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ry licences to generic producers in India and Brazil for supply of affordable medicines.\par Faced with severe public criticism and the outbreak of Sars (severe acute respiratory syndrome) and A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 thrax, the Bush administration was forced to give up its strident opposition to this agreement.\par The final three-page chairman's statement that Mr Menon issued late on Wednesday evening to members lists the 'the good faith' intentions for members to follow during the implementation of the 'paragraph six' mechanism. It would ensure that the proposed Doha agreement on TRIPS and Public Health is not pursued for 'industrial or commercial policy objectives'.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par  INTERNATIONAL ECONOMIC ORGANIZATIONS (91%); PHARMACEUTICALS INDUSTRY (90%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TENTS (90%); TRADE DEVELOPMENT (90%); PHARMACEUTICAL PREPARATION MFG (90%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 LECTUAL PROPERTY LAW (90%); INTELLECTUAL PROPERTY (90%); INTERNATIONAL TRADE (90%); RESPIRATORY DISEASE (78%); TRADE TREATIES & AGREEMENTS (78%); TALKS & MEETINGS (78%); INTERGOVERNMENTAL TALKS (78%); PATENT LAW (78%); FREE TRADE TREATIES & AGREEMENTS (78%); PUBLIC POLICY (78%); GENERIC DRUGS (78%); LICENSES & PERMITS (77%); MALARIA (77%); MANUFACTURING FACILITIES (76%); MULTINATIONAL CORPORATIONS (73%); G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NERIC PRODUCTS (72%); APPROVALS (71%); EUROPEAN UNION (68%); SARS (61%); \par \par  PFIZER INC (58%); CIPLA LTD (58%); RANBAXY LABORATORIES LTD (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 THE NEWS; World\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 416 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 August 28, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2003 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Last-minute deal on cheap drugs: Late deal on cheap drugs The Guardian (London) August 28, 2003 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_54}{\*\bkmkstart DOC_ID_54_0}{\*\bkmkstart doc_id_25}{\*\bkmkend DOC_ID_54}{\*\bkmkend DOC_ID_54_0}{\*\bkmkend doc_id_25}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_25"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 25 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Guardian (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  28, 2003\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Last-minute deal on cheap drugs: Late deal on cheap drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Charlotte Denny and Sarah Boseley\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Guardian Home Pages, Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 757 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  An eleventh-hour deal to provide cut-price drugs for the world's poorest people was being finalised in Gen}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 va last night in an effort to save next month's trade summit in Cancun, Mexico, from collapse.\par  After being delayed for nine months by intense lobbying from US pharmaceutical companies, the agreement between key developing countries and Washington is meant to open the door for poor countries to import copies of life-saving drugs without running foul of global patent laws.\par  But fears expressed by US pharmaceutical companies, led by Pfizer, that relaxing the rules will open wes}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ern markets to a flood of copycat drugs, have forced poor countries to accept strict safeguards against smuggling.\par  The deal represents a climbdown for Washington, which has single-handedly blocked agreement at the World Trade Organisation's Geneva headquarters since December, demanding that the patent override be restricted to the poorest countries and for a limited list of diseases. \par  Agreement was secured after the US agreed instead to accept assurances from developing countries that they would not bend the rules for "commercial objectives".\par  Diplomats said a deal on drugs was the bare minimum needed to prevent the trade ministers' Cancun mee}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing turning into a rerun of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  disastrous Seattle meeting, which ended in chaos after African cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tries walked out. Even now, heated disagreements over agriculture and whether the liberalisation of trade should be extended into new areas are clouding last-minute preparations for next month's meeting.\par  Washington was under intense pressure to deliver a package on drugs for poor countries after concessions were promised at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  meeting in Doha, Qatar, in November 2001, as a way of getting the sceptical d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 veloping world on board.\par  The details were supposed to have been hammered out in Geneva by the end of last year, but the White House vetoed the proposed deal after heavy lobbying from US drug companies.\par  Aid agencies said America's intransigence had forced the developing world to accept a flawed agreement with significant hurdles for countries hoping to import cheap drugs from abroad.\par  Oxfam said last night that the draft agreement had left the world's poorest states dependent upon other countries standing up to the intense pressure from the US pharmaceutical industry. "This deal has been w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tered down so much that it isn't really anything to cheer about," said Oxfam's Michael Bailey.\par  Under current trade rules any country can override patents in its home market and authorise production of the generic equivalent - as the US threatened to do during the anthrax scare in 2001 to force down the price of treatment. But global trade rules prevent generic manufacturers from exporting to countries that do not have a domestic drug industry.\par  Under the deal, exporting countries would have to issue a compulsory licence overriding foreign patents, something the agencies fear they may be reluctant to do.\par  Ellen t'Hoen, of the volunteer doctors' organisation Medecins sans Frontieres, said the deal was disastrous. She said: "It poses so many hurdles and hoops to jump through that we are really worried it may not work at all.\par  "By continually demanding more restrictions, the US seems to be pushing for a watertight system so that no generic drugs ever get through to the patients in developing countries who desperately need them.\par  "(This) will, over time, lead to the complete drying up of availability of generic sources and will inevitably lead to increased drug prices."\par  The undertaking that the Doha get-out clause, allowing the overriding of patents, should not be used for commercial advantage meant that generics companies such as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  in India, which undercut the multin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tionals to offer Aids drugs for less than Dollars 300 (pounds 190) a year and forced the big companies to bring down their prices, would have no incentive to produce cheap copies.\par  "The drugs that we have access to now that are affordable are produced by commercial entities," Ms t'Hoen said. "We need more industrial activity and greater competition in the market. That is the mechanism which is being killed."\par  She blamed pressure from the US for "a text that is blatantly ridiculous", but also the EU for failing to join the closed discussions. "After all the rhetoric of (Pascal) Lamy (its chief trade negotiator), he is completely a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 sent from these talks," she said.\par  Notebook, page 22\par  Gordon Brown, page 25\par  guardian.co.uk/aids\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PFIZER INC (90%);   WORLD TRADE ORGANIZATION  (83%); WORLD TRADE ORGANIZ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANIZATION  (83%); WORLD TRADE ORGANIZATION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PFZ (LSE) (90%); PFE (NYSE) (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (90%); NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (90%); SIC2836 BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UNITED STATES (95%); MEXICO (93%); QATAR (92%); SWITZERLAND (91%); AFRICA (79%);   WASHINGTON, USA (79%);   SEATTLE, WA, USA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UNITED STATES (95%); MEXICO (93%); QATAR (92%); SWITZERLAND (91%); AFRICA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TRADE DEVELOPMENT (91%); PHARMACEUTICALS INDUSTRY (90%); DEVELOPING COUNTRIES (90%); INTERNATIONAL TRADE (90%); PATENTS (89%); EMERGING MARKETS (89%); EXPORT TRADE (89%); PHARMACEUTICAL PREPARATION MFG (89%); AGRICULTURAL TRADE (89%); GENERIC DRUGS (89%); INTERNATIONAL TRADE LAW (89%); IMPORT TRADE (89%); LOBB}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 Y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ING (89%); RELIEF ORGANIZATIONS (88%); GENERIC PRODUCTS (78%); POVERTY & HOMELES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NESS (78%); TALKS & MEETINGS (77%); GLOBALIZATION (76%); INTERNATIONAL ECONOMIC O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GANIZATIONS (76%); VETO (75%); SMUGGLING (73%); COMMERCE DEPARTMENTS (72%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 LECTUAL PROPERTY LAW (71%); PATENT LAW (70%); ANTHRAX (67%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 August 28, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2003 Guardian Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Americans seeking pledges on drug rules The Toronto Star August 26, 2003 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_55}{\*\bkmkstart DOC_ID_55_0}{\*\bkmkstart doc_id_26}{\*\bkmkend DOC_ID_55}{\*\bkmkend DOC_ID_55_0}{\*\bkmkend doc_id_26}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_26"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 26 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Toronto Star\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  26, 2003 Tuesday Ontario Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Americans seeking pledges on drug rules}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Warren Giles, Bloomberg News\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 BUSINESS; Pg. D02\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 238 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The United States is pressing poor countries to accept a new condition before agreeing to let them bypass drug patents to import copies of medical treatments for AIDS, malaria and other diseases, according to aid agencies including Oxfam.\par In December, the United States was the only member of the World Trade Organization to block an accord to ease the supply of essential medicines to poor countries. \par Washington says a pact may enable generic drug makers, such as India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ltd., to sidestep patents held by U.S. companies including Pfizer Inc. and Merck & Co. on other drugs, such as those used to treat obesity or hair loss.\par The administration of U.S. President George W. Bush is trying to secure guarantees from countries including Brazil, Kenya, South Africa and India that they won't apply the new agreement except for "humanitarian use" to fight AIDS, tuberculosis and malaria, according to Oxfam, Doctors Without Borders and the Third World Network. Treatments for illnesses such as cancer may be excluded.\par "The U.S. seems to be pushing for a watertight system so that no generic drugs ever get through to the p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tients in developing countries who desperately need them," Ellen 't Hoen, a spokesperson for Paris-based Doctors Without Borders, said in an e-mail. "We are really worried it may not work at all."\par Dave Hamill, a spokesperson for the U.S. mission to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  in Geneva, declined comment.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PHARMACEUTICALS INDUSTRY (91%); RELIEF ORGANIZATIONS (91%); AIDS & HIV TREATMENT (90%); PHARMACEUTICALS PATENTS (90%); DISEASES & DISORDERS (90%); PHA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MACEUTICAL PREPARATION MFG (90%); AIDS & HIV (90%); MEDICAL CHARITIES (90%); GENERIC DRUGS (90%); DEVELOPING COUNTRIES (90%); MALARIA (90%); CANCER (78%); INTERNATIONAL ASSISTANCE (77%); PHYSICIANS & SURGEONS (75%); TUBERCULOSIS (73%); US PRESIDENTS (73%); BARIATRICS (73%); INTERNATIONAL ECONOMIC ORGANIZATIONS (73%); OBESITY (72%); HAIR LOSS (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MRK (PAR) (91%); MRK (NYSE) (91%); PFZ (LSE) (91%); PFE (NYSE) (91%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (91%); SIC2834 PHARMACEUTICAL PREPARATIONS (91%); NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NOSTIC) MANUFACTURING (91%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (91%); SIC2836 BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES (91%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (91%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GEORGE W BUSH (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANIZATION  (84%); WORLD TRADE ORGANIZATION (84%); DOCTORS WITHOUT BORDERS  (83%); DOCTORS WITHOUT BORDERS (83%); THIRD WORLD NE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORK  (56%); THIRD WORLD NETWORK (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UNITED STATES (98%); INDIA (92%); KENYA (79%); BRAZIL (79%); SWITZERLAND (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GENEVA, SWITZERLAND (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GENEVA, SWITZERLAND (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MERCK & CO INC (91%); PFIZER INC (91%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (83%);   WORLD TRADE ORGAN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ZATION  (84%); WORLD TRADE ORGANIZATION (84%); DOCTORS WITHOUT BORDERS  (83%); DO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TORS WITHOUT BORDERS (83%); THIRD WORLD NETWORK  (56%); THIRD WORLD NETWORK (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 August 26, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2003 Toronto Star Newspapers, Ltd.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Uganda;3 Firms to Supply Cheap Aids Drugs Africa News May 8, 2003 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_56}{\*\bkmkstart DOC_ID_56_0}{\*\bkmkstart doc_id_27}{\*\bkmkend DOC_ID_56}{\*\bkmkend DOC_ID_56_0}{\*\bkmkend doc_id_27}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_27"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 27 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  8, 2003 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Uganda;\par 3 Firms to Supply Cheap Aids Drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 363 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The National Drug Authority has licensed three Indian companies to supply cheap Aids drugs, lawmakers heard yesterday.\par The head of drug registration at the National Drug Authority Francis Otim told a seminar organised for me}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 bers of the committee on Legal and Parliamentary Affairs that Ranbaxy Laboratories Ltd, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  Ltd and Hefero Drugs Ltd have been licensed, while five others are being appraised.\par Unfortunately, he said, a proposed patent law could bar Uganda from importing the cheap generic drugs from the Indian companies. \par "That is what we are fighting," Mr Otim said. "If government passes this law the way it is, it will exclude Uganda from using these cheap drugs."\par The seminar, held at the International Conference Centre in Kampala, was organised by Uganda Access to Essential Medicines Coalition to discuss the proposed patent law now before the Law Reform Commission.\par The United States Agency for International Development (USAID) is funding the exercise.\par The revelation followed fears from some of the MPs that if the law is not enacted, cheap but ineffective drugs could find their way here.\par "NDA does not in any way allow poor quality drugs to come into the market," Mr Otim said. "The companies we allow into the country do research. They are approved by the Medicine Control Authority of the UK and even the World Trade Organisation. So their quality is not any different from that of the companies in deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 oped countries."\par Ms Winnie Masiko (Rukungiri) said that government should instead provide incentives such as tax exem}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tions on packaging materials for local pharmaceuticals to manufacture drugs.\par "Many of these drugs, I hear are made from simple raw materials like plants," she said.\par The MPs also wondered why government is in such a hurry to enact the law yet }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  allows poor countries up to 2016 to enact it.\par "I get worried; most of our people use generic drugs," Ms Jane Alisemera (Bundibugyo) said. "If we are going to pass a law allowing the manufacturer to charge expensively, I look at a situation where our people can not even get an Aspirin. When we pass the law, it may make some of these drugs inaccessible."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AIDS & HIV TREATMENT (90%); GENERIC DRUGS (90%); LEGISLATORS (90%); INTELLE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TUAL PROPERTY LAW (78%); PHARMACEUTICALS INDUSTRY (78%); PATENTS (78%); CONFE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENCES & CONVENTIONS (78%); INTERNATIONAL ECONOMIC ORGANIZATIONS (77%); LEGISLATION (76%); PATENT LAW (76%); TRADE DEVELOPMENT (76%); INTERNATIONAL ASSISTANCE (74%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TERNATIONAL TRADE (74%); APPROVALS (73%); LICENSES & PERMITS (73%); GENERIC PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UCTS (73%); TAX LAW (73%); PHARMACEUTICALS PRODUCT DEVELOPMENT (73%); INTERNATIO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AL ECONOMIC DEVELOPMENT (68%); PACKAGING MATERIALS (64%); TAX INCENTIVES (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (84%); RANBAXY (NSE) (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (84%); SIC2834 PHARMACEUTICAL PREPARATIONS (84%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ING (72%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 FRANCIS OTIM (87%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 US AGENCY FOR INTERNATIONAL DEVELOPMENT (83%); WORLD TRADE ORGA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 IZATION  (54%); WORLD TRADE ORGANIZATION (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 UGANDA (95%); UNITED KINGDOM (79%); UNITED STATES (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 KAMPALA, UGANDA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HEFERO DRUGS LTD (73%); INDIAN COS (73%); INTERNATIONAL DEVELOPMENT CO (68%); RANBAXY LABORATORIES LTD (68%);  NATIONAL DRUG AUTHORITY (90%); WORLD TRADE ORGANISATION (68%); AGENCY FOR INTERNATIONAL DEVELOPMENT (53%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 May 8, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2003 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PanAfrica;Aids: Even With Discounts from Drug Firms, Generics Remain Far Cheaper Africa News May 5, 2003 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_57}{\*\bkmkstart DOC_ID_57_0}{\*\bkmkstart doc_id_28}{\*\bkmkend DOC_ID_57}{\*\bkmkend DOC_ID_57_0}{\*\bkmkend doc_id_28}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_28"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 28 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  5, 2003 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 PanAfrica;\par Aids: Even With Discounts from Drug Firms, Generics Remain Far Cheaper}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The East African\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1233 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 SEAN FLYNN, senior attorney at the Consumer Project on Technology (CPTech), a non-profit organisation in Washington DC that focuses on the impact of intellectual property protection on consumer interests, spoke to GICHINGA NDIRANGU on compulsory licensing in relation to the HIV/Aids pandemic\par What is the problem you are addressing?\par It is the lack of access to medicines needed to treat Aids. About 95 per cent of people who have HIV/Aids live in the developing world. Africa accounts for over 70 per cent of the world's Aids deaths and Aids is the leading cause of deaths in Africa. \par Since 1996, there have been antiretroviral (ARV) medicines that can cut Aids deaths by up to 70 per cent and allow people with Aids to live relatively normal lives. There are about 30 million people with Aids in Africa and between four and five million Africans need immediate access to ARV treatment or they will soon die. Yet, only 30,000-50,000 people in Africa have access to this treatment, including only about 7,000 in Kenya and 10,000 people in Uganda. We want to help increase the accessibility of treatment.\par How do you plan to do that?\par For there to be treatment, affordable medication must be available as well as effective health systems, sele}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tion of medicines through registration procedures and funding. CPTech's work focuses on expanding access to affordable medicines by attacking patent barriers that prevent low-cost/high-quality drugs from reaching African markets. We are helping citizen groups and government officials understand the flexibilities they have under national and international law to force patent holders to allow competition in the supply of life-saving products, thereby bringing the prices of the products down. Of course, to get the drugs to people who need them, the other barriers - health systems, drug registration and funding - need to be addressed.\par How can a government force a patent holder to allow competition?\par We are educating African decision makers on compulsory licensing. Patents are sets of rights granted by the government to an inventor to use and profit from an invention. Since the first international agreement regar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ing patents in the late 1800s, governments have always retained the right to allow others to use the patent without permission from the patent holder if the holder fails to serve the needs of the market on reasonable terms.\par The act of allowing another to use a patent without permission of the patent holder is called "non-voluntary use" or a "compulsory licence."\par The latest international agreement, the World Trade Organisation Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS), authorises governments to use compulsory licences for government use, to meet public emergencies or circumstances of extreme urgency (including health crises), as a remedy to anticompetitive practices or for any other public purpose, as long as certain procedures are followed.\par The Ministerial Conference of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  in Doha (2001) instructed states to interpret the TRIPS agreement "in a manner supportive of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  members' right to protect public health and, in particular, to promote access to medicines for all." Specifically, the Conference agreed that "each member has the right to grant compulsory licences and the freedom to determine the grounds upon which such licences are granted."\par Has competition affected the price of Aids drugs?\par In the past few years, several countries have allowed the manufacture of generic ARVs with the result that prices dropped. In 1998, multinational companies were charging about $12,000 per year for the cheapest ARV treatment - a combination of d4T+3TC+nevirapine. In 2000, Brazil began offering this triple drug ther}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 py for $2,767 annually after allowing local suppliers to make or import the medicines. By March 2001, Indian drug manufacturer }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  was offering a generic treatment for $350 and the brand name version had dropped to $727. Today, suppliers offer the treatment for as low as $200 per year.\par Are there other benefits of competition for the supply of medicines?\par Competition has multiple benefits. One of the most dramatic in the supply of ARV medicines has been the ability to compete to provide the most innovative product for developing countries.\par For example, none of the brand name companies provides a d4T+3TC+nevirapine treatment in a single pill because the drugs are patented by different companies and they do not work together. But several generic firms now provide these treatments in a single pill, allowing increased ease of administration.\par Having one company provide each drug has also caused shortages of supplies because when the supplier runs out of a product there are no alternatives, as has happened several times recently in Kenya.\par Another benefit may be the possibility that local production could begin to capture a share of the market, providing positive feedback effects in terms of employment and technology transfer.\par There is an argument that patents cannot be a problem in Africa because most ARVs are not patented in most countries in Africa?\par It is true that not all ARV drugs are patented Africa. The multinational pharmaceutical companies use this information to argue that patents are not a problem. But when one looks at which drugs are patented in Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ca, one finds that the drugs that are the cheapest to produce and the most effective to administer are widely patented.\par For example, a drug called Indinivir is only patented in two African countries. But it is very expensive to pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 duce and is not appropriate for many patients in Africa because you must consume at least two litres of w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ter each day (more in hot areas) to prevent kidney stones. The least expensive, easy to administer and most effective treatments are (AZT or d4T)+3TC+nevirapine. One or more of these drugs or combinations are p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 tented in 37 African countries.\par When should countries grant compulsory licences?\par To maximise the ability of competition in the supply of medicines to drive down prices and foster innovation, compulsory licences of right (a licence for any supplier to compete that can meet regulatory approval r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 quirements) should be granted whenever the number of people who need access to the medicines signif}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cantly exceeds those with access; or the patent holder has not implemented an automatic licensing pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 gramme for all qualified suppliers on reasonable terms (international standard of two per cent to five 5 per cent royalties on annual sales) or if the major barrier to access is price. These drugs have been available in the West since 1996. The time to act is now.\par Are discounts and donations by the brand companies not solving the problem?\par No. Even with the most recent discounts by GlaxoSmithKline last week, the generic price for ARVs remains far cheaper than those of the brand name companies. The drug company discounts do not reach the private sector where perhaps a majority of people receive treatment now, and where more could receive treatment if prices were low enough. In addition, the prices will not fall further unless competition is allowed.\par Finally, the other benefits of competition - incentives to innovate, an increase in the number of suppliers to avert shortages and an allowance of local production - will not occur through discounts and donations.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 GENERIC PRODUCTS (90%); HEALTH CARE ACCESS (90%); AIDS & HIV TREATMENT (90%); PHARMACEUTICALS INDUSTRY (90%); AIDS & HIV (90%); PHARMACEUTICAL PREPARATION MFG (89%); INTELLECTUAL PROPERTY LAW (89%); PATENTS (89%); NONPROFIT ORGANIZATIONS (89%); LICENSING AGREEMENTS (89%); PATENT LAW (78%); ANTIVIRALS (76%); DEATHS & DEATH RATES (76%); INTERNATIONAL ECONOMIC ORGANIZATIONS (74%); EPIDEMICS (72%); RESTRAINT OF TRADE (72%); INFECTIOUS DISEASE (72%); TRADE TREATIES & AGREEMENTS (71%); INTERN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TIONAL TRADE LAW (68%); TREATIES & AGREEMENTS (65%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANISATION (66%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 AFRICA (94%); UNITED STATES (92%); KENYA (79%); UGANDA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 DISTRICT OF COLUMBIA, USA (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 WORLD TRADE ORGANISATION (66%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 May 13, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2003 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Saving grace: Yusuf Hamied Generic drugs boss: He says he could save millions from death if the western giants would waive their patent rights and more governments would buy his drugs The Guardian (London) February 18, 2003 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\bkmkstart DOC_ID_58}{\*\bkmkstart DOC_ID_58_0}{\*\bkmkstart doc_id_29}{\*\bkmkend DOC_ID_58}{\*\bkmkend DOC_ID_58_0}{\*\bkmkend doc_id_29}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 HYPERLINK \\l"cite_id_29"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid1384955 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 29 of 29 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 The Guardian (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  18, 2003\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid1384955 Saving grace: Yusuf Hamied Generic drugs boss: He says he could save millions from death if the western giants would waive their patent rights and more governments would buy his drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Guardian Special Supplement, Pg. 8\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 1353 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  The drug barons consider him a pirate and a thief. Yusuf Hamied, a Cambridge-educated multi-millionaire who lives for the summer months in what used to be Lady Shirley Porter's London apartment, believes he is doing Ghandi's bidding. He manufactures perfect copies of many of the world's best and most important medicines and sells them at a snip. Dr Hamied and his family are certainly very rich but many poor people owe him their health, without which they would be destitute indeed.\par  The question of Dr Hamied's motivation is absorbing but at the end of the day irrelevant. What matters is that he exists. He single-handedly broke the cartel of the big drug companies by offering to supply Aids drugs at less than a tenth of their prices. That audacious offer at a big European Commission meeting on Aids in September 2000 ("you could hear the breath being sucked out of the room" said Bill Haddad, former New York Post investigative journalist turned US generics boss) made everything possible. The assumption that Aids drugs were not for the poor - that they could not afford them and therefore that there was no point even thinking about ways to get people treated - was blown out of the water. \par  Now, in the post-Hamied era, the genie will not go back in the bottle. The big drug companies have been forced to drop their prices for these new and powerful drugs and offer them to a market they had no interest in developing - the impoverished African states where a whole generation of parents, teachers and workers are dying.\par  Dr Hamied's prices are still lower - his Bombay-based company, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 , offers a three-drug cocktail for around Dollars 304 per year which used to sell for around Dollars 12,000 and would now cost Dollars 727 from the brand-name companies. And yet his sales are few in countries where the need is desperate. Fewer than 50,000 people are being treated out of nearly 30 million infected with the lethal HIV virus in Africa, and - although Malawi is buying them - most of those are not getting }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  drugs.\par  Part of the reason is money - Dollars 304 is still impossible in countries with a per capita income of under Dollars 200 a year. But another part of it is a fight-back by the US and Europe-based big-name pharmaceut}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 cal industry, which has long wanted to wipe the buccaneering generics companies off the face of the planet. Their long-term strategy to do that, through a World Trade Organisation agreement called Trips (trade rela}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ed intellectual property rights) - which will sign up every nation to protect patents on new drugs for 20 years - is now in jeopardy because of the Aids crisis and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  affordable medicines.\par  The drug giants have dropped their prices and argue that there is no need for generic piracy. But many of those who are concerned about the damage being wreaked on the economies of poor nations by a single virus have come to believe that it is not safe for the world to rely on voluntary price reductions by generous drug barons for desperately needed medicines to keep poor people alive and nations stable.\par  Campaigners in the US and Europe, as well as governments in developing countries, now see generics - or the threat of them - as the only way to get affordable medicines for all sorts of diseases that afflict the pop}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 lation of poor countries and damage their economies. Just over a year ago, they secured an exemption clause to Trips, called the Doha Declaration, which allows developing countries to ignore patents and buy generics in a health crisis. Now the fight is on to decide in which countries and for which diseases poor pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ple should be allowed cheap medicines - the US government, which champions the industry, wants to rule out such illnesses as asthma, diabetes and cancer and restrict the concession to the very poorest nations.\par  The crucial issue is whether the generics companies of India, Brazil and Thailand will be allowed to export to countries that cannot make their own cheap copies after the Trips patent rules bite in 2005. Unless they can, new drugs invented for Aids or other diseases will be untouchable and unaffordable in Africa for 20 years.\par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  was set up as an Indian solution to India's health problems by Dr Hamied's father in 1935 when war stopped medicines arriving from Europe. Its website features a picture of Ghandi expressing his delight at visiting "this Indian enterprise". In 1972, India passed a law which permitted medicines to be copied even if they were under international patent, as long as the process was not the same. There are now hundreds of generic companies in India - many of them tiny. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  is one of the biggest, with a market capitalisation, said Dr Hamied, of about Dollars 1.4bn. "I don't want to make money on Aids drugs," he says. "I make enough money on other things. On this particular issue, can't we all pool our resources? I make 800 drugs. If I don't make money on six, why should I worry?"\par  Dr Hamied runs a free cancer hospital in India. There are reasons to believe in his altruism. "I'm not going to take it with me, so I have to leave it here," he says. But there's no doubt he stands to win all ways round. His public stand has given }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  excellent publicity. The World Health Organisation has endorsed the quality of his generic Aids drugs and approved his factories. And the fight over the Trips agreement could bring him a lot more business not only from the poorest countries but - and this is why the research-based companies are fighting so hard - also the massive developing markets of China and South America.\par  Dr Hamied, though, is frustrated. He is disappointed with the governments of Aids-hit nations, who are not placing orders for his drugs. "It is a joke," he says. "I should have the demand. Demand creates the incentive to produce, but with only 50,000 in the whole of Africa, where is the demand?"\par  If demand grew as fast as the spread of the virus, he could not keep pace. He would like to see countries set up their own generics factories, and he has offered to show them how to produce Aids drugs for free. The Global Fund should put up the money, he says. None of that is happening. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  sells a three-drug cocktail in one pill, called Triomune, to be taken twice a day, which makes treatment much easier in poor countries. Malawi buys it for the couple of thousand patients who can afford to pay Dollars 28 a month, but its Dollars 196m from the Global Fund will only buy treatment for 50,000 more.\par  Dr Hamied will shortly launch the world's first once-a-day, three-drug treatment, called Odivir. It's clearly well suited to poor countries and it will be affordable, he says, but there's no reason to suppose it will be taken up where his other drugs have not been. "India has four million cases and I'm breaking my head to make my government take a more active role," he says. "I offered totally free nevirapine (to prevent babies being i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 fected by their mothers at birth) and nobody takes it. It is up to the various governments to avail (themselves) of the opportunities offered. What has really saddened me is, firstly, the governments and, sec ondly, I have been totally disillusioned by the UN who talk, talk, talk and do nothing at all."\par  What, apart from lack of money in the poorest, is stopping the governments biting }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  hand off? The research-based pharmaceutical industry would say the political will is not there. But patents have been an issue. In Ghana, for instance, says Dr Hamied, it was GlaxoSmithKline that challenged the decision to import generic versions of drugs which were under patent there.\par  But there are countries where Aids drugs are not patented. According to Bill Haddad, who has voluntarily taken up }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  cause in the US, "the governments are too scared of the US government to buy generics". The US trade representative bats for the giant pharmaceutical companies. Whatever the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  trade rules say about allowing countries to buy generics in a health crisis, he suggests, there are those who would rather not risk the wrath and possible sanctions of the US.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  LTD (82%);   EUROPEAN COMMISSION  (56%); EUROPEAN COMMISSION (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 EUROPEAN COMMISSION  (56%); EUROPEAN COMMISSION (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid1384955 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955  (NSE) (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (82%); SIC2834 PHARMACEUTICAL PREPARATIONS (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 EUROPE (92%); AFRICA (92%); UNITED STATES (79%); MALAWI (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 EUROPE (92%); AFRICA (92%); UNITED STATES (79%); MALAWI (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 PHARMACEUTICALS INDUSTRY (90%); WEALTHY PEOPLE (90%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ERTY LAW (90%); GENERIC DRUGS (90%); AIDS & HIV TREATMENT (89%); PHARMACEUTICALS P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TENTS (89%); PATENTS (83%); PHARMACEUTICALS ASSOCIATIONS (78%); CONTROLLED SU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 B}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 STANCES CRIME (78%); AIDS & HIV (78%); INTELLECTUAL PROPERTY (78%); TRADE DEVELO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 MENT (73%); TALKS & MEETINGS (73%); GENERIC PRODUCTS (73%); INVESTIGATIONS (72%); CA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 TELS (69%); TREATIES & AGREEMENTS (50%); VIRUSES (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 February 18, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid1384955 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 Copyright 2003 Guardian Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0\afs24 \ltrch\fcs0 \fs24\insrsid1384955 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid1384955 \par }{\*\themedata 504b0304140006000800000021009be8704ffc0000001c020000130000005b436f6e74656e745f54797065735d2e786d6cac91cb6ac3301045f785fe83d0b6d872ba28a5d8cea28f5d1f8bf40306796c8bd823214d42f2f71d3b2e941202856e04d2ccbdf7cca85c1fc641ed3126e7a9d2abbcd00ac9fac65157e9cfcd4b76af5562a006064f58e92326bdaeafafcacd316052a2a654e99e393c18936c8f23a4dc0724a9b43e8ec0728d9d0960b7d0a1b92d8a3b633d3112673c79e8ba7cc2167603abe7833c9f4844aed5e3a96f8aaa348430380b2ca066aa9ab3ba8843ba20dc53f38b2e5bc87251cee6a97721dd2c09efb29ae81a541f10f90d46e1302c43e2cff31548468bf965e633d1be6d9dc5c6dbdd28ebc867e3c5ec4f00abff89fece34f3dfd65f000000ffff0300504b030414000600080000002100a5d6a7e7c0000000360100000b0000005f72656c732f2e72656c73848fcf6ac3300c87ef85bd83d17d51d2c31825762fa590432fa37d00e1287f68221bdb1bebdb4fc7060abb0884a4eff7a93dfeae8bf9e194e720169aaa06c3e2433fcb68e1763dbf7f82c985a4a725085b787086a37bdbb55fbc50d1a33ccd311ba548b63095120f88d94fbc52ae4264d1c910d24a45db3462247fa791715fd71f989e19e0364cd3f51652d73760ae8fa8c9ffb3c330cc9e4fc17faf2ce545046e37944c69e462a1a82fe353bd90a865aad41ed0b5b8f9d6fd010000ffff0300504b0304140006000800000021006b799616830000008a0000001c0000007468656d652f7468656d652f7468656d654d616e616765722e786d6c0ccc4d0ac3201040e17da17790d93763bb284562b2cbaebbf600439c1a41c7a0d29fdbd7e5e38337cedf14d59b4b0d592c9c070d8a65cd2e88b7f07c2ca71ba8da481cc52c6ce1c715e6e97818c9b48d13df49c873517d23d59085adb5dd20d6b52bd521ef2cdd5eb9246a3d8b4757e8d3f729e245eb2b260a0238fd010000ffff0300504b030414000600080000002100215aa28421070000db1d0000160000007468656d652f7468656d652f7468656d65312e786d6cec594f6f1b4514bf23f11d467b2fb113274da23a55ecd80db469a3d82dea71bc3bf64e33bbb39a1927f10db547242444411ca8c48d03022ab51297f269024550a47e05deccecae77e271939400153487d63bfb7b6fdefbbd3ff367af5c3d4a183a2042529e3683fa7bb5009134e4114d47cde076bf7b69354052e134c28ca7a4194c880cae6ebcfbce15bcae62921004f2a95cc7cd20562a5b5f5890210c63f91ecf480aef865c2458c1a3182d44021f82de842d2cd66a2b0b09a66980529c80da5bc3210d09ea6b95c146a1bcc3e03155520f844cf4b46ae248186cb45fd70839916d26d00166cd00e689f8619f1ca900312c15bc680635f3172c6c5c59c0ebb9105373642b725df397cbe502d1fea299538c06e5a4f56e63edf256a9df00989ac5753a9d76a75eea33001c86e0a9b5a5aab3d15dadb70a9d1590fd39abbb5d5bae355c7c45ffd28ccd6bad566b792db7c52a3520fbb331835fadad3436171dbc0159fcf20cbed1da6cb7571cbc0159fcca0cbe7b796da5e1e20d286634dd9f41eb8076bbb9f61232e46cdb0b5f05f86a2d874f51900d6576e929863c55f3722dc1f7b8e8024003195634456a9291210e218bdb98d181a07a02bc4e70e58d1d0ae5cc909e0bc950d04c35830f320c1531d5f7f2d9772f9f3d41c7f79f1edffff1f8c183e3fb3f58458ed4364e4755a917df7cfac7a38fd0ef4fbe7ef1f0733f5e56f1bf7cfff1cf3f7de60742f94ccd79fec5e35f9f3e7efee527bf7dfbd003df14785085f7694224ba490ed11e4fc031c38a6b391988f349f4634cab129be948e214eb593cfa3b2a76d0372798610fae455c06ef08681f3ee0b5f13dc7e05e2cc62a8fb7e3d9f53871803b9cb316175e16aeebb92a34f7c7e9c83fb91857717b181ff8e66ee3d4896f679c41dfa43e95ed983866ee329c2a3c22295148bfe3fb8478f8ba4ba9c3eb0e0d05977ca8d05d8a5a987a29e9d381934d53a16d9a405c263e0321de0e373b77508b339fd75be4c045425560e631be4f9843e3353c5638f1a9ece3845509bf8155ec33b237116115d7910a223d228ca34e44a4f4c9dc12e06f25e8d7a175f8c3bec326898b148aeefb74dec09c57915b7cbf1de324f3617b348dabd8f7e53ea42846bb5cf9e03bdcad10fd0c71c0e9dc70dfa1c409f7e9dde0361d39264d1344bf190b4f2caf11eee46f6fc286989856034ddde9d5094d5fd5b813e8dbb9e317d7b8a1553effea91c7ee37b5656f0209be9ad93ed1a8e7e14eb6e73617117df3bbf3161ea7bb040a6276897adb9cdf36e7e03fdf9ce7d5f3c5b7e469178606adb74c76a36db6ddc9dc5df79032d65313466e48b3f196b0f6445d18d472e6c449ca535816c34f5dc93081831b096c6490e0ea43aae25e8c33d8b4d703ad642473d52389322ee1b06886bdba351e36feca1e3597f521c4760e89d50e8fecf0921e2ece1aa51a63d5c81c688b8996b482b34eb67439570abebdce64756dd49967ab1bd34c5374662b5dd6149b4339505eba0683259bb0a941b015029657e0ccafa786c30e6624d2bcdb1815613151f87b42947b6d1d8971446c889ce10a9b7513bb228566fcd3eed91c391f9b256b40dae94698b4989f3f6724b950302519044f56134babb5c55274d80cd69617970314e2ac190ce1980b3f930c8226f53610b311dc15854ad8ac3db5164d914e3d5ef367551d6e2ee6148c53c699906a0bcbd8c6d0bcca43c5523d93b57f71b9a193ed621cf03493b359b1b40a29f2af5901a176434b864312aa6ab02b239a3bfb9877423e5644f4e2e8100dd858ec61083f70aafd89a884db0a53d0fa01aed634dbe695db5bf34e53bdd032383b8e5916e3bc5beaab99a2e22cdcf493d206f354310f7cf3da6e9c3bbf2bbae22fca956a1affcf5cd1cb015c1e2c453a0221dcec0a8c74a534032e54cca10b65310dbb02d67dd33b205be07a165e03f970bf6cfe17e440ff6f6bceea30650d6740b547474850584e542c08d985b664b2ef1465f57ce9b12a59aec86454c55c9959b307e480b0beee812bba070728865437dd246f03067732ffdce7bc820623bd47a9d69bd3c9caa5d3d6c03fbd71b1c50c4e9dd84be8fc2df82f4d2c57f7e9ea67e58d78b146561dd12fa6bba4465115cee2b7b6964ff59a269c6501aeacb5b663cd78bcb85c1807519cf51806cbfd4c06574048ff03eb1f1521b31f2bf482dae77bd05b117c7bb0fc21c8ea4bbaab4106e906697f0d60df63076d32695596da7ce7a3592b16eb0bdea896f39e205b5b7696789f93ec7213e54ee7d4e245929d33ec706dc7e6520d913d59a230342cce212630e62b57f543141fdc83406fc195ff98d94f533283275307d9ae30d935e0d124ffc9a45d706dd6e9338c46b2748f0c118d8e8af347c9842d21fb79a4d8221bb416d389560a2ef90e0dae608ed7a276b52c85174f172e25ccccd0b24b617397e653001fc7f2c6ad8f7680b74dd67aad8bab608aa57f85b23318efa7cc7bf2392b65f6a0f8ca40bd0665eae8d594e54c0179b389079f370586a357cff45f58746ca69b94ddf8130000ffff0300504b0304140006000800000021000dd1909fb60000001b010000270000007468656d652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73848f4d0ac2301484f78277086f6fd3ba109126dd88d0add40384e4350d363f2451eced0dae2c082e8761be9969bb979dc9136332de3168aa1a083ae995719ac16db8ec8e4052164e89d93b64b060828e6f37ed1567914b284d262452282e3198720e274a939cd08a54f980ae38a38f56e422a3a641c8bbd048f7757da0f19b017cc524bd62107bd5001996509affb3fd381a89672f1f165dfe514173d9850528a2c6cce0239baa4c04ca5bbabac4df000000ffff0300504b01022d00140006000800000021009be8704ffc0000001c0200001300000000000000000000000000000000005b436f6e74656e745f54797065735d2e786d6c504b01022d0014000600080000002100a5d6a7e7c0000000360100000b000000000000000000000000002d0100005f72656c732f2e72656c73504b01022d00140006000800000021006b799616830000008a0000001c00000000000000000000000000160200007468656d652f7468656d652f7468656d654d616e616765722e786d6c504b01022d0014000600080000002100215aa28421070000db1d00001600000000000000000000000000d30200007468656d652f7468656d652f7468656d65312e786d6c504b01022d00140006000800000021000dd1909fb60000001b0100002700000000000000000000000000280a00007468656d652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73504b050600000000050005005d010000230b00000000}{\*\colorschememapping 3c3f786d6c2076657273696f6e3d22312e302220656e636f64696e673d225554462d3822207374616e64616c6f6e653d22796573223f3e0d0a3c613a636c724d617020786d6c6e733a613d22687474703a2f2f736368656d61732e6f70656e786d6c666f726d6174732e6f72672f64726177696e676d6c2f323030362f6d61696e22206267313d226c743122207478313d22646b3122206267323d226c743222207478323d22646b322220616363656e74313d22616363656e74312220616363656e74323d22616363656e74322220616363656e74333d22616363656e74332220616363656e74343d22616363656e74342220616363656e74353d22616363656e74352220616363656e74363d22616363656e74362220686c696e6b3d22686c696e6b2220666f6c486c696e6b3d22666f6c486c696e6b222f3e}{\*\latentstyles\lsdstimax276\lsdlockeddef0\lsdsemihiddendef1\lsdunhideuseddef1\lsdqformatdef0\lsdprioritydef99{\lsdlockedexcept \lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority0 \lsdlocked0 Normal;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 1;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 2;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 3;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 4;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 5;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 6;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 7;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 8;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 9;\lsdpriority39 \lsdlocked0 toc 1;\lsdpriority39 \lsdlocked0 toc 2;\lsdpriority39 \lsdlocked0 toc 3;\lsdpriority39 \lsdlocked0 toc 4;\lsdpriority39 \lsdlocked0 toc 5;\lsdpriority39 \lsdlocked0 toc 6;\lsdpriority39 \lsdlocked0 toc 7;\lsdpriority39 \lsdlocked0 toc 8;\lsdpriority39 \lsdlocked0 toc 9;\lsdqformat1 \lsdpriority35 \lsdlocked0 caption;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority10 \lsdlocked0 Title;\lsdpriority1 \lsdlocked0 Default Paragraph Font;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority11 \lsdlocked0 Subtitle;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority22 \lsdlocked0 Strong;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority20 \lsdlocked0 Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdpriority59 \lsdlocked0 Table Grid;\lsdunhideused0 \lsdlocked0 Placeholder Text;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority1 \lsdlocked0 No Spacing;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 1;\lsdunhideused0 \lsdlocked0 Revision;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority34 \lsdlocked0 List Paragraph;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority29 \lsdlocked0 Quote;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority30 \lsdlocked0 Intense Quote;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority19 \lsdlocked0 Subtle Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority21 \lsdlocked0 Intense Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority31 \lsdlocked0 Subtle Reference;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority32 \lsdlocked0 Intense Reference;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority33 \lsdlocked0 Book Title;\lsdpriority37 \lsdlocked0 Bibliography;\lsdqformat1 \lsdpriority39 \lsdlocked0 TOC Heading;}}{\*\datastore 010001000200000008000000556e6b6e6f776e00000000000000000000060000d0cf11e0a1b11ae1000000000000000000000000000000003e000300feff090006000000000000000000000001000000010000000000000000100000feffffff00000000feffffff0000000000000000fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfffffffeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff5200000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000002000500ffffffffffffffffffffffff0c6ad98892f1d411a65f0040963251e50000000000000000000000005a858f9c98eace01feffffff00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000100010000000000}}